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Abstract 
Infectious bronchitis virus (IBV) variants have wide tissue tropism and high pathogenicity which 
provides a unique opportunity to dissect the molecular mechanisms contributing these 
differences. After infection of chicken embryo kidney (CEK) cells infected with IBV strains 885, 
QX and M41, to establish the role of host response signature to envisage the tissue tropism and 
pathogenicity, the apoptosis and innate immune responses were investigated. The CEK cells 
infected with 885 and QX shown higher cell death rate than M41.  These differences in cell 
death rate were due to higher levels of apoptosis induction by 885 and QX as compare to M41. 
We found that up-regulation of toll like receptor 3 (TLR3), melanoma differentiation associated 
protein 5 (MDA5) and interferon beta (IFN-β) 9 hours after infection corresponded to IBV 
pathogenicity. In summary, higher apoptosis and elevated levels of TLR3, MDA5 and IFN-β 
expression correlates to pathogenicity of IBVs in kidney (CEK cells) tissues.  
To further analyse the differences in early host innate immune responses and apoptosis after 
IBV infection, we infected chicken tracheal organ cultures (TOCs) with IBV strains 885, QX and 
M41. We demonstrated that IBV strain M41 induced stronger innate immune response as 
indicated by up-regulations of TLR3, MDA5 and IFN-β and apoptosis than 885 or QX in TOCs. 
These observed effects suggest that higher apoptosis together with elevated levels of TLR3, 
MDA5 and IFN-β expression appears to be correlates to pathogenicity of IBVs in TOCs 
(respiratory tissue). 
For corroborating theses in vitro results further work involved the differential 
immunopathogenesis in chickens infected with IBV strains 885, QX or M41. We confirmed that 
the histopathological changes, proinflammatory and innate immune gene response could be 
induced to varied degrees, depending on the IBV strain. Essentially, our results indicates that 
higher upregulation of expression of proinflammatory cytokines (such as IL-6 and IL-1β) and  
lipopolysaccharide-induced tumor necrosis factor-alpha factor (LITAF) is induced by M41 in 
trachea and 885 and QX in the kidney, which seem to mainly coincide with tracheal and renal 
histopathological lesions caused by these strains, respectively. In addition, elevated levels of 
TLR3, MDA5 and IFN-β expression correlated with lesion severity in IBV infected trachea and 
kidney tissues. Overall, this study reports striking differences in the activation of host responses 
by diffrerent pathogenic IBV strains. 
Despite vaccination IBV 793B infections continue to be a major threat to the health of all types 
of chicken in many parts of the world. In this study, the immunopathogenesis of 793B serotype 
was comprehensively analysed after IBV infection either in vitro (CEK cells and TOCs) or in vivo 
(SPF chicks). In conclusion this study reports higher levels of apoptosis together with elevated 
TLR3, MDA5 and IFN-β expression in vitro which correlates to the pathogenicity of 793B in 
trachea and kidney in vivo. Furthermore, we observed that greater upregulation of 
proinflammatory cytokines (such as IL-6 and IL-1β) and LITAF is induced by 793B infection in 
trachea and kidney which appears to be partially implicated lesions caused by IBV. Our findings 
contribute to the underlying mechanisms of induction of host immune responses to IBV in SPF 
chicks in vivo as well as in vitro. 
The project aimed to assess the mucosal, cellular and humoral immune responses induced by 
two different infectious bronchitis virus (IBV) vaccination regimes and their efficacy against 
challenge by a variant IBV Q1. Day-old broiler chicks were vaccinated with live H120 alone 
(Group I) or in combination with CR88 (Group II).  Both groups were again vaccinated with CR88 
at 14 days of age (doa). One group was kept as a control (Group III). All groups were challenged 
oculo-nasally with a virulent Q1 strain at 28 doa, and their protection was assessed. Both 
vaccinated groups gave excellent ciliary protection against the Q1, though group II’s 
histopathology lesion scores and viral RNA loads in the trachea and kidney showed greater 
levels of protection compared to group I.  
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1.1 The disease 
Infectious bronchitis (IB) is an acute and highly contagious viral disease causing 
severe economic losses for those involved in the chicken industry. It was first 
reported by Schalk and Hawn as a respiratory infection prominent in chickens 
ranging from 2 days to 3 weeks of age, with a high mortality rate and on 
post-mortem revealing congested respiratory pathways of the bird (Schalk & Hawn, 
1931). Later a virus was established as the causative agent of this disease and 
named as infectious bronchitis virus (IBV) (Beach & Schalm, 1936). IBV has an 
incubation period of 24 to 48 hours and viral spread occurs rapidly among chickens 
in a flock by aerosol and mechanical means. The spread of infection between flocks 
on farms with in close proximity is also likely to occur by aerosol (Jackwood & de 
Wit, 2013). Since the virus has been reported to replicate in the chicken’s intestine 
(Ambali & Jones, 1990),  other routes of spread may include contact with faeces 
and fomites. Role of vertical transmission reported in case of IBV (Cook, 1971) is 
considered to be of little importance. 
It is accepted that chickens are the most significant natural hosts of IBV, however, 
there are some reports of genetically very similar coronaviruses causing enteric 
disease in turkeys (Cavanagh et al., 2001; Guy, 2000), and respiratory and kidney 
disease in pheasants (Cavanagh et al., 2002; Gough et al., 1996). Despite these IBV 
infection has also been detected in turkeys in Oman (Al-Shekaili et al., 2015) and  in 
apparently healthy ducks in China (Feng et al., 2012). 
IBV replicates in upper respiratory tissues, with infection of bronchi and severe 
disease in young animals. Some strains of IBV cause more systemic infections, 
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replicating in other tissues, including the kidney (causing nephritis), the oviduct 
(causing decreased egg production), and the gut (Ganapathy et al., 2012). It has 
been reported that the virus can cause infertility in male chickens (Boltz et al., 
2007). While chickens of all ages are susceptible, very young chicks exhibit more 
severe respiratory signs and much higher mortality than older birds (Raj & Jones, 
1997c). The severity of the clinical signs is influenced by several factors associated 
with the IBV (eg. strain, virulence and dosage), the host (eg. age, sex, type and 
immune status), the environment (eg. dust, ammonia and stress), management and 
biosecurity levels (Ganapathy, 2009). IBV respiratory infection causes characteristic, 
but not pathognomonic signs, such as gasping, coughing, tracheal rales and nasal 
discharge (Raj & Jones, 1997c). Puffy, inflamed eyes and swollen sinuses may 
occasionally be noticed and usually persist for 5 to 7 days and diminish within 10 to 
14 days (Raj & Jones, 1997c). Infected chickens can also appear depressed with a 
remarkable decrease in weight gain and food consumption within 3 days post 
infection (dpi) (Otsuki et al., 1990). Mortalities are usually low, possibly due to 
asphyxiation induced by the blocking of the lower trachea or bronchi by plugs of 
mucus (Raj & Jones, 1997c). In layers, IBV can cause egg production losses or 
quality decline with mild (Muneer et al., 1986) or no respiratory signs (Cook & 
Huggins, 1986). However, the severity of decline in egg production quantity and 
quality is strain dependent (Jackwood & de Wit, 2013). In broilers, mostly the 
nephritic form of IBV occurs (Butcher et al., 1989) and the stress of the disease 
reduces meat production by increasing the feed conversion ratio and reducing 
weight gain. These losses from production inefficiencies are usually of greater 
concern than losses from mortality. Mortality in broilers is economically significant 
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with peaks between 5 to 6 weeks, usually caused by secondary bacterial infection 
(Chandra, 1987). This association between IBV respiratory reactions and 
susceptibility to E. coli in chickens has been studied extensively (Avellaneda et al., 
1994; Cook & Huggins, 1986; Hopkins & Yoder, 1984; Smith et al., 1985). The 
damage caused by IBV to the tracheal epithelium facilitates E. coli invasion and 
multiplication leading to lesions or even death, causing a major clinical and 
economic impact especially in broilers (Hopkins & Yoder, 1984; Smith, et al., 1985). 
1.2 Infectious Bronchitis Virus 
1.2.1 Genome and protein 
IBV is a positive-sense single-stranded (ss) RNA virus of 120 to 160 nm in diameter 
and with typically large surface clubs of 20 nm, with heavily glycosylated spike 
projections (Figure 1.1). IBV belongs to Group 3 of the coronavirus genus within the 
Order Nidovirales and family Coronaviridae (Cavanagh, 2003). The IBV has a 
genome length of approximately 27.6 kilobases (kb) encoding both structural 
proteins; spike (S1 and S2), membrane (M), envelope (E), and nucleocapsid (N), and 
the non-structural proteins (Nsps) that are important for the proliferation or 
replication of the virus.  
The S proteins are found on the surface of the viral envelope has two cleaved 
forms, S1 and S2 with molecular weights of 92k and 84k, respectively. The S1 
subunit contained epitopes responsible for inducing neutralizing antibodies against 
IBV in chickens, while S2 is responsible for fusion of the virus with the host’s cells 
(Belouzard et al., 2012; Ignjatovic & Sapats, 2005). The S protein has also been 
associated with in vitro host cell specificity (Casais et al., 2003; Casais et al., 2001). 
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The M glycoprotein is embedded in the viral lipid bi-layer with a small protruding 
portion on the outer surface which is glycosylated on the N terminal domain 
(Rottier & Rose, 1987), while E protein is a scant protein and contains highly 
hydrophobic transmembrane N-terminal and cytoplasmic C-terminal domains. Both 
proteins are important for virus particle formation during replication specifically, 
the E protein has the role of forming cation-selective ion channels within the host 
membrane to enhance viral morphogenesis, assembly and apoptosis (Corse & 
Machamer, 2003; Wilson et al., 2004). 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1. Electron micrograph of an IBV virion showing the club-shaped 
projections. 
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The N protein surrounds the single stranded positive sense RNA genome of IBV 
forming a structure termed as ribonucleoprotein (RNP) (Jackwood & de Wit, 2013; 
Lai & Cavanagh, 1997). The N protein is generally localised within the cytoplasm of 
the host cell, but as a strategy to control host and viral transcription of subgenomic 
RNA, may also migrate to the host cell nucleolus (Hiscox et al., 2001). Coronavirus 
N-proteins including that of IBV also play a role in stimulation of cell-mediated 
immune responses against IBV infection in chickens due to the presence of multiple 
T lymphocyte epitopes located at its carboxylic terminus (Collisson et al., 2000; Seo 
et al., 1997). In addition, novel linear B-cells epitope peptides, which are conserved 
among avian coronaviruses, have also been mapped within the nucleocapsid 
N-terminal domain (Yu et al., 2010). 
IBV genome possesses two small nsp genes, 3 and 5, that express three (3a, 3b, and 
3c) and two (5a and 5b) gene products, respectively. These mature and 
intermediate products are involved in the genomic and subgenomic RNA synthesis 
(Ng & Liu, 1998, 2000) 
1.2.2 Virus replication 
IBV replication starts with the binding of S protein of the virus to receptors present 
in the cell membrane (Belouzard, et al., 2012). Thereafter host-cell dependent 
proteolytic cleavage of the viral S protein and the fusion of the viral envelope with 
the plasma membrane are observed. It is not clear if the virus is internalized by 
either receptor-mediated endocytosis or by fusion with the host cell membrane. 
After the entry and uncoating of the viral particle into the host cell, the (+)ssRNA of 
the virus is used as a template by the host polymerase to synthesizes the viral RNA 
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polymerase directly. The viral RNA polymerase uses the (+)ssRNA as a template for 
the production of a full length negative-stranded (-)ssRNA, which is used as a 
template to produce genomic and subgenomic RNAs (Zhao et al., 1993). For the 
production of subgenomic length RNA, the viral polymerase transcribes short 
leader sequences found at the 3’ end and allows for elongation either up to the 
first transcription-regulating sequence and stops synthesis, or to skip over this 
sequence to continue to elongate the nascent strand (Siddell & Snijder, 2008). The 
(-)ssRNA is used to synthesize the other proteins of the virus. The first step in virus 
assembly is the binding of N protein to viral RNA forming the helical nucleocapsid 
(Lai & Holmes., 2001), alongside the integration of the M and E proteins into the 
membrane of the endoplasmic reticulum (ER) of the host cell (Vennema et al., 
1996). Incorporation of the S protein occurs by interaction with M protein forming 
a S-M complex at the pre-Golgi complex (Nguyen & Hogue, 1997; Opstelten et al., 
1995). After budding, virus particles may undergo further morphologic changes 
within the Golgi, resulting in the appearance of mature virus particles (Salanueva et 
al., 1999). The virions are then transported to the cell surface via the Golgi 
transport apparatus, and released into extracellular space by exocytosis. 
1.2.3 Pathogenesis of IBV 
IBV is primarily epitheliotropic and has wide tissue tropism including respiratory, 
urogenital and digestive system (Ganapathy, et al., 2012; Ignjatovic et al., 2002).  
Although all IBV strains appear to infect the birds via the respiratory tract, later it 
finds favourite sites for further replication and persistence. The dissemination of 
IBV from the respiratory tract to other tissues is believed to occur through the 
process of viremia. Virus replication in ciliated epithelial and mucus-secreting cells 
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of the trachea (Nakamura et al., 1991; Owen et al., 1991; Yagyu & Ohta, 1990) and 
its isolation from trachea has been reported in many studies (Janse et al., 1994; Lee 
et al., 2002; Otsuki, et al., 1990). The persistence of virus in trachea is strain 
dependent. Infection by strain G in the upper respiratory tract shows the highest 
viral titres within 3 dpi and virus isolation was observed up to 14 dpi (Ambali & 
Jones, 1990). On the other hand IBV 793B was isolated from the trachea of infected 
specific pathogen free (SPF) chicks for up to 7 dpi (Raj & Jones, 1996a). Respiratory 
infection results in de-ciliation of the cells of the nares and trachea and inflamed 
lung tissue as well as thickened and cloudy air sacs along with the infiltration of 
mononuclear cells in the surrounding mucosal layers (Cavanagh, 2003). The 
tracheal damage in terms of ciliary activity is variable as it depends on the virulence 
of IBV strains involved (Otsuki, et al., 1990; Raj & Jones, 1997b). The severity of the 
ciliostasis caused by 793B strain proved to be the mild, while more severe effect 
was observed after M41 infection (Benyeda et al., 2009). Respiratory signs are 
characterized by nasal discharge, sneezing, rales, watery eyes, and lethargy, 
combined with reduction in feed consumption and weight gain (Jackwood & de 
Wit, 2013). In addition, nephritis caused by viral replication in the kidneys is not 
uncommon during IBV outbreaks. The damage to the kidneys occurs in infections 
with the nephropathogenic strains of IBV, with the virus targeting the lower 
nephron of the kidney down to the collecting duct epithelial cells for replication 
(Cavanagh et al., 1997). Furthermore, presence of high titres of the virus in the 
kidney does not correlate well with observed kidney disease, as Moroccan G strain 
replicated to similar titres in the kidney or trachea, though no gross kidney changes 
were observed (Ambali & Jones, 1990). These nephropathogenic strains produce 
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fewer respiratory signs (Ziegler et al., 2002) and lesions (Glahn et al., 1989) but can 
induce high mortality in younger birds (Cook et al., 2001; Liu et al., 2006). 
IBV can replicate in the epithelium of the oviducts in young chicks (Crinion & 
Hofstad, 1972b) and in laying hens (Jones & Jordan, 1971). IBV infection in young 
pullets can result in permanent damage to the oviduct, resulting in a significant 
decrease in both egg quality and numbers, and the production of “false” layers who 
are unable to lay eggs due the formation of cysts within the oviducts (Boltz et al., 
2004; Jones & Ambali, 1987). The pathology of IBV infection in the male 
reproductive tract has not been well documented. IBV has been identified in the 
testes of cockerels, indicating a potential expansion in the tissue tropism for some 
strains of IBV, and the resulting danger of infertility in males if replication of IBV 
occurred in the spermatozoa producing cells of the testes (Boltz, et al., 2004). 
As discussed earlier, IBV grows at many epithelial surfaces beyond the respiratory 
tract (Raj & Jones, 1997c) (reviewed by Raj & Jones, 1997). Although many 
alimentary tract tissues are susceptible to IBV, infection of enteric tissues usually 
does not manifest itself clinically (Cavanagh, 2003). IBV has also been isolated from 
various tissues such as lung, airsacs, oesophagus, proventriculus, duodenum, 
jejunum, liver, spleen, bursa of Fabricius, caecal tonsils, ileum, rectum, cloaca, 
semen and eggs (Ambali & Jones, 1990; Dolz et al., 2012; Lucio & Fabricant, 1990; 
Otsuki, et al., 1990) and virus isolation from the Harderian gland (HG) has also been 
reported following experimental infection with live attenuated H120 (Toro et al., 
1996).   
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1.3 Serotype and strain variation  
IBV strains have been classified into different serotypes based on the antigenicity of 
S protein. Traditionally serotyping has been performed using virus neutralization 
(VN) and haemagglutination inhibition (HI) tests (Toro et al., 1987) however, 
cross-reactions may occur between serotypes especially when sera are collected 
from field samples (Jackwood & de Wit, 2013). In addition to this some laboratories 
also use ELISA with monoclonal antibodies directed against specific epitopes of the 
S1 protein (Jackwood & de Wit, 2013). In recent years genotype classification based 
on the S1 region of the spike gene has become the most widely used method for 
IBV typing (Cavanagh et al., 1999; Jackwood et al., 1992; Lee et al., 2000), and 
replaced conventional HI and VN serotyping methods used for determining the 
identity of a field strain (Jackwood & de Wit, 2013). Genotype classification involves 
use of RT-PCR amplification of the S1 portion of the S gene. The cDNA is further 
confirmed by sequencing or RFLP analysis (Jackwood & de Wit, 2013). Despite 
these procedures being widely used in molecular epidemiology studies (De Wit, 
2000), the correlation between genotype and serotypes of IBV strains has been 
contradictory.  Strains of the same serotype tend to have S1 amino acid identity of 
≥90% however, not all isolates from the same genotype belong to the same 
serotype (Cavanagh et al., 1992). 
After the initial description of IB in 1931, to date, a wide range of different IBV 
serotypes and genotypes have been reported around the world (Jackwood et al., 
1997; Sjaak de Wit et al., 2011). The first isolate of IBV was the Beaudette strain 
(Beaudette & Hudson., 1937) and later, the M41 strain related to the Beaudette 
strain was isolated in the North Dakota, USA. Despite being first identified in USA, 
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the classical M41 serotype and the Dutch H120 serotype derived from a Dutch 
isolate of 1955 are the most widely used vaccine viruses (Sjaak de Wit, et al., 2011) 
Since then many different IBV variants have been isolated and characterised in 
different parts of the world.  
In the USA, the most commonly found type of IBV is Arkansas (Ark) (Jackwood, 
2012). Other commonly detected viruses in the USA are Connecticut (Conn) and 
Mass types (Jackwood et al., 2005). In Europe the majority of the strains are related 
to 4/91 (793B, CR88), Italy 02 and D274 (Capua et al., 1999; Cavanagh, et al., 1999). 
In recent years,  IBV QX first identified in China (Wang Y, 1998), appears to have 
spread among poultry flocks in many countries (Bochkov et al., 2006; Ducatez et al., 
2009; Terregino, Toffan, Beato, et al., 2008; Worthington et al., 2008) 
demonstrating a shift in geographical distribution and importance of the QX-like 
genotype. Another IBV genotype, the Q1, which was genetically and serologically 
distinct from IB classical strains, was reported in China from 1996 to 1998 (Yu et al., 
2001) and recently this Q1 IB strain has  also been identified in Europe (Toffan et 
al., 2011).  
1.4 Variation in virulence  
The evaluation of the pathogenicity of different IBV strains for the respiratory 
tissue has been found difficult to quantify (Cook et al., 1986). Cubillos et al. (1991) 
has reported differences in virulence of IBV strains for the trachea based on the 
variability of the tracheal damage in terms of ciliary activity in unvaccinated 
chickens. It has been suggested that the tracheal damage in terms of ciliary activity 
is variable since it depends on the virulence of IBV strains for the trachea (Otsuki, et 
al., 1990; Raj & Jones, 1997b). The severity of the ciliostasis caused by 793B strain 
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proved to be mild, while the effect of M41 was more severe (Benyeda, et al., 2009). 
However, there have been conflicting reports on the difference in virulence among 
IBV strains using this in vitro system. Cook et al. (1976b) did not find marked 
differences when compared three strains of IBV on the basis of their effect on 
tracheal cilia. Raj and Jones (1996b) also reported little difference among several 
IBV strains using measurement of ciliary activity as a criterion for damage to the 
tracheal epithelium. However, Abd El Rahman et al. (2009) have revealed that the 
strains differed in their efficiency to infect the tracheal epithelium. Infection by 
Beaudette and QX resulted in a larger number of infected cells compared to Italy 02 
and 4/91, when tracheal organ cultures (TOCs) were infected with the same 
amount of virus (Abd El Rahman et al., 2009).  
The severity of kidney lesions produced may vary depending on the IBV strains 
(Albassam et al., 1986; Chandra, 1987). However, using a model to titrate kidney 
infectivity by intra-venous inoculation, no differences were found in the infectivity 
among Belgian field nephropathogenic IBV isolates (Lambrechts et al., 1993).  
Variations among IBV strains in terms of the severity of egg production decline in 
quantity and quality have also been reported (Jackwood & de Wit, 2013). In 1986, 
Cook and Huggins reported that some variant strains of IBV which had a marked 
effect on egg color caused only small decreases in egg production (Cook & Huggins, 
1986). The Massachusetts and T strains were found to be virulent for the immature 
chicken oviduct while the Connecticut and Iowa 609 strains were not (Crinion & 
Hofstad, 1972a).  An in vitro study using oviduct organ culture (OOC) system has 
compared the virulence of seven strains of IBV by calmodulin assay (Raj & Jones, 
1996b). In this study, the isolate D207 was the most virulent while the enterotropic 
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G variant strain was the least virulent in terms of damage to oviduct epithelium (Raj 
& Jones, 1996b). 
1.5 Immunity against IBV  
1.5.1 Innate immunity  
The innate immune response is the first line of defence and comprises a set of 
mechanisms, molecules and cells that often non-specifically target invasive 
pathogens as they enter the potential host. This can be achieved through physical 
barriers provided by skin and mucous membranes, soluble factors such as 
complements and acute phase proteins, anti-microbial peptides, and leukocyte 
subsets such as heterophils, macrophages, natural killer (NK) cells, mast cells, 
basophils and eosinophils.  
One of the first reactive components of innate immunity against IBV infection is 
hyperplasia of goblet cells and alveolar mucous glands, leading to seromucous 
nasal discharge and catarrhal exudates in the trachea (Nakamura, et al., 1991). Five 
dpi, when a loss of cilia, epithelial degenerative changes and depletion of goblet 
cells and alveolar mucus glands have occurred, other immunological components 
become activated (Nakamura, et al., 1991). 
1.5.1.1 Pattern recognition receptors (PRRs)  
The PRRs are present on the cytoplasmic surfaces of immune cells, such as 
dendritic cells, macrophages, lymphocytes, and several non-immunological cells 
such as endothelial cells, mucosal cells, and fibroblasts. These cells rapidly 
recognize infectious agents through PRRs such as Toll-like receptors (TLR), retinoic 
acid-inducible gene 1 (RIG-I) like receptors (RLRs), and nucleotide-binding 
oligomerization domain (NOD) like receptors (NLRs). TLRs are one of the primary 
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mediators of the innate immune system, recognising conserved structures in a 
broad range of pathogens. In chickens, the currently known TLRs are TLR-1 LA, 
TLR-1 LB, TLR-2A, TLR-2B, TLR-3, TLR-4, TLR-5, TLR-7, TLR-15 and TLR-21 (St Paul et 
al., 2013). An increase in TLR-3 mRNA expression in tracheal epithelial cells after 
intranasal inoculation with IBV-M41 strain at 3 dpi has been reported (Wang et al., 
2006) and its function in viral immunology is well established (Le Goffic et al., 
2007). 
In another study, TLR-1 LA, TLR-1 LB, TLR-2, TLR-3 and TLR-7 gene expression were 
all significantly upregulated in the tracheal epithelial cells of 3 weeks old chickens 
immunised with attenuated IBV-Massachusetts (IBV-Mass) by intranasal 
inoculation (Guo et al., 2008). These studies have not shown whether host 
responses are elicited against IBV strains in lung tissue, though the lung is also a 
target organ for IBV. This was attempted in a more recent study (Kameka et al., 
2014), where 6-day-old SPF chickens were intra-tracheally infected with a 
Connecticut strain of IBV and thereafter, an up-regulation of TLR-3 and TLR-7 mRNA 
was identified in the trachea and lung. Conversely, down-regulation in the 
expression of TLR-3, along with IL-1β and IFN-γ, was also observed in the early 
phase (12 hpi) of viral replication. This early delay in induction of innate responses 
following infection was thought to be due to an increase in IBV genome load and 
worsening histopathological lesions in the trachea and lungs of IBV infected 
chickens. The chicken TLR-21 is a functional homologue of mammalian TLR-9 and 
after stimulation with deoxyoligonucleotides containing CpG motifs, it induces 
nuclear factor kappa-light-chain-enhancer of activated B cells (NFκ-B) production, 
leading to enhanced transcription of a number of cytokines (Brownlie et al., 2009). 
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A decrease in viral load has been reported after treatment of 18-day-old embryos 
with deoxyoligonucleotides containing CpG motifs prior to inoculation with IBV (Dar 
et al., 2009).  Melanoma differentiation-associated protein 5 (MDA 5) expression 
levels were reported to be significantly increased in chicken kidney tissue after 
nephropathogenic IBV infection, suggesting a role for chicken MDA5 against IBV 
infection (Cong et al., 2013).  In a more recent study, it has been shown that in vitro 
virulent IBV infection leads to a significant induction of INFβ transcription through 
an MDA5-dependent activation of the IFN response (Kint et al., 2015).  
1.5.1.2 Heterophils 
Activation of the innate immune response leads to the recruitment of phagocytic 
heterophils and macrophages.  Heterophils form the polymorphonuclear cell 
population of the chicken and are the primary phagocytic cells that are first 
recruited to the infection site during the early stages of IBV induced inflammation 
in chickens, along with other lymphocytes in the HG and trachea of IBV-infected 
tissues (Nakamura, et al., 1991; Raj et al., 1997; Toro, et al., 1996). The dramatic 
increase in heterophil numbers during IBV infection from 24-72 hpi has been 
reported in experimental studies by respiratory lavage analysis (Fulton et al., 1993). 
Although heterophils lack the expression of major histocompatibility complex 
(MHC) class I and II molecules seen in other chicken innate immune cells, they are 
highly phagocytic and express most of the TLRs found in chickens (Brune, 1972). 
Heterophils have been proposed to be responsible for the destruction of 
IBV-infected cells during initial infection by phagocytosis and oxidative lysozomal 
enzyme release (Fulton et al., 1997). This was supported by another study (Guo, et 
al., 2008), where an upregulation in the gene expression of heterophil cathepsin S 
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and bactericidal permeability-increasing protein (BPI) was detected in IBV-infected 
chicks. These antimicrobial cytotoxic molecules are released by heterophil 
degranulation to degrade and neutralize pathogens. The important role for 
heterophils in the chicken immune response is also evident as heterophil-depleted 
chickens infected with IBV showed more severe nasal exudation compared to 
controls (Raj, et al., 1997). In the tracheal epithelium however, heterophils did not 
reduce virus replication and worsened the severity of lesions  (Raj, et al., 1997).  
1.5.1.3 Macrophages  
Macrophage and monocyte chemotaxis to the area of infection is regulated by the 
production of chemokines by the other innate immune leucocytes. Information on 
the functional roles of macrophages in response to IBV infection is scarce. 
 It is clear that virus-induced cytolytic necrosis accounts for many of the 
pathological changes that are observed in IBV infections (Dar et al., 2005). 
However, an increase in the number of macrophages was found in spleens of 
chickens inoculated with IBV-M41 from 1 to 7 days post vaccination (dpv) (Dar, et 
al., 2005). Similarly, infiltration of macrophages into the tracheal and bronchial 
lumen of IBV-M41 infected chickens has also been reported when collecting 
respiratory lavage fluid between 24 and 96 hpi (Fulton, et al., 1993). A rapid influx 
of macrophages within hours post infection was also seen in the lung after 
individual or mixed avian pathogenic E. coli (APEC) and IBV infections (Matthijs et 
al., 2009). These findings were confirmed in a more recent study (Kameka, et al., 
2014), where macrophage numbers within the lungs and tracheas of chickens 
infected with Conn strain IBV were found significantly increased at 24 hpi 
compared to uninfected controls, suggesting that respiratory macrophages may 
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play an important role in limiting the replication of IBV within respiratory tissues. 
An upregulation in the gene expression of monocyte and macrophage signalling 
molecules has also been reported, including Spi-1/PU.1, glia maturation factor 
GMF-β and macrophage colony stimulating factor receptor M-CSFR in IBV-Mass 
infected chicks (Guo, et al., 2008). Spi-1 induces macrophage differentiation, GMF 
stimulates NF-κB, GM-CSF and CD4-/CD8+ cell differentiation and M-CSF is a key for 
macrophage linage development (Garceau et al., 2010).  
Unlike certain other avian viral respiratory infections, IBV was initially reported to 
have no effect on macrophage-mediated phagocytosis of serum opsonised E. coli 
(Naqi et al., 2001). Macrophages isolated from peripheral blood or the respiratory 
tracts of chickens infected with IBV-M41 showed effective phagocytic activity or 
bactericidal function for E. coli in vitro (Naqi, et al., 2001). However, IBV was later 
shown to lower the bactericidal activity of peripheral blood mononuclear cells 
(PBMCs) and splenocytes, though their phagocytic capacity and recruitment 
remained unaffected (Ariaans et al., 2008). 
1.5.1.4 Dendritic cells  
Dendritic cells (DCs) are members of the mononuclear phagocytic system. Innate 
activation of a variety of these cell subsets can increase their capacity to interact 
with T cells , the most important of these  being the DC subsets (Helle R. Juul-
Madsen et al., 2014). DCs play an important role in the initiation of the adaptive 
immune response, being the only cells that can activate naive T cell subsets by 
virtue of their high levels of MHC molecules and co-stimulatory activity (e.g., 
expressing CD80/86) (Helle R. Juul-Madsen, et al., 2014). Still little is known about 
the function and migration of chicken DCs (Wu et al., 2010).  In recent years, with 
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the emergence of new chicken DCs markers, it has become increasingly possible to 
culture chicken DCs in vitro (Fu et al., 2014; Wu, et al., 2010). However, currently 
no publications are available on the nature of IBV interactions with chicken DCs.  
Hence, further characterization and studies on this cell may yield important 
immunological mechanisms conferring protection against virulent or vaccine strains 
of IBV. 
1.5.1.5 Natural killer cells 
Natural killer (NK) cells are cytotoxic lymphocytes that play a key role in the early 
defence against viral infections. As opposed to in mammals, NK cells are found in 
very low numbers in the spleen or peripheral blood of birds (Göbel, 2001). The role 
of NK cells in IBV infection has not been studied extensively. It was initially reported 
that an IBV vaccine designated as the Holland strain, Mass serotype, had caused no 
alterations in NK cell activity (Wakenell et al., 1995). However, it was later shown 
that infection of chickens with IBV-M41 induced rapid NK cell activation in the lung 
and blood (Vervelde et al., 2013). Five week old chickens receiving IBV-M41 via 
intratracheal and intranasal routes showed an increase of CD107+CD3- NK cells in 
the lungs only on 1 dpi, whereas the change of NK cells in PBMC levels was biphasic 
with an increase on 1 and 4 dpi but not 2 dpi.  
1.5.1.6 Acute phase proteins 
In general, inflammatory cytokines and chemokines stimulate the production of 
acute phase proteins (APP) in chickens, including αI acid-glycoprotein (AGP), 
mannose binding lectin (MBL), transferrin-ovotransferrin (OVT), fibrinogen and 
C-reactive protein. AGP has various biological activities, including 
immunomodulation of the inflammatory response, and its concentration has been 
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recorded to increase during IBV infection (Asif et al., 2007). MBL plays a role in the 
innate immunity against IBV through an acute phase response, whereby it is able to 
activate complement and inhibit the propagation of the virus in the trachea (Juul-
Madsen et al., 2007). MBL has also been found to be associated with increased 
disease severity after IBV infection, as lower levels of MBL in serum lead to 
increased replication of IBV in chickens (Juul-Madsen et al., 2011). Another recent 
study by Kjaerup et al. (2014) has shown that MBL has the capability to bind to IBV 
in vitro and is involved in the immune response to IBV vaccination. In their study, 
two inbred lines (L10H and L10L) selected on the basis of high or low MBL serum 
concentrations, respectively, were vaccinated against IBV with and without the 
addition of the MBL ligands mannan, chitosan and fructooligosaccharide (FOS). The 
addition of MBL ligands to the IBV vaccine, especially FOS, enhanced the 
production of IBV-specific IgG antibody in L10H chickens, but not L10L chickens 
after the second vaccination, suggesting that MBL is involved in the immune 
response to IBV vaccination. Elevated levels of OVT in serum, which is a moderate 
APP, have also been documented after challenge with IBV (Xie et al., 2002).  
1.5.1.7 Complement system 
The complement system, as a component of innate immunity, is immediately ready 
to target and eliminate virus particles and to interact with the surface of virus 
infected cells (Baelmans et al., 2006). The trachea of IBV-Mass infected chickens 
demonstrated an increase in the gene expression of C1q, C1s, anaphylatoxin C3a 
receptor and complement C4, and a down-regulation in factor H (an inhibitor of the 
complement system) (Guo, et al., 2008). C1q and C4b mediate opsonisation and the 
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activation of the classical pathway of the complement system whilst C3a and C4a 
elicit local inflammatory responses to limit infection (Guo, et al., 2008).  
1.5.1.8 Cytokines 
Cytokines are crucial regulators of the immune system (both innate and adaptive), 
and bind to specific cell surface receptors to initiate cascades of intracellular 
signalling for specific cell functions (Kruth, 1998). The infection of chicken with 
attenuated IBV-Mass elicited the gene expression of IL-1β (10.8-,5.5-, 2.1-, and 
2.5-fold for 1, 3, 5, and 21 dpi), IL-10R2 (6.9-, 2.4-, and 2.3-fold for 1, 3, and 12 dpi), 
and common cytokine receptor g (increased 2.4-, 4.0-, 4.4-, and 2.9-fold from 1 to 8 
dpi) to bind IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21 in the tracheal tissue (Guo, et al., 
2008). IBV infection has previously been found to induce IFNs in the trachea, lung 
and at lower levels in the plasma, kidney, liver and spleen (Otsuki et al., 1987). The 
role of the proinflammatory cytokine, IL-6, has been investigated for its 
contribution to nephritis in the two genetic line of chicken regarding the 
susceptible S-line and a more disease-resilient HWL line infected with T strain of 
IBV (Asif, et al., 2007). Although IL-6 mRNA levels were elevated in the kidneys of 
both bird lines at 4 dpi, these levels were 20 times higher in S line chickens than 
HWL chickens. Furthermore, serum IL-6 levels were found to be three times higher 
in S-line chickens when compared to HWL chickens after IBV infection, suggesting 
that IL-6 may play a role in IBV-induced nephritis. Differential immune responses of 
chickens using two IBVs with different genotypes, KIIa and ChVI have also been 
reported (Jang et al., 2013). In chickens infected with KIIa genotype, at 7 dpi in the 
trachea and 9 dpi in the kidney, simultaneous peaks occurred in the number of 
virus copies and the upregulation of mRNA levels of pro-inflammatory cytokines (IL-
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6 and IL-1β) and lipopolysaccharide-induced tumor necrosis factor (TNF)-α factor 
(LITAF). This appeared to contribute to the scale of pathophysiological effect in the 
chickens. Alternatively, chickens infected with ChVI genotype showed 
comparatively mild upregulation in pro-inflammatory cytokines mRNA expression. 
In a recent report, after infection with IBV-M41 strain, an early (3 dpi) upregulation 
of proinflammatory cytokines IL-6 and IL-1β was reported. This coincided with the 
highest viral loads and microscopic tracheal lesions, indicating a role for both of 
these cytokines with high virus loads and the development of tracheal lesions 
(Okino et al., 2014).  
In another study, a disorder was hypothesised in the expression of eggshell 
components in laying hens after IBV infection, linked with the expression of these 
proinflammatory cytokines (Nii et al., 2014). A significant down-regulation in the 
relative expression of IFN-γ and IL-1β mRNA has also been noted within the trachea 
during the initial phase of Conn strain IBV infection when compared to uninfected 
controls. Conversely, IL-1β mRNA showed a sharp increase in expression as the IBV 
infection progressed (Kameka, et al., 2014). The transcriptomics study of the host 
kidney, in response to IBV infection, revealed that viral infection contributed to 
differential expression of 1777 genes, of which 876 were up-regulated and 901 
down-regulated compared to those of control chickens, and103 were associated 
with immune and inflammatory responses (Cong, et al., 2013). In this study, 
increased expression of IL-6, IL-18, IL-10RA, IL-17RA, CCL4, CCL20, CCL17, and 
CCL19 was found after IBV infection. However, chemokine (C-X-C motif) ligand 12 
expressions were found to be decreased. 
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The studies involving IBV sensitivity to chicken interferon (ChIFN) have shown 
conflicting results. Initially, Holmes and Darbyshire (1978) reported that none of 
the six strains of IBV examined were sensitive to ChIFN  as tested in cultures of 
chick embryo tracheal rings. In contrast, Otsuki et al. (1979) reported that all 10 
strains of IBV tested were sensitive to the action of IFN in chicken kidney cells 
(CKC). Later, type I interferon, IFN-α, was reported to inhibit IBV (Beaudette or Gray 
strains) replication both in vitro (CKC) and in vivo (Pei et al., 2001). Intravenous or 
oral administration of IFN-α prevented IBV-related respiratory clinical signs by 
delaying the onset of the disease and decreasing the severity of illness (Pei, et al., 
2001). Moreover, IBV stimulated chicken IFN-γ production in leukocytes of both 
infected birds and uninfected birds (Ariaans et al., 2009). This stimulation was 
reduced when IBV was inactivated, but IFN-γ production still remained elevated 
when compared to unstimulated cells (Ariaans, et al., 2009). Recently, an increased 
expression of IFN-γ was reported in the lungs of IBV-M41 infected birds at 2 to 4 
dpv and in the PBMCs within 1 dpv (Vervelde, et al., 2013). In a 2014 study, IFN-γ 
was upregulated in the trachea after infection with IBV-M41 which implicated viral 
infection in the tracheal pathology of non-immune challenged chickens (Okino, et 
al., 2014) . 
1.5.1.9 Chemokines and other factors for immune cell trafficking 
Chemokines orchestrate the migration of cells during immune surveillance. 
Attenuated IBV-Mass stimulated the gene expression of CXCR4 (2.1-, 2.1-, 3.0-, 
2.2-fold for 1, 3, 5, and 12 dpi), CCR6 (2.0-, 2.5-,2.2-fold for 1, 3, and 5 dpi), 
chemokine-like receptor 1/CHEMR23 (3.0- and 2.9-fold for 1 and 3 dpi) in chicken 
trachea (Guo, et al., 2008). In addition, integrin β2 (CD18) was also upregulated in 
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the tracheas of chickens following attenuated IBV-Mass infection, which indicates 
the activation of leukocyte chemotaxis and therefore chemokine production (Guo, 
et al., 2008). Matrix metalloproteinase (MMP) levels were also increased 
implicating the migration of immune cells, possibly T cells, in the trachea of IBV 
infected chicks (Guo, et al., 2008).  
Most recently an association of CpG-ODN induced changes in cytokine/chemokine 
gene expression has been found to coincide with suppression of IBV replication in 
chicken lungs (Dar et al., 2014). The data showed that significant differential 
suppression of IL-6 gene expression and up-regulation of IFN-γ, IL-8 (CXCLi2) and 
MIP-1β genes was associated with inhibition of IBV replication in lung tissue from 
embryos which were pre-treated with CpG ODN.  
1.5.1.10 IBV and apoptosis 
Apoptosis is a highly controlled mode of cell death characterized by cell shrinkage, 
plasma membrane blebbing and nuclear fragmentation (Taylor et al., 2008). The 
induction of apoptosis represents one of the major components of the host 
antiviral responses containing virus replication by rapid induction of cell death 
following infection of target cells. Nonetheless, viruses establish intricate and 
complex interactions with the host to regulate apoptosis to ensure a successful 
replication cycle that allows the production and spread of virus progeny to 
neighbouring cells (Hay & Kannourakis, 2002). Studies involving IBV Beaudette 
showed that it induced cell cycle arrest and apoptosis in infected Vero cells (Li et 
al., 2007; Liu et al., 2001). It has been demonstrated that IBV induces apoptosis in 
late stage of infection and identified proapoptotic (e.g., Bcl-2 associate X protein) 
and anti-apoptotic proteins (e.g., Bcl-2 and Bcl-XL) from the B-cell lymphoma 2 (Bcl-
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2) family that modulate IBV-induced apoptosis (Li, et al., 2007; Liu, et al., 2001; 
Zhong, Liao, et al., 2012; Zhong, Tan, et al., 2012). In a recent study involving the 
role of unfolded-protein response (UPR) sensor IRE1α in IBV Beaudette-induced 
apoptosis, it  has been found that IBV induces ER stress in infected cells and 
activated the IRE1α-XBP1 pathway at late stage of infection (Fung et al., 2014). 
Moreover, Cong et al. (2013) have concluded in their study that apoptosis is a 
nonspecific defence mechanism against IBV infection through abortion of viral 
multiplication by premature lysis of infected cells. 
1.5.2 Adaptive Immunity  
Augmenting innate immune mechanisms, adaptive immunity allows the activation 
of antigen-specific effector mechanisms including B-cells, T cells, macrophages and 
the production of leucocytic memory cells which play a significant role in antiviral 
immunity against IBV.  
1.5.2.1 Humoral immunity  
Research of the humoral immune response to IBV has been extensively studied 
since the first detection of the virus. Upon immunostimulation, B-cells differentiate 
into plasma cells and secrete antibodies either in the presence or absence of 
T-helper cells. Chickens develop a humoral response to IBV infection, which can be 
continually measured in serum by ELISA, HI or VN serological tests (Raj & Jones, 
1997c). The measurement of different classes of IBV-specific antibodies in 
particular tissues, after an IBV infection, has also gained importance. 
1.5.2.1.1 Antibody kinetics 
IgG (also known as IgY in chickens) is the major circulating immunoglobulin, and the 
kinetics of the IgG response to IBV is very different to that of the IgM response.  
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Anti-IBV IgG can be detected in serum within 4 dpi, peaking at about 21 dpi  with 
the high titre  possibly remaining for many weeks (Mockett & Darbyshire, 1981). 
Thus, the primary IgG response lasts much longer than the IgM response. After two 
vaccinations, serum IgG levels were much higher than those observed in the 
primary response but follow a similar pattern as observed after the primary 
vaccination (Mockett & Darbyshire, 1981). Moreover, in vitro stimulation of chicken 
PBMCs and splenocytes with IBV activates memory B cells to secrete antibodies at 
21 dpi (Pei & Collisson, 2005). Memory B cells secreting IBV antibody (IgG) were 
detected by ELISPOT assays in both PBMCs and splenocytes collected from chicks 
after 3 to 7 dpi  infected with IBV Gray strain (Pei & Collisson, 2005). A study by Raj 
and Jones (1996a) showed that IgG antibody content was highest in tears at 7 dpi 
and was still detectable at 23 dpi. However, significant levels of IgG antibody were 
also present in oviduct washes at 7 and 23 dpi. 
IBV IgA antibodies have been detected in the lamina propria, tracheal washes and 
between epithelial cells in the trachea of IBV infected chickens (Joiner et al., 2007). 
IBV-specific IgA antibodies have also been demonstrated in lachrymal fluid (tears), 
which correlated with resistance to IBV reinfection (Davelaar et al., 1982; Gelb et 
al., 1998). IBV-specific IgA in lachrymal fluid was initially detected 10 days after 
vaccination with live attenuated Ark DPI-type IBV vaccine. However, no further 
significant increase was noticed for IgA after subsequent challenges with Ark-IBV 
isolate AL/4614/98, clarifying the probable role of lachrymal fluid neutralizing 
antibodies at the time of challenge. This stimulation of the IgA antibody response 
upon challenge acts to reduce the potency of IBV infection (Joiner, et al., 2007). Raj 
and Jones (1996a) reported that tears showed the highest IgA antibody 
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concentration on 7 dpi but this decreased to an insignificant level by 17 dpi. In 
addition, ocular vaccination with a live-attenuated H120 vaccine induced 
IgA-positive plasma cells in the HG at 14 dpv (Davelaar & Kouwenhoven, 1981; 
Davelaar, et al., 1982). Alternatively, after ocular vaccination with a low passage, 
mildly pathogenic Ark-type IBV isolate, IBV-specific IgA secreting cells increased at 9 
dpv in the HG. Moreover, IBV-specific IgA was found in cecal tonsils at 14 dpv, 
representing a delay in the IgA response at this site compared to that in the HG 
(van Ginkel et al., 2008). In a recent study, it has been demonstrated that ocular 
vaccination with live attenuated Ark IBV vaccine induced higher IgA antibodies (in 
tears and plasma) in the primary IBV response, while the memory response is 
dominated by IgG antibodies. Therefore, lower mucosal IgA antibody levels are 
observed upon secondary exposure to IBV, which may contribute to increased 
susceptibility of host epithelial cells to reinfection by IBV and the persistence of the 
Ark serotype (Orr-Burks et al., 2014). 
1.5.2.1.2 Role of antibodies in protection 
Maternally-derived antibodies can provide a short-lived resistance to IBV (Cook et 
al., 1991; Darbyshire & Peters, 1985). Newly hatched chicks would therefore 
require to develop specific humoral responses to counter IBV infections. However, 
the precise role of antibody in the control of IBV infections remains controversial. 
Several studies have shown that circulating antibody titres do not highly correlate 
with protection from IBV infection. A lack of correlation between infectivity, 
serological response and challenge with IBV vaccine was first reported in 1965 
(Raggi & Lee, 1965). Later in 1979, no correlation was found between HI antibody 
titres and susceptibility to challenge, as measured by re-isolation of virus from the 
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trachea (Gough & Alexander, 1979). Nevertheless, other studies have 
demonstrated that humoral immunity plays an important role in disease recovery 
and virus clearance. Cook and co-workers (Cook, et al., 1991) have reported that 
following IBV infection, bursectomised chicks showed more severe and longer 
lasting illness than intact chicks. The viral titres in tissues were also higher and 
lasted longer in bursectomised chicks compared to normal chicks though no 
difference in mortality was observed (Cook, et al., 1991). Similar earlier results 
were also reported using cyclophosphamide-treated chickens, which showed 
severe clinical signs and more severe histopathological renal lesions due to the 
prolonged persistence of IBV compared to controls (Chandra, 1988). It has also 
been reported that high titres of humoral antibodies correlate well with the 
absence of virus re-isolation from the kidneys and genital tract (Gough et al., 1977; 
Macdonald et al., 1981; Yachida et al., 1985), and protection against a drop in egg 
production (Box et al., 1988). Later, IBV-specific antibodies were suggested to be 
involved in limiting IBV spread by viraemia from the trachea to other susceptible 
organs including the kidneys and oviduct (Raj & Jones, 1997c). 
In general, serum antibody levels do not closely correlate with tissue protection, 
but local antibodies may contribute to the protection of the respiratory tract 
(Ignjatovic & McWaters, 1991; Raggi & Lee, 1965). Thus, antibodies at mucosal 
surfaces could contribute to this protection as IBV enters through this site and 
initially replicates in the HG and trachea. However, the role local antibodies play in 
preventing the re-infection is not clear. Some studies have reported that local 
antibodies plays a role in protecting the respiratory tract principally in the 
prevention of re-infections (Hawkes et al., 1983; Holmes, 1973) and that the HG 
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contributes to the protective local immunity (Hawkes, et al., 1983; Toro & 
Fernandez, 1994; van Ginkel, et al., 2008). Alternatively, Gelb et al. (1998) found 
that some chickens with high tear IBV antibody titres were susceptible to IBV and 
that some chickens with low tear titres were protected, suggesting that 
mechanisms other than antibody mediated immunity in tears are important in viral 
clearance following infection. 
Studies on isotype of antibodies involved in protection showed that after 
vaccination of broilers with IBV vaccine (H120 and D274 combination), the groups 
with 50% positive sera in IBV specific IgM at 10 days post vaccination had better 
protection against IBV-M41challenge (De Wit et al., 2010). However, most groups 
of broilers with low levels of IBV specific IgM had a low or moderate level of 
protection against IBV-M41 challenge (De Wit, et al., 2010). It has been 
demonstrated that IBV-specific IgG responses were less protective against IBV than 
IBV-specific IgA antibodies found in tears (Toro & Fernandez, 1994). Furthermore, 
IBV-specific IgA antibodies were first detected in tears and later in serum, which 
suggests that IgA is important in neutralizing IBV at mucosal surfaces and is thought 
to play a role in the control of IBV locally (Davelaar, et al., 1982). In a study 
involving transcriptome analysis of tracheal samples from chickens ocularly 
vaccinated with attenuated IBV-Mass, a marked decreased was reported in 
expression of IgA at 8 and 12 dpi. Conversely, an up to 7-fold increase in the 
expression of IgG at 5 and 8 dpi was demonstrated, suggesting that IgA might not 
be important in protection against IBV infection of the upper respiratory tract 
whereas locally produced IgG, after a secondary immunization, provided effective 
protection against IBV by neutralizing this virus (Guo, et al., 2008). This was also 
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supported by a study that showed a significant correlation between the levels of 
lachrymal anti-IBV IgG at 5 dpi in chickens vaccinated with the full dose of H120 and 
tracheal protection against homologous IBV challenge (Okino et al., 2013). In 
addition, a recent study also corroborates this hypothesis which reported that 
secondary antibody response at mucosal sites (lachrymal secretion) induced by 
attenuated IBV vaccines are dominated by an early and high production of anti-IBV 
IgG in re-immunized chickens (Orr-Burks, et al., 2014). 
1.5.2.2 Cellular Immunity 
Our understanding of immunity against IBV is deficient,  especially the roles of 
cell-mediated responses (Cook et al., 2012). Several studies examined the CTL 
responses in chickens to IBV infections and its correlation with early decreases in 
infection and clinical signs (Pei, et al., 2001; Seo & Collisson, 1997). CTL activity was 
dependent on the MHC and lysis was mediated by CD8+CD4- cells.   In addition, the 
passive transfer of IBV-infection induced αβ T lymphocytes bearing CD8+ antigens 
protected naive chicks challenged with IBV (Seo et al., 2000).  
Antigen specific CTL activity was detected at 3 dpi and reached its peak level at 10 
dpi in chickens infected with nephropathogenic Gray strain of IBV (Seo & Collisson, 
1997). Throughout this period, acute IBV infection was contained and detectable 
IBV was neutralized. Viral titres were decreased in the lungs and kidneys of IBV 
infected chickens, and this was followed by a decline in CTL activity 10 dpi (Seo & 
Collisson, 1997). Such memory T cells persisted up to at least 10 weeks in blood 
post infection with IBV (Pei et al., 2003). However, the duration of these memory T 
cells in tissues such as lungs, kidneys, spleens and trachea needs to be further 
examined in chickens.  
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During the course of experimental viral infection, Kotani et al. (2000) assessed the 
immunophenotype of mononuclear cells in the tracheal mucosa. The CTLs were 
found to be significantly increased in the tracheal mucosa after 3 or 4 dpi, peaking 
at 5 dpi and then decreasing to baseline levels by 14 dpi. So these infiltrating CTLs 
at the trachea mucosa were proposed to be involved in the clearance of IBV at this 
site, in an early phase of infection. 
Effector CD8+ T cells were shown to be critical in containing acute IBV infection 
(Collisson, et al., 2000). Adoptive transfer of immune T cells to chicks, prior to 
infection, demonstrated that IBV primed CD8+, αβ T lymphocytes could protect 
chicks from acute infection (Collisson, et al., 2000; Pei, et al., 2003). The kinetics of 
viral load in the lungs and kidneys of IBV (Gray strain) infected chicks correlated 
with the level of IBV-specific CTL activity of effector cells isolated from spleen of the 
same infected chicks (Collisson, et al., 2000). Such IBV-specific CTL activity was 
dependent on the S and N proteins of IBV (Collisson, et al., 2000). Furthermore, the 
CD8+ T cell response in the blood and spleen occurred prior to the serum IgG 
antibody response to IBV (Liu et al., 2012) supporting the hypothesis that the CTL 
response correlated with decreased viral load and an improved clinical response.    
In vitro studies have shown that CTL activity also induced IBV (Gray strain)-infected 
cell lysis. This lysis was dependent on the concentration of effector T lymphocytes, 
mostly CD8+, with lower effect from CD4+ cells (Collisson, et al., 2000). CD4+ 
lymphocytes’ minimal effect was suggested to be possibly due to either CD4-/CD8+ 
or CD4+/CD8- (Collisson, et al., 2000). In another study, donor CD8+ memory T cells 
protected recipient chicks from acute IBV infection for the first 4 dpi, and showed 
mild clinical illness at 5 dpi (Pei, et al., 2003). In addition, adoptive transfer of CD4+ 
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T cells did not appear to be important in initially containing IBV infection in 
chickens (Seo, et al., 2000). However, the low levels  of protection in IBV infected 
chicks, that received CD4+ T cells, was suggested to be because of contamination by 
CD8+ T cells (Pei, et al., 2003).  
In 1991, the first IBV-specific T cell epitope in the IBV nucleoprotein (IBV N71-78) 
from an IBV H52 strain was described (Boots et al., 1991). This study revealed that 
only the S1 and N proteins of IBV generated cytotoxic T cell responses, but not the 
M protein of IBV. Later, the whole N protein and its carboxy-terminal region were 
reported to induce a CTL response, but not its amino terminal region (Seo, et al., 
1997). This was further supported by another study (Guo et al., 2010) wherein, 
increased numbers of CD4+ and CD8+ T cells in the PBMCs were found after 
vaccination of chickens with a DNA vaccine containing the sequence of N protein. In 
addition, immunization of chickens with a DNA vector expressing GM-CSF and S1 
subunit of the spike protein, resulted in high antibody levels in serum, lymphocyte 
proliferation (including CD4+ and CD8+ T cells in PBMCs), and reduced the severity 
of clinical signs and mortality rate after challenge (Tan et al., 2009). 
Cytotoxic enzymes, granzymes and perforin, which are secreted by cytotoxic cells 
such as CTLs, γδ T cells and NK cells etc., play an important role in the cytotoxic 
activity induced following exposure to IBV (Vervelde, et al., 2013; Wang, et al., 
2006). Transcriptome analysis of tracheal cells at 3 dpi with IBV-Mass revealed 
induction of genes involved in cytotoxicity such as Granzyme-A precursor, Fas, CD3 
δ and γ chain, MHC II, and TLR-2. This expression pattern could be due to cytotoxic 
T cell responses as suggested by the authors (Wang, et al., 2006). More recently, 
after infection with IBV-M41, a late (7 dpi) induction of CD8αα and Granzyme 
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homolog A mRNA has been reported to be associated with highest scores of viral 
load and microscopic lesions in trachea, suggesting a role of both these cytotoxic 
enzymes and virus load on the development of tracheal lesions (Okino, et al., 
2014). In addition, one study showed that the levels of expression of these genes 
evaluated at mucosal sites correlated significantly with the parameters of tracheal 
pathologic changes (viral load, histopathology and ciliostatsis) against homologous 
IBV challenge in a vaccine dose-dependent manner (Okino, et al., 2013). 
1.5.3 Maternal derived antibodies (passive immunity) 
Passive immunity was initially suggested protect young chicks from the 
development of abnormal oviducts when challenged with  virulent field strains of 
IBV (Broadfoot et al., 1954). IgG antibodies were detected in serum and respiratory 
mucus of newly hatched chicks that passed from vaccinated hens, via the yolk, to 
the progeny (Hawkes, et al., 1983).  
In another study, chicks hatched with high levels of maternally-derived antibodies 
were also found to have excellent protection (>95%) against IBV challenge 
(IBV-Mass strain) at 1 day of age but not at 7 days (>30%) (Mondal & Naqi, 2001). 
This protection significantly correlated with levels of local respiratory antibody and 
not with serum antibody. Neither group of chicks produced IBV-specific antibodies 
when vaccinated with live IBV-Mass vaccine at 1 day of age by the intraocular route 
(Mondal & Naqi, 2001). Live vaccination of 1-day-old chicks induced a rapid decline 
in maternally derived antibodies due to the binding and partial neutralization of 
vaccine virus by these antibodies (Mondal & Naqi, 2001). Moreover, de Wit and 
colleagues recently challenged 6 or 10 day old chicks and reported that maternally 
derived IBV (D388 serotype, QX genotype) neutralizing antibodies provide partial 
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protection against tracheal damage and a high protection against viral replication in 
the chicks’ kidney (de Wit et al., 2011). Such protection was achieved in SPF layer 
breeders with a combination of heterologous live and inactivated IBV vaccines to 
boost their production of IBV maternally-derived antibodies (de Wit, et al., 2011). 
1.6 Control of IBV 
To control IBV infection in the field, IB vaccination programmes in broilers and 
breeders include application of both live attenuated and killed or inactivated 
vaccines (Jackwood & de Wit, 2013). Live attenuated IB vaccines are the first 
generation IBV vaccines which have been attenuated by successive passage in ECE 
(Klieve & Cumming, 1988). Experimental administration of live vaccine can be 
performed individually  by oculonasal (Cook JKA, 1999) or intratracheal routes 
(Yachida et al., 1986). However, in the field live vaccines are usually applied via 
drinking water, by coarse spray and aerosols at 1 day or within the first week of age 
(Jackwood & de Wit, 2013). Though these mass administration methods are 
popular because of convenience, problems in attaining uniform vaccine application 
can occur, and the aerosol method may cause more severe respiratory reactions. 
As the duration of immunity following live vaccine administration is short, a booster 
vaccination is carried out with the same strain or combination of other strains, 2-3 
weeks after prime vaccination (Cavanagh, 2003). This combination of two 
serologically different vaccines (e.g. Ma5 and 4/91) has been shown to give wide 
immunity against many heterologous strains (Cook, et al., 2001; Cook JKA, 1999; 
Terregino, Toffan, Serena Beato, et al., 2008). In addition, this vaccination strategy 
was found to be more effective than revaccination with a vaccine of the same 
serotype as the first vaccine (Cook JKA, 1999). 
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Most commonly live vaccines are derived from virulent strains such as M41 
serotype and the Dutch H52 and H120 strains (Jackwood & de Wit, 2013; Lee et al., 
2010). However, in order to obtain optimal protection, variation may exist among 
countries on the type of IBV vaccine strain approved for use depending on the 
prevalent serotypes. For example, in the USA, M41, H120, Conn, JMK, Ark and 
Cal99 derived vaccines are frequently used for vaccination programme (Alvarado et 
al., 2003; Gelb et al., 1989; Martin et al., 2007). In Australia, the B and C strains are 
being used. In Europe, vaccine strains include M41, 793B (4/91 and CR88) and D274 
(Cook JKA, 1999; de Wit, et al., 2011; Terregino, Toffan, Serena Beato, et al., 2008). 
Despite these, some strains with regional or local impact have been used in 
different parts of the world. In some counties in Asia, apart from M41, 793B (4/91 
and CR88) and D274, vaccines based on the local strains have been used widely (Lin 
et al., 2005).   
Inactivated or killed vaccines have been used either alone or in combination with 
live attenuated IBV vaccines to obtain long-lasting immunity to protect breeders 
and layers prior to the onset of egg production (Cavanagh, 2003; Finney et al., 
1990). These vaccines usually are administered by the intramuscular or 
subcutaneous route to layers and breeders at 13 to 18 weeks of age for induction 
of high levels of humoral antibodies, which can protect the oviduct of the birds 
against circulating IBV and avoids drops in egg production or quality. In the poultry 
industry the practice of vaccinating young females with live vaccines two or more 
times, followed by one dose of killed vaccine before the birds come into lay, is very 
common. However, in comparison to live vaccines, killed vaccines alone induce 
short-lasting immune response which is characterized by antibody production but 
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not T-cell-mediated responses (Collisson, et al., 2000; Ladman et al., 2002). 
Therefore, the efficacy of killed vaccines in most cases depends on the proper 
priming with live vaccines (Cavanagh, 2003; Jackwood & de Wit, 2013). 
In the recent past with the advancements in molecular biology techniques, novel 
approaches such as sub-unit vaccines, plasmid DNA vaccines and vector-based 
vaccines along with reverse genetics vaccines have been tried. The experimental 
recombinant vector vaccines most commonly containing IBV-S1-glycoprotein have 
been developed against IBV. These vaccines were shown to induce significant 
increase in the immune response and protect against tracheal lesions following 
homologous and heterologous challenge with Vic S (serotype B) or N1/62- 
(serotype C-) IBV strains (Johnson et al., 2003). While the advances in viral vector 
vaccines seem promising in providing effective immune response against IBV, this 
technology does have some limitations that include issue of pre-existing immunity 
or maternally derived immunity that interferes with the live vector itself and 
reduces the uptake of the antigen by the antigen presenting cells (Faulkner et al., 
2013).  
However, oral immunization of mice with adenovirus vector was shown to avoid 
neutralization of the vector by maternally derived antibody (Xiang et al., 2003). 
Interestingly, such adenovirus vector vaccines have been shown to be promising for 
use in poultry oral vaccines as they have several advantages including ease of 
application. 
 A DNA vaccine based on the S1-gene of Arkansas IBV serotype was developed 
(Kapczynski et al., 2003). Immunization via the in ovo route with this vaccine, 
followed by application of a live attenuated vaccine at 2-week intervals, resulted in 
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a significant immune response and 100% protection against clinical disease 
(Kapczynski, et al., 2003). Enhancement of a vaccine-induced immune response was 
achieved by co-administration of a DNA vaccine encoding for IBV N or S1-
glycoprotein genes with IL-2 (Tang et al., 2008) or chicken granulocyte-macrophage 
GM-CSF, respectively (Tan, et al., 2009). 
Recently, using reverse genetics technology, a recombinant BeauR-IBV vaccine has 
been constructed by substituting the antigenic S1-glycoprotein of an apathogenic 
Beaudette-IBV strain with another S1-gene from pathogenic M41 and 4/91 strains, 
respectively (Armesto et al., 2011). Use of this recombinant vaccine was shown to 
result in protective immune responses against the IBV. In another study, a modified 
H120 (R-H120) virus was constructed and was found to elicit a high level of HI 
antibodies and a comparable protection rate compared with an intact H120-
vaccinated group (Zhou et al., 2013). These new generation vaccines can be 
administered in ovo or to live birds, but whether they will increase or reduce the 
chances of mutation and viral selection pressure and indeed be more economical 
than existing traditional vaccines requires further studies. 
1.7 Laboratory diagnosis 
The diagnosis of IBV infections can be done by detection of the virus itself or the 
specific antibody response against it. The routinely used diagnostic assays for 
detection of virus are virus isolation (VI), immunofluorescence assay (IFA), 
immunoperoxidase assay (IPA) and reverse transcription polymerase chain reaction 
(RT-PCR). Serologically, IBV can be detected by the demonstration of IBV-specific 
antibodies using various serological tests viz. HI test, the agar gel precipitation test 
(AGPT), VNT, and the enzyme linked immunosorbent assay (ELISA) (De Wit, 2000). 
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1.7.1 Detection of virus 
1.7.1.1 Virus isolation 
IBV can be isolated from infected birds using ECE and chicken tracheal organ 
cultures (TOCs), preferably from SPF sources (Jackwood & de Wit, 2013). 
Depending on the history of the disease, samples from the trachea,  lungs, kidneys, 
oviduct and  OP, tracheal or cloacal swabs can be required for the isolation of virus 
(Jackwood & de Wit, 2013). Embryonated SPF eggs and TOCs are reported to be 
more sensitive than cell cultures, especially from samples involving field strains 
(Cook et al., 1976b). IBV grows well in the 10-days old SPF ECE, showing higher 
titres in allantoic fluid harvested between 48 and 60 hours after inoculation  
(Jackwood & de Wit, 2013). Though direct isolation of virus in conventional primary 
cell cultures has been proved unsuccessful (Cook, et al., 1976b), adaptation of IBV 
strains is necessary for replication and induction of observable cytopathic effects 
(Gillette, 1973; Otsuki et al., 1979). TOCs have also been found to be very 
successful for isolation of virus from field samples (Cook, 1984). After 3 to 4 days of 
inoculation, ciliostasis is usually observed, which may vary depending on strains 
and inoculation dose (Cook, et al., 1976b). However these observations are not 
sufficient to confirm the presence of IBV; it has to be confirmed by virus antigen 
detection methods. 
1.7.1.2 Detection of virus by antibody-based methods 
The AGPT is not expensive, fast and can be easily performed in the laboratory 
(Lohr, 1981). Though this test requires few laboratory facilities, it is relatively 
insensitive (De Wit, 2000). In addition, to prevent false negative results caused by 
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imbalance of the antigen:antiserum ratio, several antisera or an antiserum at 
different dilutions are required (Lohr, 1981). 
The IFA is relatively a cheap and fast technique for detection of IBV antigen in post 
mortem materials (scrappings of tracheal mucosa or other tissue), cells sedimented 
from allantoic fluid, TOCs and cell culture. However, it is not always easy to 
interpret the results, especially with field samples because of non-specific reactions 
(Jackwood & de Wit, 2013). The IFA can be used as a group-specific test when using 
IBV-specific polyclonal sera or type-specific by using type-specific monoclonal 
antibodies (Mabs) (De Wit et al., 1995). 
1.7.1.3 Detection of IBV genome 
The RT-PCR reaction can been used to detect the presence of IBV genome though; 
it does not distinguish between infectious and non-infectious virus particles. 
Therefore, sequences of the RT-PCR product should compared with the 
corresponding sequences of the vaccine strains (Jackwood & de Wit, 2013). The 
RT-PCR exhibits a moderate sensitivity when performed directly on samples from 
infected chickens (Jackwood, et al., 1997), but its sensitivity can be improved by 
performing one or two passages in embryonated eggs or TOCs to increase viral load 
followed by detection of the IBV genome by RT-PCR (De Wit, 2000; Jackwood & de 
Wit, 2013). The primers for RT-PCR are designed near hypervariable regions in the 
S1 gene and are designed to work with many types of IBV (Adzhar et al., 1996; 
Worthington, et al., 2008). The primer pairs for group-specific RT-PCR are usually 
annealed to segments of the IBV genome in the very well conserved regions of viral 
M and N protein genes (Andreasen et al., 1991; Falcone et al., 1997).  
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In addition to conventional RT-PCR, another method for detecting IBV genome is 
through the use of nested RT-PCR. It has been shown to be more sensitive than 
conventional RT-PCR because of the addition of a second amplification step 
(Cavanagh, et al., 1999). Owing to high risk of contamination during performing the 
test and high sensitivity, possibility of getting false positive results as a result of 
contaminations is high in nested RT-PCR (De Wit, 2000; Jackwood & de Wit, 2013). 
After detecting the IBV genome, several methods including sequencing the PCR 
product, subjecting the DNA to restriction enzyme fragment length polymorphism 
(RFLP) or hybridization using IBV-specific probes have been used to group IBV 
strains based on genetic characterization (Binns et al., 1985; De Wit, 2000; 
Jackwood, et al., 1992; Moore et al., 1998). 
1.7.2 Demonstration of IBV-specific antibodies 
1.7.2.1 VNT 
The VNT is the gold standard serotype-specific tests for detection of IBV antibodies, 
induced primarily by the S1 spike protein. When performing the VNT, appearance 
of cross-reactions has been reported, especially after multiple contacts with 
different IBV serotypes (Gelb & Killian, 1987; Karaca & Naqi, 1993). This test can be 
performed in various test systems viz. ECE (Davelaar et al., 1984; Gelb, et al., 1989; 
Gelb, Wolff, et al., 1991), CEK cells (Hopkins, 1974) and TOCs (Cook, 1984; 
Darbyshire et al., 1979). 
1.7.2.2 HI test 
In general, the HI test has been considered to be strain-specific (de Wit et al., 1997; 
King & Hopkins, 1983; Monreal et al., 1985), therefore its use is limited to monitor 
response after vaccination. The serotype specificity of the HI test has been reported 
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to be much lower following re-infection, especially when a heterologous serotype 
was used for second or subsequent infection (Gelb & Killian, 1987; King & Hopkins, 
1983). For instance, the HI response was lower when strain M41 used as antigen in 
the test following vaccination with H120 as compared to  using H120 antigen (de 
Wit, et al., 1997). Similar results have also been observed wherein, the birds were 
vaccinated with Mass and 793B types and HI test was performed using M41, 793B, 
624/I, It-02 and QX as antigens (Terregino, Toffan, Beato, et al., 2008). 
1.7.2.3 ELISA 
The ELISA can be used for detection of IBV antibodies after vaccination as well virus 
infection. By using group-specific ELISA, IBV antibodies can be first detected within 
1 week after vaccination or infection (Hawkes, et al., 1983; Mockett & Darbyshire, 
1981). Because of the short period between infection and the detection of the first 
antibodies by ELISA, paired serum sampling is required, one at the first sign of 
infection and one a week or more later. Delay in first sampling can prevent 
detection of seroconversion (Jackwood & de Wit, 2013). For IBV-specific antibody 
detection several ELISA kits are commercially available. The antibody titres 
detected by ELISA were considerably higher than those obtained by HI (de Wit, et 
al., 1997) or VN (Marquardt et al., 1981).  In general, IBV antibodies can be first 
detected by ELISA followed by HI test, and last by VNT (Marquardt, et al., 1981; 
Mockett & Darbyshire, 1981).  
1.8 Objectives of the study 
New IBV variants constantly emerge across the world that may differ in antigenic 
properties, tissue tropism and pathogenicity. Little is known about underlying 
molecular mechanism behind marked difference in pathogenicity by different IBV 
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genotypes. Though the differences in the tissue tropism and thus differences in the 
pathogenicity of IBV strains hypothesised to be associated with differences in the 
binding properties of their spike (S) proteins. Objectives of the work described in 
the thesis were to 1) study of cellular response to infection by different strains 
(885, M41, QX and 793B) of IBV in CEK cells and 2) TOCs (Chapter 3, 4 and 6). 
Further, 3) to study differential immunopathogenesis in chickens (in vivo) infected 
with these IBVs (Chapter 5 and 6). In addition, 4) study on mucosal, cellular and 
humoral immune responses induced by different live infectious bronchitis virus 
vaccination regimes and the protection conferred against infectious bronchitis virus 
Q1 strain was undertaken (Chapter 7). 
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In this chapter the general materials and methods used in various experiments 
have been defined. The procedures only used in specific experiments are described 
in those relevant chapters.  
2.1 Embryonated chicken eggs, cell and organ cultures 
i) SPF eggs 
The ECE obtained from a commercial source1 were used for virus propagation, virus 
titration, in vitro CEK cell and TOC preparation as well as a source of day-old SPF 
chicks for in vivo studies. They were incubated at 37.8°C and 55% humidity. The 
parental flock was free from all major infectious disease agents, including IBV.  
ii) Primary CEK cells 
Monolayers of primary CEK cells were prepared from kidneys of SPF ECE after 18 
day incubation. Kidneys removed aseptically were collected in Minimum Essential 
Medium (MEM)2 and 1% antibiotics (penicillin and streptomycin) solution 
(Appendix I). The kidneys were minced gently in to small pieces with scissors taking 
care to avoid piercing the gut, followed by trypsinization using  0.25% trypsin 
solution (Appendix I) for 30 min at 37°C and filtered through a 100 µm mesh to 
remove tissue debris. After centrifugation at 1500 g for 10 min, cell pellet was 
resuspended in the growth medium supplemented with 0.5% fetal bovine serum 
(Appendix I), seeded at 1x105 cells/cm2 in cell culture plates3 and incubated at 37oC 
with 5% CO2. 
 
                                                          
1
 Lohman, Cuxhaven, Germany 
2
 Gibco, UK 
3
 CELLSTAR, Grenier bio-one, UK 
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iii) Tracheal organ culture (TOC) 
 TOC from chicken were prepared using 18-day-old SPF ECE. Briefly, embryos were 
decapitated; the tracheae were removed under sterile conditions and immediately 
placed in prewarmed TOC culture medium (Appendix I). The extraneous tracheal 
tissue was removed using a small scalpel blade and forceps. The trachea was then 
placed on sterile filter paper4 and each trachea was cutted into approximately     
0.6-mm-thick rings using a tissue chopper5. Several rings from the top and the 
bottom ends were discarded and only one ring was placed per tube6 with 0.6 ml of 
prewarmed TOC culture medium. TOCs were cultured at 37°C in a rotating 
incubator7 at lowest rotation speed (8 rpm). After 24 hours, the ciliary activity of 
the respiratory epithelium of each TOC was assessed using an inverted microscope 
under a low power (100 x magnifications). Only rings with 100% ciliary activity were 
used for the experiments. 
2.2 Viruses and vaccines 
All the virus stocks were stored at -70°C and vaccines were kept in refrigerator until 
used. The different types of field and vaccine strains were used in various 
experiments; their details are given in the respective chapters. 
2.3 Virological methods 
i) Propagation of viruses in ECE 
The titration of different IBVs was performed using 9 to 11-day-old SPF ECE via the 
allantoic cavity. At candling eggs were marked around the edge of the air-cell 
                                                          
4 Fisher scientific, UK 
5 McILWAIN tissue chopper  
6 Nunclon™ culture tubes, sterile, Thermo Scientific, UK 
7 Lab Thermal Equipment, Greenfield, NR OLDHAM 
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avoiding the area with blood vessels. The marked area was disinfected with 70% 
alcohol and drilled to make a small hole just above the mark. A 1-ml syringe with a 
25-gauge needle was used to inoculate the eggs via the allantoic cavity. The holes 
were sealed with molten paraffin wax and eggs were incubated at 37oC in an 
incubator for 3 days.  Eggs were examined daily and any embryos dying within 24 
hours were discarded. The end points were decided on the basis of IBV specific 
lesions (death, curling and dwarfing) of the embryos (Figure 2.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
+ - 
Figure 2.1. Typical IBV lesions (curling and dwarfing) induced after inoculation of 
ECE with M41 via allantoic cavity. Plus indicates embryo infected with IBV, minus 
indicates non-infected embryo 
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ii) Propagation of viruses in TOCs 
TOCs from 18-day-old ECE were prepared as per method described in 2.1 (iii). The 
rings with 100% ciliary activity were used for virus propagation. The medium was 
removed from the tubes and each ring was inoculated with 0.1 ml of the stock 
virus. The TOCs were incubated at 37oC for one hour to allow virus attachment. 
After incubation, 0.6 ml TOC culture medium (Appendix I) was added and tubes 
were further incubated at 37oC in the roller drum. After 5 days, the supernatants 
were collected, pooled, aliquoted and stored at -70oC until used. 
iii) Titration of viruses in ECE and TOCs 
To know the definite level of virus in the propagated virus stock, the titration of 
different IBVs was performed in ECE or TOCs. In brief, three ECE or TOCs rings were 
inoculated with a tenfold dilution of the virus stock.  The eggs were candled after 
24 hours of incubation. The embryo mortality occurring up till 24 hpi was 
considered nonspecific and therefore these eggs were discarded. The ECE were 
examined for IBV specific lesions (curling and dwarfing) of the embryos up to five 
days post inoculation. For TOCs, following incubation for up to 7 days at 37oC, 
complete ciliostasis was taken as the endpoint. The titres were calculated according 
to the method described earlier (Reed & Muench, 1938) and expressed as the egg 
infective dose (EID50/ml) or median ciliostasis dose (log10 CD50/ml), respectively. 
iv) Titration of viruses in CEK cells 
To calculate the multiplicity of infection (MOI), all IBV strains were amplified with 
same passage level and titrated on CEK cells using an immune cytochemical focus 
assay as described previously (Nelli et al., 2012). In brief, serial 2-fold dilutions of a 
known volume of TOC supernatants were used to infect CEK cells (prepared as 
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described above 2.1.ii.) in 96-well cell culture plates8. Cells were washed after 2 
hours incubation with virus, followed by further 4 hours incubation at 37°C. Cells 
were then fixed in ice-cold acetone: methanol (1:1) for 10 min. For immune 
staining, cells were pre-incubated with Tris-buffer saline (TBS, Appendix I) for 5 min 
and endogenous peroxidase activity blocked with 0.03% hydrogen peroxidase9. 
Thereafter, cells were washed 3 times with TBS followed by addition of 50 µl of 
primary antibody10 (mouse monoclonal antibody to IBV nucleoprotein diluted 1:500 
in TBS). After incubation of the cells at room temperature for 40 min followed by 
washing with TBS, 50 µl of labelled polymer-HRP11 was added. The plates were 
incubated at room temperature for 40 min. Finally, cells expressing the viral 
nucleoprotein were visualized by using DAB (diaminobenzidine) solution12 
according to the manufacturer's instructions. The cells expressing viral 
nucleoprotein were counted and the mean number of positive cells in five fields 
used to calculate focus-forming units of virus per microlitre of inoculum.  
2.4 Molecular biology methods 
i) Extraction of total RNA  
The total RNA from CEK cell pellets, TOC rings and tissue samples was extracted 
using the RNeasy Mini kit13. Briefly, samples were mixed with 600 μl of RLT buffer 
with mercaptoethanol. This mixture was homogenized using a TissueLyser14 and a 
                                                          
8
 Grenier bio-one, UK 
9 Sigma-Aldrich, UK 
10 Prionics, Lelystad, The Netherlands 
11 Envision+system-HRP (DAB; Dako, Ely, UK) 
12 Envision+system-HRP (DAB; Dako, Ely, UK) 
13 QIAGEN, UK 
14 QIAGEN, UK 
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stainless steel beads15 (5 mm), and lysate was centrifuged at 13000 rpm for 3 min. 
To the supernatant, 600 μl of 70% ethanol was added, and the solution was 
transferred to a spin column in two steps. Washing and elution was performed 
according to the manufacturer’s instructions (Appendix I for detailed protocol). The 
elution volume was 30 μl. Extracted RNA was quantified using NanoDrop16 1000 
spectrophotometer and stored at -70oC until used for quantitative reverse 
transcription PCR (qRT-PCR) analysis. 
ii) Extraction of viral RNA  
Total viral RNA was extracted using the QIAamp viral RNA mini kit17 as per 
manufacturer’s instructions. Briefly, 140 µl of each sample was mixed with 560 µl of 
lysis buffer, vortexed briefly and incubated for 10 min at room temperature. 
Thereafter, 560 µl of 100% ethanol was added to each sample. After mixing gently, 
the mixture was transferred to spin-cloumn followed by two steps washings with 
washing buffers (AW-1 and AW-2) (Appendix I). Finally, the RNA was eluted in 60 µl 
RNase-free water and stored at -70oC till further used. 
iii) cDNA synthesis 
For further use in host gene expression analysis, first strand cDNA from the total 
RNA was synthesized using the SuperScript III First-strand synthesis system18.  A 
total of 1 µg of the RNA sample was added to reaction mixture I containing random 
primers, dNTP mix and diethyl-pyrocarbonate (DEPC) treated water (Appendix I).  
                                                          
15
 QIAGEN, UK 
16 Thermo Scientific, Wilmington, DE 
17 QIAGEN, UK 
18 Life Technologies, UK 
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The mixture was incubated in a thermocycler19 at 65oC for 5 min, and then placed 
on ice for at least 1 min. Next 10 μl of cDNA synthesis mix (Appendix I) was added 
to each RNA/primer mix. The tubes were then centrifuged for 10 s at 5000 rpm, 
incubated for 10 min at 25oC, followed by 50 min at 50oC and the reaction was 
terminated at 85oC for 5 min. Finally the tubes were chilled on ice.   
iv) Quantitative reverse transcription PCR (qRT-PCR) for host gene expression 
analysis 
QRT-PCR of cDNA for the relative expression analysis of selected genes in triplicate 
was performed on the LightCycler® 48020, using LightCycler 480 SYBR Green I 
Master mix21 and primers listed in Table 2.1. All primers were provided by Eurofins 
Genomics22. A master mix was prepared for each target gene comprising 10 µl of 
master mix, 1.8 µl each of forward and reverse primers (each at 300nM), and 1.4 µl 
of nuclease free water. Five micro litres of cDNA diluted at 1:50 was used per 
reaction in a total reaction volume of 20 µl. The cycling conditions were 10 min at 
95°C, 45 cycles of 10 s at 95°C, 10 s at 60°C annealing temperature  and 10 s at 
72°C, followed by a final step of melting curve analysis to ensure the specificity of 
the SYBR green PCR. QRT-PCR data was normalised using a relative standard curve 
method to 18S ribosomal RNA (18SrRNA) expression (Kuchipudi, Tellabati, et al., 
2012) and the data were presented as fold difference in gene expression of virus vs 
mock infected samples or uninfected controls. 
                                                          
19
 GeneAmp PCR system 9700 
20 Roche, UK 
21 Roche, UK 
22 Edersberg, Germany 
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 Table 2.1. Primer abbreviations, full names and sequences 
S No. Primer abbreviation and full name Primer sequences: sense (S) and anti-sense (AS) 
1.Reference gene 18S rRNA (ribosomal RNA ) (S) TGTGCCGCTAGAGGTGAAATT 
(AS) TGGCAAATGCTTTCGCTTT 
2. Viral recognition LGP2 (Laboratory of genetics and physiology 2) (S) AGCCCACGAAGCAGTACGA  
(AS) CGGCAACTCGGGCATCT 
 MDA5 (Melanoma differentiation-associated protein 5) (S) AGGAGGACGACCACGATCTCT 
(AS) CCACCTGTCTGGTCTGCATGT 
 TLR1 (Toll like receptor 1) (S) GGGAAACCGCTCTGCAGTT 
(AS) CATTCTTCACCCACAGGGAATC 
 TLR2 (Toll like receptor 2) (S) CCACCGGTCCCTCCTAGTGT 
(AS) ACCCAACGACCACCAGGAT 
 TLR3 (Toll like receptor 3) (S) GCAATTTCTCCTTCACCTTTTCA 
(AS) CCTTTATGTTTGCTATGTTGTTATTGCT 
 TLR7 (Toll like receptor 7) (S) GAATTCAAGAGGTTCAGGAACATGA 
(AS) TTAGGGCAGGGAGTACAAGGATAT 
3. Interferons IFNα (Interferon alpha (Type I)) (S) CTTCCTCCAAGACAACGATTACAG 
(AS) AGGAACCAGGCACGAGCTT 
 IFNβ (Interferon beta (Type I)) (S) TCCAACACCTCTTCAACATGCT 
(AS) TGGCGTGTGCGGTCAAT 
4. Inflammation IL1β (Interleukin 1 beta) (S) TGCTGGTTTCCATCTCGTATGT 
(AS) CCCAGAGCGGCTATTCCA 
 IL-6 (Interleukin 6) (S) CACGATCCGGCAGATGGT 
(AS) TGGGCGGCCGAGTCT 
 NLRP3 (NLR family, pyrin domain containing 3) (S) TGTGTGTCATCCCTGTCATGAG 
(AS) TGGTCTTAGAGCACGCAAGGA 
5. Other cytokines IL-8 (Interleukin 8) (S) CCCTCGCCACAGAACCAA 
(AS) CAGCCTTGCCCATCATCTTT 
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v) Quantitative reverse transcription PCR (qRT-PCR) for quantification of viral RNA 
Quantification of the viral RNA was done by quantitative real-time RT-PCR 
(RT-qPCR) using the following IBV 3’untranslated region (UTR) gene-specific primer 
and probe sequences as described previously (Jones et al., 2011): IBVRT1 forward 
primer CTA TCG CCA GGG AAA TGT C, IBVRT2 reverse primer GCG TCC TAG TGC TGT 
ACC C, IBVRT3 TaqMan® probe FAM-CCT GGA AAC GAA CGG TAG ACC CT-TAMRA. 
The qRT-PCR was performed according to the manufacturer’s instructions using the 
One-Step RT-PCR kit23 and 40 ng of total RNA per reaction (Appendix I). The cycling 
conditions were 10 min at 50°C and 5 min at 95°C, 40 cycles of 5 s at 95°C, 10 s at 
60°C annealing temperature and followed by a final step of 10 s at 72°C. 
Amplification plots were recorded, analyzed, and the threshold cycle (Ct) 
determined with the software of Rotor-Gene® Q thermocycler24. The Ct values were 
converted to log relative equivalent units (REU) of viral RNA by a standard curve 
generated using five 10-fold dilutions of extracted RNA from infective allantoic fluid 
of 106 EID50 of M41 as described earlier (Londt et al., 2013).  
 
 
 
 
 
 
 
                                                          
23
 Qiagen, UK 
24 Qiagen, UK 
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vi) RT-PCR protocol 
The RT-PCR amplification method used in this study was carried out as described 
previously for IBV (Worthington, et al., 2008) using oligonucleotides as given in 
Table 2.2. 
Table 2.2. Oligonucleotides used in RT- PCR amplification 
 
Step Oligonucleotides Sequence (5’ to 3’) Gene 
Product 
size (bp) 
Nested 
PCR 1 
SX1+ CACCTAGAGGTTTG T/C T A/T GCAT 
S1 393 
SX2- TCCACCTCTATAAACACC C/T TT 
Nested 
PCR 2 
SX3+ TAATACTGG C/T AATTTTTCAGA 
SX4- AATACAGATTGCTTACAACCACC 
 
a) Reverse transcription (RT) reaction  
A total of 5 µl of RT reaction mixture containing superscript II RT and one of the 
negative oligonucleotides (Appendix I) was taken into a 0.5 ml pre-labelled clip top 
Eppendorf tube25. This reaction mixture was overlaid with 2 drops of mineral oil26 
followed by addition of 0.5 µl of RNA under the oil. The RT reaction was carried out 
in a thermocycler 27 with the following cycle profile: 42oC for 1 hour, 72oC for 10 
min and then held indefinitely at 8oC. Positive and negative controls were included 
in each run. The cDNA was further amplified by using a nested PCR process. 
 
 
                                                          
25
 Elkay Laboratory Products UK (Ltd), Basingstoke, Hampshire, UK 
26 Sigma-Aldrich, UK 
27 GeneAmp PCR system 9700 
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 b) Nested PCR 1  
The first round PCR (nested PCR 1) was performed in a final volume of 25 l. The 
PCR reaction mixture (Appendix I) was thoroughly vortexed and dispensed in 20 l 
aliquots under the oil layer in each tube containing the RT-PCR product. The PCR 1 
reaction was performed using thermocycler with the following cycle conditions: 
94oC for     15 s followed by 35 cycles of 94oC for 10 s, 50oC for 20 s, and 72oC for 40 
s and then held indefinitely at 8oC. 
c) Nested PCR 2  
The total volume of the reaction mixture used for each PCR 2 reaction was 24.5 l 
(Appendix I). To 24.5µl of reaction mixture in a 0.5 ml clip top Eppendorf tube, 0.5µl 
of PCR 1 product was added. After gentle flick and quick spin, the tubes were 
placed in thermocycler. The nested PCR 2 reaction was performed using following 
cycle conditions: 94oC for 15 s followed by 35 cycles of 94oC for 10 s, 50oC for 20 s, 
and 72oC for 40 s and held indefinitely at 8oC. 
d) Agarose gel electrophoresis   
PCR products were run on a 1.5% w/v agarose gel prepared by dissolving agarose in 
1x TBE buffer (Tris-borate-EDTA) (Appendix I). This agarose solution was cooled, 
stained with 2 µl nucleic acid solution (RedsafeTM)28 and poured into a gel mould 
(12cm x 9cm) Hybaid Electro-4 gel tank.29. Each well in the agarose gel was loaded 
with 10 µl of product from PCR 2 mixed with 4 µl of loading buffer. A 100 bp ladder 
(Molecular marker)30 was also included for comparing the amplicon. The PCR 
                                                          
28
 Intron Biotechnology, Inc 
29 Hybaid Ltd, Middlesex, UK 
30 Amersham Pharmacia Biotech, UK 
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products were run at 75V for 55 min in 1x Tris-borate-EDTA (TBE) buffer (Appendix 
I).  The gels were viewed and analysed using UV transillumination.  
vii) DNA sequencing 
The positive nested PCR amplicons (393 bp)  were purified with 0.15 µl Exonuclease 
1 (EXO) 31 and 0.99 µl shrimp alkaline phosphatase (SAP) 23 at 37oC for 30 min and 
then at 80oC for 10 min. For direct sequencing, the purified products along with 
forward primer (SX3+; see table 2.2) were submitted to a commercial laboratory32. 
Alignment of sequences was done by  Clustal W (Thompson et al., 1994) and were 
compared with IBV references available in GenBank (National Centre of 
Biotechnology Information; http://www.ncbi.nlm.nih.gov/) and BLAST searches 
were performed to confirm the identification. 
2.5 Animals 
i) SPF and broiler chicks  
The SPF chicks were hatched in our facility (Figure 2.2) from fertile SPF eggs without 
any previous exposure to IBV i.e. lacking maternally-derived antibodies. The day-old 
commercial broiler chicks with IBV maternally-derived antibodies were procured 
from a commercial hatchery33. The details of these chicks are included in relevant 
chapters in which they were used. 
 
 
 
                                                          
31
 78250, Affymetrix 
32 Source bioscience sequencing, Nottingham, UK 
33 Frodsham Hatchery, Frodsham, UK 
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ii) Environment, housing and management for chickens 
The chickens were housed in the high containment experimental poultry facility at 
Leahurst campus (University of Liverpool), with ample access to food and water 
that was nutritionally complete and appropriate for the age of the chicks. Heat was 
supplied from an electrical heater which also served as a red light source when the 
Figure 2.2. (A to C) SPF eggs incubated at 37
o
C for 21 days for hatching. (D) 
Chicks in an isolation unit on deep litter system 
A B 
C D 
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main lighting was turned off to prevent any cannibalism amongst the birds. The 
chicks were reared on deep litter in the isolation pens. Appropriate room 
temperature and humidity was maintained and recorded daily. Approval was given 
by the University of Liverpool ethical review committee under the project license 
PPL 40/3723. According to the UK legislation all the correct animal care protocols 
were in place prior to the experiments. Strict biosecurity measures were in place 
throughout the experimental period to avoid the risk of cross contamination 
between different groups. These included footbaths with 2% Virkon34 disinfectant 
placed both outside and inside each experimental room and use of protective 
clothing (overalls, masks, latex gloves and boots). All used gowns, gloves, face 
masks and carcases were properly disposed of. 
2.6 Clinical signs and histopathology 
i) Assessment of clinical signs  
The experimental chickens were observed daily (for 3 min) for the development of 
clinical signs. The scoring of clinical signs was done as described previously (Grgic et 
al., 2008). The clinical signs such as coughing, head shaking and depression of short 
duration were considered as mild signs, whereas gasping, coughing and depression, 
along with ruffled feathers were recorded as severe signs.  
ii) Histopathology 
For histopathological examination, the upper part of the trachea and anterior 
kidney tissues of IBV infected and control chicks were fixed in 10% buffered 
formalin. The tissues were embedded in paraffin; sections of 5 μm thickness were 
cut for haematoxylin and eosin (H&E) staining. The histopathological changes in 
                                                          
34
 Antec International, Suffolk, UK 
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trachea and kidney were examined and scored based on visible changes as follows: 
0 = no change, 1= mild, 2 = moderate, 3 = severe (Chen & Itakura, 1996) 
iii) Examination of gross lesions  
Gross lesions were examined on all dead or scarified chicks and were scored 
according to the scoring system as described in Table 2.3. 
Table 2.3. Scoring system of gross lesions  
Tissue Lesions Scores 
 
Respiratory 
tract 
No lesions 0 
Congestion 1 
Mucoid exudate  2 
Caseous plug  or  airsacculitis, perihepatitis  and 
pericarditis 
3 
 
Kidney 
 
No lesion 0 
Swelling and pale 1 
Swelling with visible urate 2 
Large swelling, pale with tubules and ureters distended 
with urates 
3 
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2.7 Collection of samples 
i)  Blood  
Blood samples were collected from the wing vein of each chick using a 23-gauge 
sterile needle35 and 2 ml syringe8. For serology, after collection blood was kept 
individually in labelled bijou tubes without anticoagulant. To allow separation of 
serum, the tubes were placed in slanting position overnight at room temperature. 
Next day, sera was separated by centrifugation at 3,000 g for 10 min and stored at    
-20oC until used. To determine the percentage of T-lymphocyte subpopulations, 
blood was collected in tubes with heparin36 (at final concentration of 10 USP/ml of 
blood). 
ii) Tissues 
Following euthanasia of bird using of 0.5-1 ml of Euthatal37 through wing vein 
injection, tissue samples were collected aseptically and placed in labelled bijou 
tubes. The samples were securely transported to the laboratory and processed as 
soon as possible. In addition, severely affected challenged and all the remaining 
chickens at the end of each experiment were humanely killed by using the same 
method of euthanasia. 
 
 
 
 
                                                          
35
 Becton, Dickinson and Co. Ltd 
36 Sigma-Aldrich, UK 
37 Pentobarbitone sodium B.P., Rhone Merieux, Ireland 
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2.8 Analysis of cell death rate in CEK cells 
i) MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide reduction) 
assay 
The MTT assay was performed using CellTiter® 96, a non-radioactive cell 
proliferation assay kit38 as per manufacturer’s instructions. CEK cells were seeded 
on cell culture plates at a density of 1x105 cells/cm2. After incubation at 37°C for 48 
hours, 80-90% confluent monolayers were washed three times with PBS, and then 
mock-infected with the growth medium supplemented with 0.5% fetal bovine 
serum (Appendix I) or infected with different IBV strains at MOI of 1.0 in total 
volume of 100 µl. Plates were incubated at 37°C for 24 hours. After incubation, 15 
µl of the dye solution was added to each well and plates were further incubated at 
37°C for 4 hours. Finally for extracting the formazan produced in the cells, 100 µl of 
solubilisation solution/stop mix was added to each well. Absorbance values were 
measured using multi plate reader39 at 570 nm with gentle shaking before reading 
to ensure uniformly coloured solution. 
ii) Apoptosis by flow cytometry 
The CEK cells were seeded on cell culture plates at a density of 1x105 cells/cm2. 
After incubation at 37°C for 48 hours, 80-90% confluent monolayers were washed 
three times with PBS, and then mock-infected with the growth medium 
supplemented with 0.5% fetal bovine serum (Appendix I) or infected with different 
IBV strains at MOI of 1.0 in total volume of 100 µl. Cells were harvested at 24 and 
48 hpi. Briefly, cells were washed in PBS and removed from the cell culture plate by 
                                                          
38
 Promega, Madison, WI, USA 
39 Thermo Scientific, Multiskan FC, Finland 
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treatment with 0.25% trypsin solution (Appendix I), followed by washing of cells 
using growth medium containing serum (Appendix I) to neutralize the trypsin. The 
cells were then washed, resuspended in binding buffer40, and subsequently 
analyzed by staining with ApoAlert® Annexin V kit41 according to the 
manufacturer’s instructions using flow cytometer42. Fluorescence was quantified 
using CFlow software. The single-dye positive controls were prepared by staining 
representative cells with Fluorescein isothiocyanate  (FITC) and propidium iodide  
(PI) dye individually and used for estimation of proper colour compensation. The 
unstained cell sample was used as a negative control to adjust the threshold. 
2.9 Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay 
for detection of apoptotic cells in TOCs 
Detection of apoptotic cells in paraffin sections of TOC was performed with TUNEL 
assay using the peroxidase (POD) in situ cell death detection kit (Roche Diagnostics, 
Indianapolis, IN, USA) according to the manufacturer's instructions. A total of five 
sections were analyzed for each time point.  After de-waxing, the TOC sections 
were incubated with 0.1 % Triton X-10043 in 0.1% sodium citrate44 at room 
temperature for 8 min. After washing 3 times with PBS, sections were overlaid with 
50 μl TUNEL reaction mixture and incubated in a humidified atmosphere for 60 min 
at 37°C in the dark. After washing the specimen 3 times with PBS, 50 μl 
Converter-POD was added and slides were incubated in a humidified atmosphere 
                                                          
40
 Clontech, UK 
41 Clontech, UK 
42 BD Accuri C6, San Jose, CA 
43 Sigma-Aldrich, UK 
44 Sigma-Aldrich, UK 
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for 60 min at 37°C. Following incubation, sections were washed thrice with PBS and 
peroxidase reaction was developed using the DAB Peroxidase Substrate kit45 
according to the manufacturer's instructions. Sections were counter stained with 
hematoxylin46 for 1 min and mounted with Aquatex47. 
2.10 Serology 
i) ELISA 
To detect specific anti-IBV antibodies serum samples were tested with a 
commercial IBV ELISA IDEXX kit48, according to the manufacturer’s instructions. In 
brief, a dilution of 1:500 of serum samples was made in sample diluent buffer. One 
hundred µl of the diluted samples were pipetted into the antigen coated plates and 
incubated at room temperature for 30 min. Thereafter, plates were washed 3-5 
times with de-ionized water followed by addition of 100 µl of goat anti-chicken 
conjugate to each well. After incubation of the plates at room temperature for 30 
min followed by washing with de-ionized water, 100 µl of the tetramethylbenzidine 
(TMB) substrate solution was added to each well. The plates were incubated for 15 
min in the dark. Finally, the reaction was stopped by adding 100 µl of stopping 
solution to each well. Absorbance values were measured using multi plate reader49 
at 650 nm. For the results to be valid the mean of the negative control should be 
less than 0.150 and the difference between the positive control mean and negative 
control mean should be 0.075. The samples with sample to positive (S/P) ratio 
                                                          
45
 Vector Laboratories, UK  
46
 Merck, Germany 
47
 Merck, Germany 
48
 Ofddrop, The Netherlands 
49 Thermo Scientific, Multiskan FC, Finland 
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greater than 0.2 were considered positive. S/P ratio was used for calculation of 
titres using formula Log10 titre = 1.09 (log S/P) + 3.36. 
ii) Haemagglutination inhibition (HI) 
The Q1 HA antigen for HI test was prepared in our laboratory as described earlier 
(King & Hopkins, 1983). The Q1 HA antigen was prepared from allantoic virus which 
was propagated in ECEs as described above in 2.3.1.  The virus was concentrated 
from the allantoic fluid by ultracentrifugation50 at 30,000 g (Rotor SW 41 Ti) for 90 
min at 4oC. The virus pellet was resuspended to 1/100 of the original volume in 
2-hydroxy-ethyl-piperazine-N2-ethane sulphonic acid (HEPES) buffer (Appendix 1). 
This concentrated virus was treated with bacterial phospholipase C type I51             
(1 unit/ml) for 2 hours at 37°C and used as HA antigens in a HI test.  
The HI test was conducted according to standard procedures (OIE), using 4 HA units 
of antigen per well. Prior to the HI test, back-titration of the HA antigen was carried 
out to ascertain the 4 HAU. HI tests were carried out in microtiter "U" shaped 
plates52. Two fold serial dilutions (starting from 1:2) of 25 µl of serum samples was 
prepared in PBS followed by addition of 25 µl 4HA antigen. The plate was incubated 
at room temperature for 30 min. After that, 25 μl of 1% RBC suspension53 was 
added to each well. After mixing by gentle tapping plate was kept at room 
temperature for 40-60 min. HA was easily determined by tilting the plate to 
observe the presence of tear shaped streaming of the RBC’s in control wells. The HI 
                                                          
50
 Beckman Coulter, USA 
51
 Sigma-Aldrich, UK 
52
 Thermo Fisher Scientific, Denmark 
53
 Sci-Tech Laboratories, UK 
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titres were read as the reciprocal of the highest dilution showing complete 
inhibition and the HI geometric mean titres were expressed as reciprocal log
2
. 
2.11 Statistical analysis 
All the parametric data were analysed using the one-way analysis of variance 
(ANOVA), followed by the post-hoc least significant difference (LSD) multiple 
comparison test. Differences between groups were considered significant at 
P<0.05. For only the trachea and kidney lesion score and viral load the significant 
differences between the groups were analysed by Kruskal-Walis test followed by 
Dunn’s mean test. Differences between groups were considered significant at 
P<0.05. The Kruskal-Wallis test is considered an acceptable alternative to ANOVA, 
as it also looks to compare between different groups at different time point, but for 
nonparametric data instead. All the statistical analysis was done using GraphPad 
Prism version 6 software.  
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Chapter 3: Comparative study of in vitro cellular response to 
infection by different strains of infectious bronchitis virus 
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The data from this Chapter and Chapter 4 has been submitted (Appendix III) in 
peer-reviewed journal as below: 
 Rajesh Chhabra, Suresh V Kuchipudi, Julian Chantrey, and Kannan Ganapathy. 
(2015) Pathogenicity and tissue tropism of infectious bronchitis virus correlates to 
elevated apoptosis and innate immune responses. Virology 488 (1): 232-241. 
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3.1 Introduction 
Infectious bronchitis (IB) is an acute and highly contagious disease affecting chicken 
of all ages and is characterized by lesions in respiratory and urogenital organs 
(Cavanagh, 2007; Dolz et al., 2006) caused by a gamma coronavirus. Avian 
infectious bronchitis virus (IBV) continues to cause serious economic losses in 
chicken production globally. Along with highly pathogenic avian influenza virus 
(HPAIV) and velogenic Newcastle disease virus (NDV) infections, IB is the most 
economically relevant viral respiratory disease of poultry industry (Cook, et al., 
2012). Vaccination has been considered as the most reliable approach for 
controlling IBV infection (Meeusen et al., 2007). However, current vaccines are 
proven to be inadequate in controlling IBV due to constant emergence of new 
variant viruses (De Wit, 2000; de Wit, et al., 2011). Concurrent circulation of both 
classic and variant IBVs has been identified in most parts of the world raising major 
challenges to global prevention and control efforts. 
In past two decades the majority of the serotypes/genotypes that have emerged 
appear to be endemic (Bochkov, et al., 2006). IBV QX was first reported in China in 
1996 from birds with proventriculitis (YuDong, 1998). Later QX was reported from 
Russia and then to Europe and rapidly spread to become the most widespread 
recent genotype of non-vaccine origin (Bochkov, et al., 2006; Worthington, et al., 
2008). In the UK, IBV QX-like was isolated from proventriculus of broilers with poor 
FCR and body weight gain also showing respiratory signs (Ganapathy, et al., 2012).  
This genotype of IBV mainly affects the respiratory and reproductive systems 
(Ducatez, et al., 2009; Terregino, Toffan, Beato, et al., 2008). In addition to these 
lesions, the QX-like serotype has been associated with proventriculitis (YuDong, 
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1998) severe kidney damage (Ganapathy, et al., 2012; Liu & Kong, 2004; Terregino, 
Toffan, Beato, et al., 2008; Worthington, et al., 2008) and false-layer syndrome (de 
Wit, et al., 2011; Landman, 2005).  
In the winter of 2000, a severe outbreak of renal disease occurred in several broiler 
farms, causing great economic loss to the Israeli broiler industry as a result of 
mortality and poor weight gain of the birds. The causative agent was determined to 
be a nephropathogenic infectious bronchitis virus (NIBV) by virus isolation from 
kidneys and molecular characterization of the isolate, designated IS/885/00 and 
protection studies have shown that Mass vaccines provide inadequate protection 
against this novel variants (Meir et al., 2004). Later on in Egypt in addition to 
circulation of Massachusetts, 793B, QX and Dutch strains, the strains similar to 885 
was reported by (Abdel-Moneim et al., 2006). Of late, 885 has also been detected 
in France and  Ukraine (Ganapathy, personal communication), and Libya (Awad et 
al., 2014). 
Despite the economic importance of IBV and decades of research into the 
pathogenesis of infection, significant gaps in our knowledge exist. The field cases 
reported until now suggest that these strains have tropism for many organs and 
high pathogenicity, which provides a unique opportunity to dissect the molecular 
mechanisms contributing these differences. Differences in the tissue tropism and 
thus differences in the pathogenicity of IBV strains have been hypothesised to be 
associated with differences in the binding properties of their spike proteins (Casais, 
et al., 2003; Wickramasinghe et al., 2011). While the ability to bind to susceptible 
host cells is the first step in virus life cycle, host innate immune responses could 
also be important in the pathological outcome of IBV infection. Variant IBVs 
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constantly emerge and the host determinants of IBV pathogenicity are not yet fully 
understood. Early host innate immune responses and apoptosis of infected cells in 
vitro could be useful indicators for predicting the pathological outcome of viral 
infection in vivo. For example the three different genotypes of NDV produce 
distinct host response patterns in chicken spleenocytes which is useful to 
differentiate the NDV genotypes (Hu et al., 2012).  However, the pattern of virus 
infection in vitro or ex vivo to differentiate IBV strains with different tissue tropism 
is not fully understood. In order to establish a host response signature to predict 
the tissue tropism and pathogenicity of IBVs, we investigated apoptosis and innate 
immune responses in chicken embryo kidney (CEK) cells following infection with 
885, QX and M41 IBV strains.  
3.2 Materials and methods 
3.2.1 Cell Culture 
Monolayers of primary CEK cells were prepared from kidneys of SPF ECE as 
described in Chapter 2.1.ii.  
3.2.2 Viruses 
To widen the range of IBV strains, in the present study, we used a traditional strain, 
M41, and two variant IBV strains, IS/885/00-like and QX-like (Table 3.1). IS/885/00 
causes mortality, poor weight gain and severe renal damages (Meir, et al., 2004), 
while QX causes economic problems in most of Europe and other parts of the world 
through renal and reproductive problems (de Wit et al., 2012). In this study, 
IS/885/00-like isolate (885) (Awad et al., 2013) and a UK QX isolate, strain KG3P 
(Ganapathy, et al., 2012) were used. These viruses were isolated in SPF ECE as 
described in in Chapter 2.3.i from either tracheal or kidney tissue collected from 
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field cases. All IBV strains were propagated in chicken TOCs prepared from 19 to 
20-dayold SPF ECE as per method described in Chapter 2.3.ii. (Cook, et al., 1976b). 
For CEK cell infection, all IBV strains were titrated on CEK cells using an immune 
cytochemical focus assay as described in Chapter 2.3.iv (Nelli, et al., 2012).  
Table 3.1 Details of infectious bronchitis viruses used in this study 
Virus Source Passage level 
Israeli variant 
IS/885 
 
Received as third passage AF 
from the Istituto 
Zooprofilattico Sperimentale 
delle Venezie, Padova, Italy 
AF went through four 
further passages in ECEs 
and 2 passages in TOCs 
QX Isolated in our laboratory 
from proventriculus from a 
flock of 
56-do commercial broiler 
chickens 
Went through five 
passages in ECEs and 2 
passages in TOCs 
Massachusetts type 
M41 
From Prof. R C Jones, 
Leahurst 
Obtained after numerous 
number of passages in 
ECEs and 2 passages in 
TOCs. 
 
3.2.3 Virus infection of CEK cells 
CEK cells were seeded on cell culture plates at a density of 1x105 cells/cm2. After 
incubation at 37°C for 48 hours, 80-90% confluent monolayers were washed three 
times with PBS, and then infected with different IBV strains. Initially, to assess the 
effect of viral infection on primary CEK cells, cultured CEK cells were infected with 
different IBV strains at a range of MOI from 0.25 to 4.0 and quantified the cell 
metabolic activity at 24 and 48 hpi using a 3-(4, 5-dimethylthiazol-2-yl)-2, 
5-diphenyltetrazolium bromide reduction (MTT) assay. Based on the preliminary 
results, finally CEK cells were infected with different IBV strains at a MOI of 1.0 or 
mock-infected with cell culture medium (Appendix I). Triplicate wells were used for 
each virus or mock infection for each time point. Cells were analyzed at 24 and 48 
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hpi to determine the effect of virus infection on cell metabolic activity, induction of 
apoptosis, and cell culture supernatant were titrated for infectious virus. At 9 and 
24 hpi cell pellets were collected in RLT buffer and total RNA was extracted using 
RNeasy Mini kit as described in Chapter 2.4.i followed by cDNA synthesis as 
described in Chapter 2.4.iii. The cDNA were used for the quantification of host gene 
expression analysis. 
3.2.4 Measurement of cell metabolic activity by MTT assay 
CEK cells in 96-well cell culture plates were analysed for metabolic activity at 24 
and 48 hpi using CellTiter 96, a non-radioactive cell proliferation assay according to 
procedure described in Chapter 2.8.i. 
3.2.5 Analysis of apoptosis by flow cytometry 
CEK cells at 24 and 48 hours after virus or mock infection were analysed to quantify 
percent of apoptosis by flow cytometry as described in Chapter 2.8.ii. 
3.2.6 Quantification of infectious virus 
Supernatants from virus infected or mock-infected CEK cells were titrated for 
infectious virus in TOCs following method described in Chapter 2.3.iii and expressed 
as CD50/ml (Cook, et al., 1976b). 
3.2.7 Host gene expression analysis 
Quantitative reverse transcription PCR (qRT-PCR) of cDNA samples in triplicate was 
performed on the LightCycler® 480 using LightCycler 480 SYBR Green I Master mix 
(Roche, UK) as described in Chapter 2.4.iv. QRT-PCR data was normalized using a 
relative standard curve method to 18S ribosomal RNA (18SrRNA) expression 
(Kuchipudi, Tellabati, et al., 2012) and the data were presented as fold difference in 
gene expression of virus vs mock-infected samples. 
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3.2.8 Statistical analysis 
The data were analysed using one-way ANOVA, followed by the post-hoc LSD 
multiple comparison test using GraphPad Prism version 6 software LSD. Differences 
between groups at that time point were considered significant at P<0.05.  
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3.3 Results 
CEK cells infected with IBV strains 885, QX, M41 at MOI 1.0 or mock-infected were 
subjected to immuno-cytochemical staining of viral nucleoprotein at 6 hpi. The 
dose used resulted in similar level of infectivity in CEK cells across all the three virus 
strains (Figure 3.1) 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. CEK cells infected with (A) 885, (B) QX, (C) M41 or (D) mock-infected and 
immuno-cyto chemical staining of viral nucleoprotein at 6 hpi revealed similar levels 
of infection of all the three viruses. 
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3.3.1 MTT assay 
In cell metabolic activity assay using MTT, we found a significant (P<0.05) reduction 
in the cell metabolic activity in IBV infected CEK cells compared with mock-infected 
cells both at 24 and 48 hpi (Figure 3.2). The pattern of reduction in cell metabolic 
activity was dose dependent both at 24 (Figure 3.2, A) and 48 hpi (Figure 3.2, B) by 
all the three viruses, since with increasing level of infection greater reductions in 
cell metabolic activity was noticed. In addition, at 48 hpi, significantly lower 
(P<0.05) metabolic activity was observed in CEK cells infected by all the three 
strains than at 24 hpi (Table 3.1). 
At MOI 1.0, after 24 hpi cell metabolic activity of CEK cells infected by 885 and QX 
showed no significant (P<0.05) difference and were overall significantly lower 
(P<0.05) than M41 infected cells (Figure 3.3). Thereafter, at 48 hpi, cell metabolic 
activity of CEK cells infected with 885 was overall significantly lower (P<0.05) 
followed by QX and M41 (Figure 3.3). 
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Figure 3.2. Measurement of cell metabolic activity of CEK cells, using an MTT assay, 
infected with different strains of IBVs, with a range of MOI from 0.25 to 4.0, at (A) 
24 hpi (B) 48 hpi. Data represents mean of triplicate wells with error bar showing 
standard error. Significant differences between the groups were detected by one-
way ANOVA, followed by the post-hoc LSD multiple comparison test (P<0.05). 
0.3000
0.4000
0.5000
0.6000
0.7000
0.8000
0.9000
No virus 0.25 0.5 1 2 4
M
ea
n
 a
b
so
rb
an
ce
 v
al
u
e
 
885 M41 QX
0.3000
0.4000
0.5000
0.6000
0.7000
0.8000
0.9000
No virus 0.25 0.5 1 2 4
M
ea
n
 a
b
so
rb
an
ce
 v
al
u
e
 
Multiplicity of infection (MOI) 
A 
B 
 
 
 
                            Chapter Three                                                              In vitro cellular response to different IBVs           
76 
 
 
Table 3.1. Mean absorbance value by MTT assay of primary CEK cells infected with different IBV strains 885, QX, M41 or 
mock-infected 
 (Values are Mean±SE) 
 
 
 
 
 
 
 
 
 
* Different letter indicate statistically significant difference  (P<0.05)
MOI 
24 hours post infection 48 hours post infection 
Mock-infected 885 M41 QX Mock-infected 885 M41 QX 
0.25 0.8146±0.012
B 
0.8326±0.088
A
 0.8210±0,004
B 
0.7475±0.004
C 
0.8241±0.013
A
 
 0.6525±0.022
E 
0.7407±0.004
C 
0.7110±0.014
D 
0.5 0.8146±0.012
A 
0.7822±0.009
B 0.8126±0.008
A 
0.7300±0.011
C 0.8241±0.013
A 
 0.6379±0.008
D 
0.7336±0.010
B 
0.6921±0.009
C 
1.0 0.8146±0.012
A 
0.7192±0.013
D 0.7913±0.008
B 
0.7301±0.010
D 0.8241±0.013
A 
 0.5974±0.015
D 
0.6694±0.006
C 0.6882±0.014
B 
2.0 0.8146±0.012
A 
0.6682±0.017
D 
0.7616±0.020
B 
0.6776±0.012
D 
0.8241±0.013
A 
 0.5791±0.022
C 
0.6393±0.006
B 
0.5986±0.017
C 
4.0 0.8146±0.012
A 
0.4173±0.012
C 
0.4408±0.019
B 
0.4140±0.009
C 
0.8241±0.013
A 
 0.3857±0.010
C 
0.4070±0.004
B 
0.3816±0.019
C 
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Figure 3.3. IBV induced cell metabolic activity in CEK cells. The cells were infected 
with 885, QX, M41 at MOI 1.0 or mock-infected and analyzed using MTT asssay at 
designated time points after infection. Data represents mean of triplicate wells 
with error bar showing standard error. Significant differences between the groups 
were detected by one-way ANOVA, followed by the post-hoc LSD multiple 
comparison test indicated with different letters (P<0.05). 
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3.3.2 Flow cytometry analysis of apoptosis 
In cell metabolic activity assay using MTT, was observed a reduction in the cell 
metabolic activity in IBV infected CEK cells compared with mock infected cells. 
Therefore, we examined whether the differences in the cell metabolic activity were 
due to different levels of apoptosis induction. The CEK cells were infected with 
different strains of IBV at MOI 1.0 or mock-infected and analysed for apoptosis at 
24 and 48 hpi. We found a significantly (P<0.05) increased in apoptosis in IBV 
infected CEK cells compared with mock-infected cells both at 24 and 48h after virus 
infection (Figure 3.4). Notably, infection of CEK cells with IBV strains 885 and QX 
resulted in significantly (P<0.05) higher apoptosis than M41 both at 24 and 48 hpi  
(Figure 3.4). 
 
 
  
 
 
 
Figure 3.4. IBV induced apoptosis in CEK cells measured by flow cytometry. CEK 
cells were infected with different strains of IBVs at an MOI of 0.1 or mock-infected 
and analysed for apoptosis at designated time points after infection. Data 
represents mean of triplicate wells with error bar showing standard error. 
Significant differences between the groups were detected by one-way ANOVA, 
followed by the post-hoc LSD multiple comparison test indicated with different 
letters (P<0.05). 
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3.3.3 Viral output in cell culture supernatant 
To determine the difference in the level of infectious virus produced following 
infection with different IBVs, we titrated the cell culture supernatants in the TOCs. 
Interestingly, IBV strains 885 or QX infection resulted in significantly (P<0.05) lower 
infectious virus production from CEK cells at 24 and 48 hpi compared with M41 
infected cells (Figure 3.5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5. CEK cells were infected with the indicated viruses at an MOI of 1.0. Virus 
production in the cell culture supernatants were determined in chicken embryo 
TOCs at the indicated times post infection. Data show the mean values (n=3) with 
standard error. Significant differences between the groups were detected by one-
way ANOVA, followed by the post-hoc LSD multiple comparison test indicated with 
different letters (P<0.05). 
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3.3. 4 Host gene expression 
Next, various host genes involved in the response to the IBV infections were 
analyzed for alterations in mRNA levels in CEK cells. 
3.3.4.1 Transcripts involved in viral recognition 
The mRNA expression data for LGP2, MDA5, TLR1, TLR2, TLR3 and TLR7 in CEK cells 
are illustrated in Figure 3.6. The LGP2 mRNA expression was significantly (P<0.05) 
down-regulated at 24 hpi in M41 and QX infected groups, but there was no 
significant change in expression level in 885 infected group (Figure 3.6 A). For 
MDA5 mRNA expression, a significant up-regulation (P<0.05) was observed at 9 hpi 
in all IBV infected groups compared with mock-infected group, with no significant 
(P<0.05) difference between expression level of 885 and QX whereas, it was 
significantly higher than M41 (Figure 3.6 B). The MDA5 mRNA expression was 
significantly down-regulated (P<0.05) at 24 hpi in all IBV infected groups compared 
with mock-infected (Figure 3.6 B). At 9 hpi, there was no significant (P<0.05) 
difference in the TLR1 (Figure 3.6, C), TLR2 (Figure 3.6 D) and TLR7 (Figure 3.6 F) 
mRNA expression levels when comparing IBV infected groups to the mock-infected 
group. Expression of TLR1 and TLR2 mRNA were also seen to have a significant 
down-regulation (P<0.05) compared with mock-infected group at 24 hpi. However, 
there was no significant (P<0.05) change of expression of mRNA for TLR7 at 24 hpi. 
Conversely, TLR3 mRNA expression (Figure 3.6 E) was significantly (P<0.05) 
up-regulated in 885 and QX infected groups than M41 at 9 hpi, whereas at 24 hpi, a 
significant down-regulation (P<0.05) was seen in QX infected group.  
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Figure. 3.6. Relative mRNA expression of (A) LGP2, (B) MDA5, (C) TLR1, (D) TLR2, (E) 
TLR3, (F) TLR7 in CEK cells infected with IBV strains 885, QX, or M41 at MOI 1.0.  
Relative mRNA expression was determined by real-time PCR normalised to 18S 
rRNA. Graphed values are the mean of three biological replicates with error bars as 
standard error and are expressed as fold change relative to the mock-infected 
group. Significant differences between the groups were detected by one-way 
ANOVA, followed by the post-hoc LSD multiple comparison test indicated with 
different letters (P<0.05). 
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3.3.4.2 Interferons, Cytokines and related transcripts 
The mRNA expression data for INF-α and INF-β is illustrated in Figure 3.7 A & B 
respectively. There was no significant (P<0.05) change in INF-α mRNA expression 
levels at 9 hpi in any of the infected groups compared with mock-infected group, 
whereas at 24 hpi, a significant (P<0.05) down-regulation was seen in all infected 
groups compared with mock-infected group (Figure 3.7 A). At 9 hpi, expression 
level of INF-β mRNA significantly (P<0.05) up-regulated in 885 infected group 
followed by QX, whereas no significant (P<0.05) change was observed in M41 
infected group compared with mock-infected group (Figure 3.7 B). At 24 hpi, a 
significant (P<0.05) down-regulation was seen in all infected groups compared with 
mock-infected group. 
Regarding mRNA expression of major pro-inflammatory cytokines involved in 
innate immune response such as IL-1β (Figure 3.7, D), IL-8 (Figure 3.7 E), and the 
inflammation associated NLRP3 (Figure 3.7 F) seen to have no significant change at 
9 hpi and trend of down-regulation compared with mock-infected group  was 
noticed at 24 hpi (P<0.05) (Figure 3.7). IL-6 mRNA expression at 9 hpi was found to 
have significant (P<0.05) up-regulation only in 885 infected group, whereas at 24 
hpi, there was no significant change in mRNA expression in any infected group 
(Figure 3.7 D). 
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Figure. 3.7. Relative mRNA expression of (A) INF-α, (B) INF-β, (C) IL-6, (D) IL-1β, (E) 
IL-8, (F) NLRP3 in CEK cells infected with IBV strains 885, QX, or M41 at MOI 1.0.  
Relative mRNA expression was determined by real-time PCR normalised to 18S 
rRNA. Graphed values are the mean of three biological replicates with error bars as 
standard error and are expressed as fold change relative to the mock-infected 
group. Significant differences between the groups were detected by one-way 
ANOVA, followed by the post-hoc LSD multiple comparison test indicated with 
different letters (P<0.05). 
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3.4 Discussion 
Though the primary target organ of IBV is the epithelial surface of the respiratory 
tract, the virus also infects several non-respiratory tissues, such as the 
gastrointestinal tract, the oviduct, and the kidney (Ganapathy, et al., 2012). 
Infection and replication in the kidney might cause mild to severe lesions 
depending on the IBV strain (Delmas, 1990). To investigate the role of apoptosis 
and innate immune responses, in order to institute a host response signature to 
envisage the tissue tropism and pathogenicity of IBVs, chicken embryo kidney (CEK) 
cells were infected with IBV strains 885, QX and M41.  
To assess the effect of infection on CEK cells, we infected CEK cells with different 
IBV strains and further quantified the metabolic activity of cells, using MTT assay. 
Overall a significantly higher death rate of CEK cells was observed in all infected 
groups compared with mock-infected and, as was expected, the effect was dose 
dependent, with increasing levels of infection inducing greater cell death rate. 
Similar phenomena of dose dependent cell death rate was observed with canine 
coronavirus (CCoV), wherein, at 48 hpi in A-72 cells proliferation rate was reduced 
by two/three times compared to the uninfected control cells at two different MOI 
chosen and was dose dependent (Ruggieri et al., 2007). 
A variety of viruses have been shown to induce apoptosis or programmed cell 
death in host cells (Clarke & Tyler, 2009; Shen & Shenk, 1995; Teodoro & Branton, 
1997). IBVs are known to induce apoptosis in infected cells and B-cell lymphoma 2 
(Bcl-2) family proteins modulate IBV-induced apoptosis (Li, et al., 2007; Liu, et al., 
2001; Zhong, Liao, et al., 2012; Zhong, Tan, et al., 2012). The modulation of Bcl-2 
family proteins during IBV infection has also been postulated to be under the 
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regulation of signalling pathways such as endoplasmic reticulum (ER) stress and 
Mitogen-Activated Protein Kinase/Extracellular signal-Regulated Kinase 
(MAPK/ERK) pathways (Fung & Liu, 2014; Zhong, Liao, et al., 2012). Further, IBV 
infection results in a growth-inhibitory effect by inducing cell cycle arrest at S and 
G2/M phases (Li, et al., 2007) both of which results in apoptosis. Therefore, due to 
the difference in induction of cell death following infection with different IBV 
strains in CEK cells, we investigated the potential role of apoptosis as a cause of this 
phenomenon at 24 and 48 hpi.  
Our findings indicate that more rapid cell death, with features of apoptosis was 
higher in CEK cells infected with 885 and QX than M41. Apoptosis is a cell-death 
programme that is initiated in response to various extrinsic and intrinsic signals 
such as cellular stress, including virus infection, and plays an important role in the 
pathogenesis of many viruses (Wang et al., 2007). Should this phenomenon occur 
in vivo in case of IBV, apoptosis and cellular destruction of kidney tissue are 
correlated. Earlier work by (Benyeda et al., 2010), reported that mild 
histopathological lesions in kidney were recorded in infection of chickens with M41 
and 793B strain, while the nephropathogenic effect of the QX-like strains was 
greater and confirmed the high affinity of this strains for the kidney. The potential 
for apoptosis to cause such tissue damage has also been recognized for the 
Coronavirus infections, wherein, apoptosis in different cell types was found to be 
consistent with the clinical observation of apoptosis in different organs infected by 
SARS-CoV (Tan et al., 2004).  
The IBV strains 885 and QX resulted in significantly higher up-regulation of innate 
immune sensing genes TLR3 and MDA5 along with higher IFN-β mRNA levels in CEK 
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cells at 9 hpi than M41 infection. Concurrent with our findings, a previous study 
observed a significant increase of TLR3 mRNA expression in both trachea and lungs 
of IBV infected chickens when compared to the uninfected controls (Kameka, et al., 
2014). We did not find any particular pattern of regulation of genes namely TLR1 
and TLR2.   
TLR3 and TLR7 are well known for recognition of RNA virus encoded pathogen 
associated molecular patterns (PAMPs) (Akira, 2001). TLR7 was not significantly 
affected by IBV infection in CEK cells. The end products of TLR3 signalling pathway 
is the production of anti-viral type I interferon (IFN)-α and -β, whereas and TLR7 
activation results in the production of pro-inflammatory cytokines (Guillot et al., 
2005). Concurrent with TLR3 activation, we found a significant up-regulation of 
IFN-β but not IFN-α mRNA expression at 9 hours after IBV infection in CEK cells. 
Likewise, lack of TLR7 induction correlated with no change in the expression of 
pro-inflammatory cytokines namely IL-1β, IL-8 and NLRP3 in IBV infected CEK cells. 
In contrast to our findings, a recent study found that IFN-β transcription was not 
found in CEK cells until 12 hours after infection with IBV M41 at MOI of 0.1 (Kint, et 
al., 2015). This difference may have been due to differences in the MOI used and 
origin of cells. Notably, expression of all the innate immune genes tested, was 
down-regulated at 24 hours after IBV infection in CEK cells. This could be a 
consequence of host shut-off induced by IBV virus replication. Coronaviruses are 
known to down-regulate host gene expression and host mRNA degradation in order 
to suppress host innate immune response (Kamitani et al., 2006; Tohya et al., 
2009). Corona virus nucelocapsid (N) protein has been shown to interfere with the 
2',5'-oligoadenylate synthetase/RNaseL (2'–5' OAS) activation, which is responsible 
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for Type I IFN induction and can also inhibit the production of various pro-
inflammatory cytokines and chemokines via global translational shutdown (Ye et 
al., 2007; Zhong, Tan, et al., 2012). 
Several in vitro and ex vivo studies have suggested a key role of TLR3 in viral 
detection (Alexopoulou et al., 2001; Bowie & Haga, 2005; Finberg & Kurt-Jones, 
2004; Tabeta et al., 2004). However, recent evidence suggests TLR3 contributes to 
detrimental effects of viral infections. TLR3 mediates West Nile virus entry into the 
brain, causing lethal encephalitis (Wang et al., 2004) and contributes to a 
detrimental inflammatory response to influenza virus infection in mice resulting in 
acute pneumonia (Le Goffic, et al., 2007). A recent study showed that MDA5, but 
not TLR3, is involved in the sensing of IBV (Kint, et al., 2015). However, higher 
mRNA levels of MDA5 and TLR3 correlated with the in vivo pathogenicity of the IBV 
strains used in this study, such that more nephropathogenic strains like 885 and QX 
induced much higher levels in CEK cells. It is possible that MDA5 activation is a 
protective antiviral host response against the virus whereas TLR3 contributes the 
detrimental effects of the viral infection.  The precise role of MDA5 and TLR3 in 
host defence against IBV infection and/or disease pathogenesis is not yet fully 
understood and hence, warrants further in-depth studies.   
The LGP2 expression was significantly increased at 9 hpi but was down-regulated at 
24 hpi in CEK cells. LGP2 functions as a negative regulator by interfering with the 
recognition of viral RNA by RIG-I and MDA5 (Yoneyama et al., 2005). MDA5 is IFN-
inducible (Kang et al., 2004); once IFN response is triggered, this innate antiviral 
loop initiates autoamplification of MDA5 until the natural inhibitor LGP2 is induced 
(Yoneyama, et al., 2005). However, we found that the expression of LGP2, MDA5 
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and IFN-β mRNA levels were down-regulated at 24 hpi, possibly due to the virus 
induced host gene shutoff. Similar to our findings, a recent study also reported a 
down-regulation of TLR3, IL-1β and IFN-γ expression in IBV infected chicken trachea 
at 12 hpi (Kameka, et al., 2014). Cells were infected at MOI of 1.0 in this study; 
infection at a lower MOI could be helpful to profile the effect of LGP2 on MDA5 and 
IFN-β regulation in IBV infected cells. 
Interestingly, IBV strains 885 or QX infection resulted in significantly lower 
infectious virus production from CEK cells at 24 and 48 hpi compared with M41 
infected cells. In fact, in case of virus-infected cells, the induction of cell death by 
apoptosis can either reduce viral spread in the host by early killing of infected cells, 
or facilitate viral progeny dissemination, through apoptotic bodies, which hides the 
virus antigen and limits induction of inflammatory and immune response (Koyama 
et al., 2000). Notably, in our study higher apoptosis and IFN-β expression correlated 
with significantly lower infectious virus production from CEK cells. This could be 
due to increased antiviral state induced by IFN-β and/or increased apoptosis. 
Apoptosis of cultured cells have previously been shown to be associated with 
reduced production of infectious influenza virus in duck cells (Kuchipudi, Dunham, 
et al., 2012).  
In summary, IBV strains 885 and QX induced stronger innate immune (TLR3, MDA5 
and IFN-β) and cell death responses (apoptosis) than M41 in CEK cells. This in vitro 
evidence indicates that higher apoptosis together with elevated levels of TLR3, 
MDA5 and IFN-β expression correlates to pathogenicity of IBVs in kidney (CEK cells) 
tissues. This study also highlights that this host response signature could be useful 
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to make a predictive prognosis of the tissue tropism of novel IBV strains using CEK 
cells.
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The data from this Chapter and Chapter 3 have been submitted (Appendix III) in 
peer-reviewed journal as below: 
 Rajesh Chhabra, Suresh V Kuchipudi, Julian Chantrey, and Kannan Ganapathy. 
(2015) Pathogenicity and tissue tropism of infectious bronchitis virus correlates to 
elevated apoptosis and innate immune responses. Virology 488 (1): 232-241. 
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4.1 Introduction 
Infectious bronchitis is an acute and highly contagious disease pathogen affecting 
chickens of all ages and causes lesions in respiratory and urogenital organs 
(Cavanagh, 2007; Dolz, et al., 2006; Jackwood & de Wit, 2013). It causes enormous 
economic problems in poultry flocks that are often difficult to control by current 
vaccines or vaccination programmes that are based on the prevalent IBV strains in 
the field (Sjaak de Wit, et al., 2011). However, the constant emergence of new IBV 
variants complicates the control of the disease. The IBV isolates present a high 
antigenic diversity (Hofstad, 1975) and  emergent strains that differ in antigenic 
properties, tissue tropism and pathogenicity are continuously being reported 
across the world (Gelb, Lunt, et al., 1991; Jackwood, 2012; Shaw et al., 1996; 
Zanella et al., 2000).  While all IBV strains appear to infect the birds via the 
respiratory tract, they subsequently reach secondary sites for further replication 
and persistence. An example is IBV strain M41, which though primarily replicates in 
the respiratory tract, is also able to replicate in a range of tissues. In contrast, other 
strains of IBV such as strain IS/885/00 are primarily nephropathogenic.  IS/885/00, 
referred as a nephropathogenic infectious bronchitis virus (NIBV), was first isolated 
from a severe outbreak of renal disease in several broiler farms in Israel (Meir, et 
al., 2004). In recent years, IBV strain QX, which mainly affects the respiratory and 
reproductive systems, is widespread among poultry flocks in many countries 
(Ducatez, et al., 2009; Terregino, Toffan, Beato, et al., 2008). In addition, QX-like 
serotypes have also been associated with proventriculitis (YuDong, 1998) and 
severe kidney damage (Ganapathy, et al., 2012; Liu & Kong, 2004; Terregino, 
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Toffan, Beato, et al., 2008; Worthington, et al., 2008) suggesting their broad tissue 
tropism. 
Cook & Huggins (1986) noted that the evaluation of the pathogenicity of IBV strains 
for the respiratory tissue has been difficult to quantify. Cubillos et al. (1991) 
suggested differences in virulence of IBV strains for the trachea based on the 
variability of the tracheal damage in terms of ciliary activity in unvaccinated 
chickens. Raj and Jones (1996a) also reported little difference among several IBV 
strain s using measurement of ciliary activity as a criterion for damage to the 
tracheal epithelium. Later a study on comparative analysis of the sialic acid binding 
activity of four different IBV strains demonstrated that sialic acid binding is 
important for the tracheal epithelium by all four strains used in the study (Abd El 
Rahman, et al., 2009). It was also reported that the strains differed in their 
efficiency to infect the tracheal epithelium.  
Interactions between viruses and hosts occur at two levels: viral capacity to gain 
access to the target cell and competition between the viruses and host cells to 
control the cellular protein synthesis machinery. The virus/host interactions are 
largely determined by the virulence of the pathogen and the host innate immune 
response (Schneider & Shenk, 1987). In addition, occurrence of cell death by 
apoptosis has been observed during infection with IBV (Li, et al., 2007; Liu, et al., 
2001; Zhong, Liao, et al., 2012; Zhong, Tan, et al., 2012). Since IBV is highly variable 
therefore, studying IBV alone to develop control strategies against IB outbreaks is 
not sufficient (Sjaak de Wit, et al., 2011). As viruses and hosts show coevolution, so 
enhancing our knowledge of host responses against IBV will be helpful to protect 
the poultry industry from the menace of IB. Based on these findings, we 
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hypothesize that early host innate immune responses and apoptosis of infected 
TOCs could be useful indicators for predicting the pathological outcome of viral 
infection in vivo. In this study comparative analysis of changes in viral growth 
kinetics, induction of apoptosis and the early host innate immune responses at host 
transcriptional level after infection of chicken TOCs with 885, QX and M41 strains of 
IBV was undertaken. 
4.2 Materials and methods 
4.2.1 Tracheal organ culture 
TOCs were prepared from tracheas of SPF ECE as described in Chapter 2.1.iii.  
4.2.2 Viruses 
To cover a range of different virus strains in the present study we have used a 
pathogenic M41, the currently important IBV variant IS/885/00 (Meir, et al., 2004) 
and a QX variant (de Wit et al., 2012) Details of the viruses are described in Chapter 
3.2.2). All IBV strains were propagated in chicken TOCs prepared from 19 to 20-
dayold SPF ECE as per method described in Chapter 2.3.ii. (Cook, et al., 1976b).  For 
TOCs infection,  all IBV strains were titrated on TOCs as described  in Chapter 2.3.iii 
and expressed as CD50/ml (Cook, et al., 1976b). 
4.2.3 Virus infection of TOCs 
TOCs were infected 5 days after preparation to allow the early inflammatory 
responses of the tissue to subside (Reemers et al., 2009). TOCs were infected with 
IBV strains using a dose of 4 log10 CD50 per individual ring or mock-infected with 
TOC medium (Appendix I) without virus. Five rings were used for each virus or mock 
infection for each time point. The infection dose of 4 log10 CD50 was chosen based 
on a preliminary study wherein, this dose caused 100% ciliostatsis in TOC by day 3 
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of infection. For quantification of ciliostasis, TOC were examined at 24 and 48 hpi 
under an inverted microscope to determine the relative ciliary activity (RCA). 
Samples of TOC supernatant or complete rings were collected at 9, 24 and 48 hpi. 
TOC rings fixed in 4% paraformaldehyde (PFA) (Appendix I) were analysed for 
apoptotic cells using in situ Terminal deoxynucleotidyl transferase dUTP nick end 
labelling (TUNEL) assay and supernatants were titrated for quantification of 
infectious virus at 24 and 48hpi. Total RNA was extracted from TOC rings collected 
at 9 and 24 hpi using RNeasy Mini kit as described in Chapter 2.4.i followed by 
cDNA synthesis as described in Chapter 2.4.iii. The cDNA were used for the 
quantification of host gene expression analysis. 
4.2.4 Quantification of ciliostatsis  
The proportion of the periphery of the tracheal rings with ciliary beating was 
assessed at every point time and expressed as peripheral ciliary activity (PCA). The 
ciliary vigour was scored as follows: 3 for fast harmonic beating, 2 for moderate 
co-ordinated beating, 1 for slow in coordinated beating and 0 for lack of beating as 
described previously (Gabridge et al., 1974; Stadtlander et al., 1991).The relative 
ciliary activity (RCA) was calculated by multiplying the PPCA to ciliary vigour. Time 
taken in dpi for IBV strains to cause a 50 % reduction in RCA was calculated using 
polynomial regression equation (3rd order). All the TOCs used in this study had a 
RCA of 100% before infection.  
4.2.5 Detection of apoptotic cells in TOCs 
Apoptotic cells were detected and quantified by the TUNEL assay using the 
peroxidase (POD) in situ cell death detection kit according to the manufacturer's 
instructions as described in Chapter 2.9. A total of five sections were analyzed for 
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each time point. The number of apoptotic cells was counted microscopically in each 
TOC ring and was presented as mean of the total apoptotic cells per complete ring. 
4.2.6 Quantification of infectious virus 
Supernatants from virus infected or mock-infected TOCs were titrated for 
infectious virus in TOCs following method described in Chapter 2.3.iii and expressed 
as CD50/ml (Cook, et al., 1976b). 
4.2.7 Host gene expression analysis 
The transcription of selected innate immune genes such as TLR3, TLR7, INF-α and 
IFN-β was quantified. Quantitative reverse transcription PCR (qRT-PCR) of cDNA 
samples in triplicate was performed on the LightCycler® 480 using LightCycler 480 
SYBR Green I Master mix (Roche, UK) as described in Chapter 2.4.iv. QRT-PCR data 
was normalized using a relative standard curve method to 18S ribosomal RNA (18S 
rRNA) expression (Kuchipudi, Tellabati, et al., 2012) and the data were presented as 
fold difference in gene expression of virus vs mock-infected samples. 
4.2.8 Statistical analysis 
The data were analysed using one-way ANOVA, followed by the post-hoc LSD 
multiple comparison test using GraphPad Prism version 6 software LSD. Differences 
between groups at that time point were considered significant at P<0.05.  
 
 
 
 
 
Chapter Four                                                   Innate response in TOC to different IBVs                                                 
             
97 
 
4.3 Results 
4.3.1 Quantification of ciliostatsis 
The time taken for a 50 % reduction in RCA of TOCs infected with different strains 
of IBVs is illustrated in   Figure 4.1.  No difference in the time taken (1.70 dpi) for a 
50 % reduction in RCA was found between the viruses. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1. Comparison of relative ciliary activity of chicken trachea organ cultures 
(TOCs). TOCs were infected with the indicated viruses using a dose of 4 log10 CD50 
per individual ring or mock-infected. 
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4.3.2 Apoptotic cells in TOCs 
Total apoptotic cells in IBV or mock infected TOCs were evaluated by TUNEL assay 
(Figure 4.2).  We found that IBV infection resulted in significant increase in total 
number of apoptotic cells in TOCs compared with mock-infected controls at 24 and 
48 hpi. Notably, infection of TOCs with IBV strains M41 resulted in significantly 
(P<0.05) higher apoptosis compared with those infected with 885 or QX both at 24 
and 48 hpi (Figure 4.3). 
 
 
 
 
 
 
 
 
 
 
 
 
A B 
C D 
50 µm 
50 µm 50 µm 
50 µm 
Figure 4.2. In situ Terminal deoxynucleotidyl transferase dUTP nick end labelling 
(TUNEL) staining of chicken embryo tracheal organ cultures (TOCs) infected with (A) 
885, (B) QX (C) M41 or (D) mock-infected at 24 hours post infection (hpi).  Apoptosis 
TUNEL staining of TOCs infected with IBVs showing multiple apoptotic cells with 
degeneration and loss of cilia. Arrows indicate apoptotic cells. 
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Figure 4.3. Total apoptotic cells in TOCs evaluated by TUNEL assay. TOCs were 
infected with IBV strains 885, QX, M41 or mock infected and evaluated at 24 and 48 
hpi. Data represents mean (n=5) with error bar showing standard error. Significant 
differences between the groups were detected by one-way ANOVA, followed by 
the post-hoc LSD multiple comparison test indicated with different letters (P<0.05). 
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4.3.3 Viral output in TOC supernatant 
To determine the difference in the level of infectious virus produced following 
infection with different IBVs, we titrated the supernatants in the TOCs. 
Interestingly, IBV strains M41 infection resulted in significantly (P<0.05) lower 
infectious virus production from TOCs at 24 and 48 hpi compared with 885 or QX 
TOCs (Figure 4.4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4. TOCs were infected with the indicated viruses using a dose of 4 log10 
CD50 per individual ring or mock-infected. Virus production in the TOC supernatants 
were determined in chicken embryo TOCs at the indicated times post infection. 
Data show the mean values with standard error. Significant differences between 
the groups were detected by one-way ANOVA, followed by the post-hoc LSD 
multiple comparison test indicated with different letters (P<0.05). 
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4.3.4 Host gene expression 
The mRNA expression data for INF-α and INF-β are illustrated in Figure 4.5 A & B, 
respectively. There was no significant (P<0.05) change in INF-α mRNA expression 
levels at 9 hpi and 24 hpi in any of the infected groups compared with the mock-
infected group. At 9 hpi, expression level of INF-β mRNA was significantly (P<0.05) 
up-regulated in the M41 infected group compared with 885 or QX. Conversely, the 
INF-β mRNA expression was significantly (P<0.05) higher at 24 hpi in M41 and QX 
infected groups compared with 885. 
TLR3 mRNA expression (Figure 4.5, C) was significantly (P<0.05) up-regulated in 
M41 infected group than 885 and QX at 9 hpi, whereas at 24 hpi, mRNA expression 
level in all infected groups was significantly (P<0.05) up-regulated compared with                
mock-infected group but without any significant (P<0.05) difference between the 
infected groups.  
For MDA5 mRNA expression, a significant up-regulation (P<0.05) was observed at 9 
hpi in all IBV infected groups compared with mock-infected group, whereas it was 
significantly higher (P<0.05) in M41 infected group than 885 or QX (Figure 4.5, D). 
Thereafter, at 24 hpi, MDA5 mRNA expression M41 infected group was overall 
significantly higher (P<0.05) followed by QX and 885. 
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Figure 4.5. Relative mRNA expression of (A) INF-α, (B) INF-β, (C) TLR3, (D) TLR7 in 
TOCs infected with IBV strains 885, QX, or M41 at a dose of 4 log10 CD50 per 
individual ring or mock-infected. Relative mRNA expression was determined by 
real-time PCR normalised to 18S rRNA. Graphed values are the mean of three 
biological replicates with error bars as standard error and are expressed as fold 
change relative to the mocked-infected group. Significant differences between the 
groups were detected by one-way ANOVA, followed by the post-hoc LSD multiple 
comparison test indicated with different letters (P<0.05). 
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4.4 Discussion 
The use of TOCs has been shown to be the most sensitive method for the isolation 
of IBV from clinical material (Darbyshire et al., 1975). Further, the use of TOC for 
investigation of virus host interactions under the controlled conditions have been 
exploited by many workers (Abd El Rahman, et al., 2009; Pei, et al., 2001). In vitro 
studies in TOCs are an excellent system to provide necessary data on possible 
adaptive mechanisms under controlled conditions. The aim of this chapter was to 
discover differences in early host innate immune responses and apoptosis of 
infected TOCs to infection by different strains of IBVs.  
The quantitative assessment of ciliary activity has been used for comparing the 
virulence of several avian respiratory pathogens (Raj & Jones, 1996b; Stadtlander, 
et al., 1991). In our study, all examined IBVs showed no difference in RCA as time 
taken for a 50% reduction of RCA was 1.70 dpi for all viruses. 
We found that IBV infection resulted in increased apoptosis in TOCs. Infection of 
TOCs with IBV M41 which causes mainly respiratory lesions resulted in greater 
apoptosis than 885 and QX. Apoptosis is a cell-death programme that is initiated in 
response to various extrinsic and intrinsic signals such as cellular stress, including 
virus infection, and plays an important role in the pathogenesis of many viruses 
(Wang, et al., 2007). As discussed in Chapter 3, IBVs are known to induce apoptosis 
in infected cells and B-cell lymphoma 2 (Bcl-2) family proteins modulate 
IBV-induced apoptosis (Li, et al., 2007; Liu, et al., 2001; Zhong, Liao, et al., 2012; 
Zhong, Tan, et al., 2012). The modulation of Bcl-2 family proteins during IBV 
infection has also been postulated to be under the regulation of signalling 
pathways such as endoplasmic reticulum (ER) stress and Mitogen-Activated Protein 
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Kinase/Extracellular signal-Regulated Kinase (MAPK/ERK) pathways (Fung & Liu, 
2014; Zhong, Liao, et al., 2012). Further, IBV infection results in a growth-inhibitory 
effect by inducing cell cycle arrest at S and G2/M phases (Li, et al., 2007) both of 
which results in apoptosis. Our findings suggest a strong correlation between 
apoptosis in TOCs to the ability of IBV strains to cause respiratory lesions in chicken.  
Higher apoptosis and IFN-β expression correlated with significantly lower infectious 
virus production from TOCs. This could be due to increased antiviral state induced 
by IFN-β and/or increased apoptosis. Apoptosis of cultured cells has previously 
been shown to be associated with reduced production of infectious influenza virus 
in duck cells (Kuchipudi, Dunham, et al., 2012).  
Notably M41 resulted in significantly higher up-regulation of innate immune 
sensing genes TLR3 and MDA5 along with higher IFN-β mRNA levels in TOCs at 9 hpi 
than 885 or QX. Concurrent with our findings, a previous study observed a 
significant increase of TLR3 mRNA expression in both trachea and lungs of IBV 
infected chickens when compared to the uninfected controls (Kameka, et al., 2014). 
The end products of TLR3 signalling pathway is the production of anti-viral type I 
IFN-α and β (Guillot, et al., 2005). Concurrent with TLR3 activation, we found a 
significant up-regulation of IFN-β but not IFN-α mRNA expression at 9 and 24 hpi in 
TOCs. Several in vitro and ex vivo studies have suggested a key role of TLR3 in viral 
detection (Alexopoulou, et al., 2001; Bowie & Haga, 2005; Finberg & Kurt-Jones, 
2004; Tabeta, et al., 2004). However, recent evidence suggests TLR3 contributes to 
detrimental effects of viral infections. TLR3 mediates West Nile virus entry into the 
brain, causing lethal encephalitis (Wang, et al., 2004) and contributes to a 
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detrimental inflammatory response to influenza virus infection in mice resulting in 
acute pneumonia (Le Goffic et al., 2006). 
MDA5 is IFN-inducible (Kang, et al., 2004), once IFN response is triggered, this 
innate antiviral loop initiates autoamplification of MDA5 until the natural inhibitor 
LGP2 is induced (Yoneyama, et al., 2005). In our study, MDA5 and IFN-β expression 
was up-regulated in TOCs at 24 hours after IBV infection compared with mock 
infected control. We found that M41 infection resulted in significantly higher 
expression of IFN-β and MDA5 than 885 or QX infection in TOCs at 24 hpi.  In 
agreement to our findings, a more recent study has shown that in vitro virulent IBV 
infection leads to a significant induction of INFβ transcription through an 
MDA5-dependent activation of the IFN response (Kint, et al., 2015). In the same 
study, in contrast to our findings, it was also reported that TLR3 is not involved in 
the sensing of IBV (Kint, et al., 2015). However, higher mRNA levels of MDA5 and 
TLR3 correlated with apoptosis caused by IBV strains used in this study, such that 
M41 induced much higher levels of apoptosis in TOCs than 885 or QX. It is possible 
that MDA5 activation is a protective antiviral host response against the virus 
whereas TLR3 contributes the detrimental effects of the viral infection.  The precise 
role of MDA5 and TLR3 in host defence against IBV infection and/or disease 
pathogenesis is not yet fully understood and hence, warrants further in-depth 
studies.   
In conclusion, IBV strain M41 induced stronger innate immune response (TLR3, 
MDA5 and IFN-β) and apoptosis than 885 or QX in TOCs. These observed effects 
suggest that higher apoptosis together with elevated levels of TLR3, MDA5 and 
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IFN-β expression appears to be correlates to pathogenicity of IBVs in TOCs 
(respiratory tissue).  
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5.1 Introduction 
In previous chapters, the pattern of virus infection has been studied in vitro or ex 
vivo to differentiate IBV strains with different tissue tropisms. It was found that 
transcriptional up-regulation of innate immune response genes, namely toll like 
receptor 3 (TLR3), melanoma differentiation associated protein 5 (MDA5) and 
interferon beta (IFN-β) corresponded to pathogenicity of infectious bronchitis 
viruses (IBVs) in kidney (CEK cells) and respiratory (TOCs) tissues. Our findings raise 
a tantalizing possibility of using CEKs and TOCs (in vitro) to rapidly predict the tissue 
tropism and virulence of novel IBV strains without the need of conducting more 
expensive and time consuming chicken in vivo. The primary cell culture (CEK cells) is 
a highly valuable tool to investigate IBV infections in vitro, but has some limitations 
as infection in chickens is a much more complex situation. Secondly, ex vivo (TOCs) 
experiments cannot include influences of immune mechanisms. This in vivo work 
was undertaken to understand the nature of the host response to different IBV 
strains complimenting the expanding knowledge of in vitro studies. 
IBV strains have tropisms for different avian cell types and produces different 
clinical signs and pathogenic lesions according to the affected tissue (Fan et al., 
2012). Virulence may differ among IBV strains and, chickens also showed different 
susceptibilities to different IBV strains (Cavanagh, 2007; Cong, et al., 2013). After 
the first identification of virus in the USA in 1930s, a high diversity among isolates 
was reported, not only in antigenicity, but also in pathogenicity (Gelb, Wolff, et al., 
1991; Lee et al., 2008). The rapid detection of the variant IBVs is being done using 
S1 sequence analysis. However, plausible tissue tropism from this method is not 
always in arrangement with the actual tissue tropism (Sapats et al., 1996). 
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Therefore, a more detailed understanding of the immunopathogenesis of IB 
infections is warranted. 
There are few studies about the course of local mechanisms involved during IBV 
pathogenesis. In one study, differential immune responses of chickens have been 
reported to two IBV with different genotypes, KIIa and ChVI (Jang, et al., 2013). In 
chickens infected with KIIa genotype, simultaneous peaks in the viral copy number 
and upregulation of mRNA levels of pro-inflammatory cytokines (IL-6 and IL-1β) and 
lipopolysaccharide-induced tumor necrosis factor (TNF)-α factor (LITAF) were 
observed at 7 dpi in the trachea and 9 dpi in the kidney, which appeared to 
contribute to the scale of pathophysiological effect in the chickens. Alternatively, 
chickens infected with ChVI genotype showed comparatively mild upregulation in 
pro-inflammatory cytokines mRNA expression. In a recent report, after infection 
with IBV-M41 strain, an early (3 dpi) upregulation of proinflammatory cytokines 
IL-6 and IL-1β was reported, which coincided with the greatest scores of viral load 
and microscopic lesions in the trachea, suggesting a role for both of these cytokines 
and also virus load on the development of tracheal lesions (Okino, et al., 2014). 
Additionally, this report demonstrated that after infection with IBV-M41, a late      
(7 dpi) induction of CD8αα and Granzyme homolog A mRNA has been associated 
with highest scores of viral load and microscopic lesions in the trachea, suggesting a 
role of both these cytotoxic enzymes and virus load on the development of tracheal 
lesions (Okino, et al., 2014). 
Pattern recognition receptors (PRRs) are present in immune cells and cells on 
mucosal surfaces. These cells rapidly recognize the infectious agents through PPRs 
such as Toll-like receptors (TLR), RIG-I like receptors (RLRs), Melanoma 
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differentiation-associated protein 5 (MDA5) and NOD-like receptors (NLRs). 
Prominent among these are TLRs. An increase in TLR3 mRNA expression has been 
reported in tracheal epithelial cells after intranasal inoculation with IBV-M41 strain 
at 3 dpi (Wang, et al., 2006) and its function in viral immunology is well established 
(Le Goffic, et al., 2007; Liu et al., 2007). In another study, TLR2, TLR3, TLR6 and TLR7 
gene expression were all significantly upregulated in the tracheal epithelial cells of 
3 week old chickens immunised with attenuated IBV-Massachusetts (IBV-Mass) by 
intranasal inoculation (Guo, et al., 2008). MDA5 expression levels were reported to 
be significantly increased in chicken kidney tissue after nephropathogenic IBV 
infection suggesting a role of chicken MDA5 against IBV infection (Cong, et al., 
2013).  In a more recent study, it has been shown that in vitro virulent IBV infection 
leads to a significant induction of INFβ transcription through an MDA5-dependent 
activation of the IFN response (Kint, et al., 2015).  
The limited information on the different immunopathogenesis of IBVs in chickens 
stimulated investigation of the host innate response in terms of the expression of 
PRRs, type I IFNs, and pro-inflammatory cytokine genes and their association with 
viral load profile and the course of pathogenic as well as serological changes 
induced by IBVs. From our studies on the comprehensive immunopathogenesis of 
these increasingly important IBV variants, we aim to recommend a strategy to 
reduce losses from IBV variants which are frequently emerging in the field. 
5.2 Materials and methods 
5.2.1 Virus  
The viruses were propagated in SPF ECE as described in Chapter 2.3.i. To calculate 
the dose of infection (105.0CD50/bird) these viruses were titrated in chicken TOCs 
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prepared from 19 to 20-days-old SPF chicken embryos (Chapter 2.3.iii) (Cook, et al., 
1976b). Confirmation of each genotype was done by RT-PCR (Chapter 2.4.vi) 
followed by sequencing (Chapter 2.5.vii). The results showed that each virus had 
99% identity across the part-S1 region with the published sequences. The TOC 
supernatant was free of NDV, AIV, avian metapneumovirus (aMPV) and infectious 
laryngotracheitis virus (ILTV) by RT-PCR and free of mycoplasma, bacterial or fungal 
contaminations. 
5.2.2 SPF eggs and chicks  
The SPF eggs were procured from a commercial source (Chapter 2.1.i). Fertile SPF 
eggs were incubated at 37°C. After checking for their fertility on day 18, eggs were 
transferred to hatching tray of the incubator in a static condition for hatching till 
day 21. Chicks were kept up to 14 days of age (doa) in an isolation unit (University 
of Liverpool) throughout the experiment and reared on deep litter with water and 
feed provided ad libitum as described in Chapter 2.5.ii. 
5.2.3 Experimental design 
One hundred SPF chicks were allocated to 4 groups (n=25). The chicks in the 
infected group were inoculated oculonasally with 105.0 CD50/bird of the virus and 
those in the control group were inoculated similarly with TOC medium to serve as 
uninfected controls. Clinical signs were observed daily throughout the experimental 
period.  All euthanised and those chicks found dead were necropsied and examined 
for any gross lesions in trachea and kidney. At 1, 3, 7, 9 and 14 days post infection 
(dpi), five chicks from each group were humanely killed and trachea and kidney 
samples were collected. A portion was stored in RNALater (Qiagen, Crawley, UK) 
and kept at -20°C until processing for viral load and expression of virus induced 
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pro-inflammatory cytokines, TLRs, and their adaptor molecules by quantitative real 
time RT-PCR (qRT-PCR). Trachea and kidney portions were also collected in 10% 
buffered formalin and examined by histopathology. At 1, 7 and 14 dpi, 5 birds in 
each group were bled. The blood was kept at room temperature for approximately 
3 h, and the serum was separated and stored at -20°C.  
5.2.4 Gross and histopathological lesions 
For gross lesions, the trachea and kidney were scored individually according to the 
criteria described in Chapter 2.6.iii. 
For histopathological examination, the upper part of the trachea and anterior 
kidney tissues were fixed in 10% buffered formalin, embedded in paraffin and 
sections were cut for hematoxylin and eosin (H&E) staining. After staining, the 
sections were scored individually according to the criteria described in the Chapter 
2.6.ii (Chen & Itakura, 1996). 
5.2.5 ELISA 
Serum samples collected from all the groups at 1, 7 and 14 dpi were tested using 
commercial ELISA kits (IDEXX) according to the manufacturer's instructions 
(Chapter 2.10.i). 
5.2.6 Total RNA isolation and cDNA synthesis 
At each time point, total RNA was extracted from trachea and kidney samples using 
the RNeasy Plus Mini Kit following the manufacturer’s instructions (Chapter 2.4.i). 
RNA concentration was quantified by NanoDrop® ND-1000. The cDNA was 
generated from 1 µg of RNA using the Superscript III First-strand cDNA synthesis 
system with random primers as per the manufacturer’s recommendations as 
described in the Chapter 2.4.iii. 
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5.2.7 Quantification of the viral RNA 
RNA was extracted from trachea and kidney samples using the RNeasy Plus Mini Kit 
following the manufacturer’s instructions (Chapter 2.4.i). For quantification of viral 
RNA quantitative reverse transcription PCR (qRT-PCR) was carried out as described 
in Chapter 2.4.v.  
5.2.8 Host gene expression analysis 
QRT-PCR of cDNA samples was performed in triplicate using LightCycler 480 SYBR 
Green I Master mix and primers as described in the Chapter 2.4.iv. QRT-PCR data 
was normalized using a relative standard curve method to 18S ribosomal RNA 
(18SrRNA) expression (Kuchipudi, Tellabati, et al., 2012) and the data were 
presented as fold difference in gene expression of virus vs mock-infected samples. 
5.2.9 Statistical analysis 
The data from host gene expression and ELISA were analysed using one-way 
analysis of variance (ANOVA), followed by the post-hoc LSD multiple comparison 
test using GraphPad™ Prism version 6.00 software. Kruskal-Wallis test followed by 
Dunn’s test was used for statistical analysis of the viral load by RT-qPCR and 
histopathological evaluation data. Differences were considered significant at 
P<0.05. 
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5.3 Results 
5.3.1 Clinical signs and gross pathological findings 
No clinical signs or mortalities were observed in the uninfected control chicks 
during the experiment. The chicks inoculated with 885 showed clinical signs from 
dpi 2 to 11. The affected chicks displayed mild tracheal rales, sneezing, coughing, 
head shaking and eye scratching. These clinical signs gradually disappeared by 11 
dpi. The group inoculated with QX showed similar clinical signs from dpi 3 to 9. 
Similarly clinical signs were also observed in the chicks inoculated with M41 but, 
from 2 to 10 dpi. In this group, one out of 25 died at 2 dpi (4.0%).  
No gross lesions were noticed in the control group. The gross lesion score seen in 
the infected chicks is presented in Figure 5.1. The tracheal lesions mostly comprised 
congestion which were started at 3 dpi in the trachea of all infected groups. No 
significant (P<0.05) differences were observed between the infected groups at any 
dpi (Figure 5.1 A).  In all infected groups, pale kidneys with swelling with varying 
severity developed from 7 dpi (Figure 5.1 B). However, these lesions peaked by 9 
dpi and were significantly higher in 885 inoculated group compared to QX and M41 
(Figure 5.1 B). 
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A 
B 
Figure 5.1. Gross lesion score in (A) Trachea and (B) Kidney samples of chicks. Birds 
(n=5/group) were infected with IBV strains 885, QX, or M41 at a dose of 10
5.0 
CD
50
/bird and examined for gross lesions at 01, 03, 07, 09, and 14 days post 
infection (dpi). Data represents the median with error bars as standard error. 
Significant differences between the groups were detected by Kruskal-Walis test 
followed by Dunn’s mean test. Where values were significantly (P<0.05) different 
these are shown with different letters and all other values were not significantly 
(P<0.05) different between the groups at those time points. 
Chapter Five                                             Differential immunopathogenesis in SPF chicks           
116 
 
5.3.2 Histopathology 
5.3.2.1 Trachea 
Normal tracheal epithelia, with healthy cilia and goblet cells, were observed in the 
uninfected control birds (Figure 5.2 A). In all tracheas, until 3 dpi, no statistically 
significant (P<0.05) differences were found in histopathological lesion score 
between the groups (Figure 5.3 A). However, pathological changes developed and 
peaked by 7 dpi and were significantly higher in the M41 inoculated group 
compared to 885 and QX (Figure 5.3 A). The most consistent lesions occurred 
mainly in the form of loss of cilia, decreased goblet cells, infiltration of plasma cell, 
heterophil infiltration, and lymphocytes (Figure 5.2 B to D). 
5.3.2.2 Kidney 
The kidneys of the chicks from the uninfected control group showed no obvious 
lesions (Figure 5.4 A). In the infected groups, the main kidney histopathological 
lesions consisted of interstitial lymphoid infiltration with mild lymphoid nodules 
(Figure 5.4 B to D), which were observed throughout the study. No significant 
(P<0.05) histological differences were found between the infected groups until        
7 dpi (Figure 5.3 B). However, on 9 dpi, 885 infected group showed significantly 
(P<0.05) higher histopathological changes than those infected with QX or M41. 
These changes became more severe and peaked by 14 dpi where lesions in 885 
infected group were significantly (P<0.05) greater when compared to QX or M41 
infected chicks (Figure 5.3 B). 
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Figure 5.2. Histopathological findings in trachea samples, using Haematoxylin and 
Eosin (H&E) stains, at 7 days post infection (dpi) from (A) Uninfected control group 
showing cilia and goblet cells (B) 885 infected group showing epithelium with an 
infiltrate of lymphocytes, plasma cells and heterophils (C) QX infected group 
showing mild epithelial deciliation, with a moderate infiltrate of lymphocytes and 
heterophils and (D) M41 infected group showing complete epithelial deciliation with 
severe lymphocyte, plasma cells & heterophil infiltration and mild epithelial 
hyperplasia (magnification at 400x).  
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Figure 5.3. Histopathological score of lesions in (A) Trachea and (B) Kidney samples 
of chicks. Birds (n=5/group) were infected with IBV strains 885, QX, or M41 at a 
dose of 10
5.0 
CD
50
/bird and processed for histopathological examination at 01, 03, 
07, 09, and 14 days post infection (dpi). Data represents the median with error bars 
as standard error. Significant differences between the groups were detected by 
Kruskal-Walis test followed by Dunn’s mean test. Where values were significantly 
(P<0.05) different these are shown with different letters and all other values were 
not significantly (P<0.05) different between the groups at those time points. 
A 
B 
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A B 
C D 
Figure 5.4. Histopathological findings in kidney samples, using Haematoxylin and 
Eosin (H&E) stains, at 9 days post infection (dpi) from (A) Uninfected control group 
(B) 885 infected group showing severe lymphoid infiltration with mild lymphoid 
nodules and mild heterophil interstitial infiltration (C) QX infected group showing 
moderate lymphocyte and heterophil interstitial infiltration (D) M41 infected group 
showing mild lymphocyte and heterophil interstitial infiltration (magnification at 
100x).  
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5.3.3 ELISA 
Serum samples from all chickens collected prior to infections were free of IBV 
antibodies (Figure 5.5). At 7 dpi, all chicks inoculated with different IBV strains 
showed a positive IBV antibody response without any significant (P<0.05) 
difference between the groups, whereas chicks in the uninfected control group 
showed a negative serum antibody response. Subsequently, the antibody levels in 
all the three groups peaked at 14 dpi whereas, M41 infected group showed 
significantly (P<0.05) higher antibody response followed by QX than 885 infected 
chicks (Figure 5.6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5. Infectious bronchitis virus (IBV) antibody titres of the different groups 
(n=5/group) infected with IBV strains 885, QX, M41 or uninfected control at a dose of 
10
5.0 
CD
50
/bird. Data are expressed as mean values ± SEM (n=5). Significant 
differences between the groups were detected by one-way ANOVA, followed by the 
post-hoc LSD multiple comparison test indicated with different letters (P<0.05). 
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5.3.4 Viral RNA quantification 
Viral RNA load in trachea and kidney was measured using the qRT-PCR (Figure 5.6). 
5.3.4.1 Trachea 
Viral RNA loads in the tracheas of birds in the uninfected control group were below 
the detection limit on all days post infection (Figure 5.6 A). At 1 dpi, all the tracheal 
samples collected from the infected groups were positive without any significant 
difference between the groups (Figure 5.6 A). The viral RNA load in all the infected 
groups peaked at 7 dpi and there was no significant (P<0.05) differences between 
these groups. Thereafter, viral RNA load decreased in all the infected groups and at 
14 dpi, nearly reached basal levels. 
5.3.4.2 Kidney 
The viral RNA load in the kidneys of birds from the uninfected control group on all 
days post infection were below the detection limit and also from infected groups 
until 3 dpi (Figure 5.6 B). At 7 dpi, all the kidneys samples from the infected groups 
were positive without any significant difference between the groups. However, at 9 
dpi, viral RNA load was significantly higher (P<0.05) in the 885 infected group 
compared to those infected with QX or M41. Viral RNA loads in kidneys from all the 
infected groups peaked at 14 dpi however; it was significantly (P<0.05) higher in 
group infected with 885 followed by those infected with QX and M41 (Figure 5.6 B). 
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Figure 5.6. Quantification of viral RNA, expressed as a log relative equivalent units 
(REU) of RNA in (A) Trachea and (B) Kidney samples of chicken. Birds (n=5/group) 
were infected with IBV strains 885, QX, or M41 at a dose of 10
5.0 
CD
50
/bird and 
analysed for quantification of viral RNA at 01, 03, 07, 09, and 14 days post infection 
(dpi). Data represents the median with error bars as standard error. Significant 
differences between the groups were detected by Kruskal-Walis test followed by 
Dunn’s mean test. Where values were significantly (P<0.05) different these are 
shown with different letters and all other values were not significantly (P<0.05) 
different between the groups at those time points. 
A 
B 
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5.3.5 Host gene expression analysis  
5.3.5.1 Relative IFN-α and IFN-β mRNA expression 
5.3.5.1.1 Trachea 
The mRNA expression data for IFN-α and IFN-β in the trachea are illustrated in   
Figure 5.7 A & B, respectively. No significant change in the IFN-α mRNA expression 
levels at any dpi was noticed in the infected groups compared with uninfected 
control group (Figure 5.7 A). Notably, at 1 dpi, tracheal samples of chicks infected 
with M41 resulted in significantly (P<0.05) greater IFN-β mRNA expression than 
those infected with 885 or QX (Figure 5.7 B). Conversely, on subsequent dpi no 
significant (P<0.05) changes in level of IFN-β mRNA expression were detected in 
any infected group compared with uninfected control group.  
5.3.5.1.2 Kidney 
The mRNA expression data for IFN-α and IFN-β in the kidney are illustrated in   
Figure 8 A & B, respectively. No significant (P<0.05) differences in the IFN-α 
expression levels at any dpi was noticed in any infected group compared with 
uninfected control group. At 1 dpi, IFN-β mRNA expression in kidney samples of 
chicks infected with 885 was up-regulated (P<0.05) whereas, it was down-regulated 
(P<0.05) in M41 infected group compared with uninfected control group. However, 
at 3 dpi it was significantly (P<0.05) higher in the group infected with 885 compared 
to those infected with QX. At this time point, no significant change was noticed in 
M41 infected group compared with uninfected control (Figure 5.8 B). No significant 
changes in level of IFN-β expression was observed in any infected group at the 
other time points (7, 9 or 14 dpi). 
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Figure 5.7. Relative Type I interferon (IFN) (A) IFN-α and (B) IFN-β mRNA 
expression in IBV infected trachea of chicks. Birds (n=5/group) were infected with 
IBV strains 885, QX, or M41 at a dose of 10
5.0 
CD
50
/bird and gene expression was 
analysed at 01, 03, 07, 09, and 14 days post infection (dpi). Relative mRNA 
expression was determined by quantitative reverse transcription PCR (qRT-PCR) 
using SYBR Green method and the data were normalised to 18S rRNA expression. 
Data represents the mean with error bars as standard error and are expressed as 
fold change relative to the uninfected controls group. Significant differences 
between the groups were detected by one-way ANOVA, followed by the post-hoc 
LSD multiple comparison test indicated with different letters (P<0.05) and all 
other values were not significantly (P<0.05) different between the groups. 
Days post infection 
B 
A 
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Figure 5.8. Relative Type I interferon (IFN) (A) IFN-α and (B) IFN-β mRNA expression 
in IBV infected kidney of chicks. Birds (n=5/group) were infected with IBV strains 
885, QX, or M41 at a dose of 10
5.0 
CD
50
/bird and gene expression was analysed at 
01, 03, 07, 09, and 14 days post infection (dpi). Relative mRNA expression was 
determined by quantitative reverse transcription PCR (qRT-PCR) using SYBR Green 
method and the data were normalised to 18S rRNA expression. Data represents the 
mean with error bars as standard error and are expressed as fold change relative to 
the uninfected controls group. Significant differences between the groups were 
detected by one-way ANOVA, followed by the post-hoc LSD multiple comparison 
test indicated with different letters (P<0.05) and all other values were not 
significantly different between the groups at those time points. 
Days post infection 
A 
B 
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5.3.5.2 Expression of mRNA of TLR3 and MDA5 in the trachea and kidney 
5.3.5.2.1 Trachea 
The mRNA expression of TLR3 and MDA5 in the tracheal samples from chicks 
infected with IBV strains 885, QX, M41 or uninfected control group are illustrated in   
Figure 5.9 A & B, respectively. It was observed that expression of TLR3 (Figure 5.9 
A) in all the infected groups were significantly (P<0.05) up-regulated at 1 dpi 
compared to the uninfected control group. At this time point, M41 infected group 
showed significantly (P<0.05) higher level of expression as compared to 885 or QX. 
However, at 3 dpi, infection of IBV strains M41 and QX resulted in significantly 
greater TLR3 mRNA expression than 885 infection in the trachea (Figure 5.9 A). No 
significant (P<0.05) changes in TLR3 mRNA expression levels were detected in any 
infected group compared with uninfected control group on subsequent dpi. 
Similarly, infection with IBV strains M41 and QX resulted in significantly (P<0.05) 
greater MDA5 expression than 885 infection in the trachea at 1 dpi (Figure 5.9 B). 
No significant (P<0.05) changes in level of MDA5 expression were observed in any 
infected group at the other time points (3, 7, 9 or 14 dpi). 
5.3.5.2.2 Kidney 
The mRNA expression data for TLR3 and MDA5 in the kidney are illustrated in   
Figure 5.10 A & B, respectively. In contrary to the mRNA expression of these two 
genes in tracheal samples infected with IBVs, at 3 dpi, 885 infection resulted in 
significantly (P<0.05) higher mRNA expression in the kidneys of TLR3 (Figure 5.10 A) 
followed by QX and M41 infection. Notably, no significant (P<0.05) changes in level 
of TLR3 mRNA expression were observed in any infected group at the other time 
points (1, 7, 9 or 14 dpi) compared with the uninfected control group. At 3 dpi, 
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MDA5 mRNA expression (Figure 5.10 B) in kidney samples of chicks infected with 
885 was up-regulated and was significantly (P<0.05) higher compared to those 
infected with QX. However, no significant (P<0.05) change was observed in group 
infected with M41 compared with the uninfected control group. At 7 dpi, MDA5 
mRNA expression level in all infected groups was significantly (P<0.05) up-regulated 
compared with the uninfected control group but, without any significant (P<0.05) 
difference between the infected groups. 
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Figure 5.9. Transcriptional regulation of innate viral sensing molecules (A) TLR3 
and (B) MDA5 in chicken trachea. Birds (n=5/group) were infected with IBV strains 
885, QX, or M4 at a dose of 10
5.0 
CD
50
/bird and gene expression was analysed at 
01, 03, 07, 09, and 14 days post infection (dpi). Relative mRNA expression was 
determined by quantitative reverse transcription PCR (qRT-PCR) using SYBR Green 
method and the data were normalised to 18S rRNA expression. Data represents 
the mean with error bars as standard error and are expressed as fold change 
relative to the uninfected controls group. Significant differences between the 
groups were detected by one-way ANOVA, followed by the post-hoc LSD multiple 
comparison test indicated with different letters (P<0.05). 
Days post infection 
A 
B 
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Figure 5.10. Transcriptional regulation of innate viral sensing molecules (A) TLR3 
and (B) MDA5 in chicken kidney. Birds (n=5/group) were infected with IBV strains 
885, QX, or M41 at a dose of 10
5.0 
CD
50
/bird and gene expression was analysed at 
01, 03, 07, 09, and 14 days post infection (dpi). Relative mRNA expression was 
determined by quantitative reverse transcription PCR (qRT-PCR) using SYBR Green 
method and the data were normalised to 18S rRNA expression. Data represents the 
mean of three biological replicates with error bars as standard error and are 
expressed as fold change relative to the mock-infected group. Significant differences 
between the groups were detected by one-way ANOVA, followed by the post-hoc 
LSD multiple comparison test indicated with different letters (P<0.05). 
Days post infection 
A 
B 
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5.3.5.3 Transcription profile of proinflammatory cytokines in the trachea and 
kidney 
5.3.5.3.1 Trachea 
The changes in levels of 3 pro-inflammatory cytokines in the trachea are illustrated 
in Figure 5.11. The results indicate that, the level of IL-1β mRNA expression peaked 
at 7 dpi in all infected groups compared with uninfected control, with mRNA 
expression being significantly (P<0.05) higher at 3 and 7 dpi in chicks infected with 
M41 as compared with 885 or QX infection. Figure 11B shows the expression of IL-6 
wherein, at 7 dpi, a significant (P<0.05) increases in the expression was noticed in 
chicks infected with M41 as compared to 885 or QX. No significant (P<0.05) 
changes in level of IL-6 expression was seen in any infected group at any other time 
points compared with the uninfected control group. At 1 dpi, LITAF transcription 
levels in all the infected groups was significantly (P<0.05) down-regulated 
compared with the uninfected control group. However, at 3 dpi, LITAF mRNA 
expression level in all infected groups was significantly (P<0.05) up-regulated 
compared with uninfected control group but, without any significant (P<0.05) 
difference between the infected groups. LITAF mRNA expression was seen to have 
the same pattern as the IL-6 measured in trachea, as at 7 dpi, M41 infected group 
showed significantly (P<0.05) higher level of expression as compared to 885 or QX 
(Figure 5.11 C). 
5.3.5.3.2 Kidney 
Conversely, in the kidney samples, IL-1β mRNA expression level expression peaked 
at 9 dpi in all infected groups and was significantly (P<0.05) up-regulated in 885 
infected group followed by QX and M41 compared to the uninfected control group 
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(Figure 5.12 A). At 7 and 14 dpi, IL-1β mRNA expression in all infected groups was 
significantly (P<0.05) up-regulated compared with uninfected control group but, 
without any significant difference between them. The mRNA expression of IL-6 in 
kidneys from all the infected groups peaked at 9 dpi (Figure 5.12 B) and it was 
significantly (P<0.05) up-regulated compared with the uninfected control group 
but, without any significant (P<0.05) difference between them. However, IL-6 
mRNA expression level was significantly (P<0.05) up-regulated at 14 dpi in 885 
infected group followed by QX and M41 compared to uninfected control group 
(Figure 5.12 B). The LITAF mRNA expression level was significantly (P<0.05) 
up-regulated in all infected groups compared with uninfected control at 7 dpi and it 
was significantly (P<0.05) higher in group infected with 885 and QX as compared to 
M41 (Figure 12 C). However, at 9 dpi, a significant (P<0.05) increases in the LITAF 
mRNA expression was noticed in chicks infected with 885 as compared to QX or 
M41. Notably, we found that 885 infection resulted in significantly (P<0.05) higher 
mRNA expression of LITAF (Figure 5.12 C) followed by QX and M41 infection in 
kidneys at 14 dpi.  
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Figure 5.11. Transcription profile of proinflammatory cytokines (A) IL-1β, (B) IL- 6 and 
(C) LITAF in IBV infected chicken trachea. Birds (n=5/group) were infected with IBV 
strains 885, QX, or M41 1 at a dose of 10
5.0 
CD
50
/bird and gene expression was 
analysed at 01, 03, 07, 09, and 14 days post infection (dpi). Relative mRNA expression 
was determined by quantitative reverse transcription PCR (qRT-PCR) using SYBR Green 
method and the data were normalised to 18S rRNA expression. Data represents the 
mean with error bars as standard error and are expressed as fold change relative to the 
uninfected controls group. Significant differences between the groups were detected 
by one-way ANOVA, followed by the post-hoc LSD multiple comparison test indicated 
with different letters (P<0.05). 
 
Days post infection 
C 
B 
A 
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Figure 5.12. Transcription profile of proinflammatory cytokines (A) IL-1β, (B) IL-6 
and (C) LITAF in IBV infected chicken kidney. Birds (n=5/group) were infected with 
IBV strains 885, QX, or M41 at a dose of 10
5.0 
CD
50
/bird and gene expression was 
analysed at 01, 03, 07, 09, and 14 days post infection (dpi). Relative mRNA 
expression was determined by quantitative reverse transcription PCR (qRT-PCR) 
using SYBR Green method and the data were normalised to 18S rRNA expression. 
Data represents the mean with error bars as standard error and are expressed as 
fold change relative to the uninfected controls group. Significant differences 
between the groups were detected by one-way ANOVA, followed by the post-hoc 
LSD multiple comparison test indicated with different letters (P<0.05). 
 
Days post infection 
A 
B 
C 
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5.4 Discussion 
IBV causes an acute and highly contagious disease in chicks, primarily targeting the 
trachea and kidney. The investigation of the course of local immunological and 
cytokine induced mechanisms involved in IBV pathogenesis will help to elucidate 
the IBV-host interaction and the pathogenic mechanisms of IBV. These pathogenic 
mechanisms may differ among IBV strains particularly regarding the kinetics, 
magnitude, and duration of local inflammatory responses and the immune 
mechanisms in the target organs. Our findings from in vitro study showed the 
possibility of using CEKs and TOCs to rapidly predict the tissue tropism and 
virulence of novel IBV strains. The main advantage of using in vitro model is that 
explants from the same animals can be used to compare different viral strains and 
for corroborating the in vitro results. In this study, we investigated the differential 
immunopathogeneses in chickens infected with three IBV strains used in the           
in vitro studies. We noted that infected chicks displayed mild clinical signs like 
tracheal rales, sneezing, coughing, head shaking and eye scratching similar to the 
signs which have been observed following infection with other virulent IBVs 
(Ambali & Jones, 1990; Butcher et al., 1990; Dolz, et al., 2012). However, the 
duration of these clinical signs differed between IBV infected groups indicating 
differences in the susceptibility of chicks to infection by these three IBV strains. In 
addition, the infection of chicks by IBV strains M41 and QX resulted in significantly 
higher antibody levels in serum at 14 dpi than 885 though all groups of chicks 
received the same amount of virus. Hence, we examined the differential 
modulation of PRRs (TLR and MDA5), type I IFNs, & pro-inflammatory cytokine 
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mRNA expression in chicks and its association with viral load profile and the course 
of histopathological changes induced by different IBVs. 
In the present study, each strain showed obvious histopathological changes in 
trachea and kidney similar to reported in previous experiments (Chousalkar et al., 
2007; Kotani et al., 2000). Based on analysis of the three strains separately, the 
pathological changes in the trachea peaked by 7 dpi in all groups but were 
significantly higher in the group infected with M41 compared to 885 and QX. A 
similar trend was found for viral load in the trachea, though no significant 
differences were observed between the groups. At 7 dpi, peak values for 
histopathological changes and viral load were found to be associated with peaks of 
expression of inflammatory cytokines, such as IL-6 and IL-1β, and higher LITAF 
mRNA expression values. Interestingly, at 7 dpi in trachea mRNA expression values 
for these inflammatory cytokines were significantly higher in M41 compared to 885 
and QX.  In kidneys, temporal associations between peak histopathological lesion 
scores and peak viral load were observed. However, the kinetics of peak values of 
histopathological changes and viral load were not in accordance with those of the 
inflammatory cytokines. In contrast to trachea, the higher values of histopathology 
scores, viral load and the expression of inflammatory cytokines were found in 885 
and QX infected group as compared to M41. The role of the proinflammatory 
cytokine, IL-6 has been investigated for its contribution to nephritis in two genetic 
lines of chickens (Asif, et al., 2007). In this study, IL-6 transcripts were found to be 
directly related to renal lesions in chicks challenged with a nephropathogenic strain 
of IBV. In the more susceptible S-line chicks, these IL-6 levels were 20 times higher 
than those in the more resistant HWL chicks. Concurrent with our findings, 
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differential immune responses of chicks to two IBV with different genotypes, KIIa 
and ChVI has also been reported (Jang, et al., 2013). In chicks infected with KIIa 
genotype, simultaneous peaks in the histopathological lesions, viral copy number 
and upregulation of mRNA levels of pro-inflammatory cytokines (IL-6 and IL-1β) and 
LITAF were observed in the trachea at 7 dpi and in the kidney at 9 dpi which 
appeared to have a detrimental effect on these tissues. This has also been 
supported by a more recent study (Okino, et al., 2014), in which upregulation of 
expression of proinflammatory cytokines such as IL-6 and IL-1β, induced by the 
M41 strain of IBV, was found to be partially associated with the pathological 
alterations and/or viral load in trachea of non-immune challenged chicks. 
Interestingly, in our study of mRNA expression values for these inflammatory 
cytokines, levels were significantly higher in M41 infected chicks compared to 885 
and QX in trachea. In contrast, levels were higher in 885 and QX infected group as 
compared to M41 in the kidney, suggesting a role of these cytokines in the 
development of different histopathological lesions in these organs caused by 
different IBVs. 
TLR3 is known for recognition of RNA virus encoded pathogen associated molecular 
patterns (PAMPs) and its function in viral immunology is well established (Akira, 
2001; Le Goffic, et al., 2007). It was observed that IBV strains M41 and QX resulted 
in significantly higher up-regulation of innate immune sensing gene TLR3 levels in 
tracheas at 3 dpi when compared to 885 infections. In contrast, upregulation was 
significantly greater for these genes in the 885 infected kidneys than those infected 
with QX or M41 at 1 dpi. Parallel with our findings, previous studies have also 
reported a significant increase of TLR3 mRNA expression in the trachea of IBV 
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infected chicks when compared to the uninfected controls (Kameka, et al., 2014; 
Wang, et al., 2006). TLR3 mediates West Nile virus entry into the brain, causing 
lethal encephalitis (Wang, et al., 2004) and contributes to a harmful inflammatory 
response to influenza virus infection in mice resulting in acute pneumonia                   
(Le Goffic, et al., 2007).  
In this study, at 1 dpi MDA5 mRNA expression values were significantly higher in 
M41 or QX infected tracheas compared to those with 885 infection. In contrast, 
expression levels were significantly upregulated in 885 infected kidneys compared 
to those infected with QX or M41 at 3 dpi. In agreement with this, in our in vitro 
studies (Chapters 3 and 4) we found that compared to M41, 885 and QX, caused 
greater induction of TLR3 and MDA5 in CEK cells.  In contrast, M41 infection caused 
greater expression of these genes than 885 or QX in TOCs. MDA5 mRNA expression 
levels were reported to be significantly increased in chicken kidney tissue after 
nephropathogenic IBV infection, suggesting a role of chicken MDA5 against IBV 
infection (Cong, et al., 2013).  This has further been supported by a more recent 
study in which it has been shown that in vitro virulent IBV infection leads to a 
significant induction of INFβ transcription through an MDA5-dependent activation 
of the IFN response (Kint, et al., 2015). Altogether, we observed that mRNA levels 
of TLR3 and MDA5 correlated with the pattern of histopathological lesion scores in 
tracheas and kidneys produced by IBV strains used in this study. 
Innate immune responses comprised a network of varied antimicrobial 
mechanisms, of which the type I IFN response is an essential defense mechanism 
against viruses. Concurrent with TLR3 and MDA5 activation, we found a significant 
up-regulation of IFNβ, but not IFNα mRNA expression, after IBV infection at 1 dpi in 
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the trachea and 3 dpi in the kidney. Many previous studies claim that the activation 
of the TLR3 pathway works towards an up-regulation of INF-β production in 
chickens (Kameka, et al., 2014; Karpala et al., 2008; Parvizi et al., 2012). The kinetics 
of IFN response observed in our study is in line with the previous studies; however 
a more recent study showed that MDA5, but not TLR3, is involved in detection of 
IBV (Kint, et al., 2015). Though, higher mRNA levels of MDA5 and TLR3 correlated 
with the most pathogenic strains of IBV in trachea and kidney. We also noted that 
tracheal samples from chicks infected with M41 resulted in significantly greater 
IFN-β expression when compared to those infected with 885 or QX. In contrast, 885 
and QX infection caused higher induction of this gene than M41 in the kidney. A 
similar trend of IFN-β expression was noted in our in vitro study (Chapter 3 and 4) 
wherein, up-regulation was observed at 9 and 24h after IBV infection in CEK cells 
and TOCs, respectively. Early studies on gamma coronaviruses in chickens also 
suggested that IBV-induced IFN production is variable and dependent on both the 
virus strain and cell type (Holmes & Darbyshire, 1978; Otsuki et al., 1988; Otsuki, et 
al., 1987). 
In this study, we reported that the histopathological changes, pro-inflammatory 
and innate immune gene responses could be induced to a diverse range depending 
on the strain of IBV. In  conclusion, our results indicate that higher upregulation of 
expression of proinflammatory cytokines (such as IL-6 and IL-1β) and  LITAF are 
induced by the M41 strain in the trachea and 885 and QX in the kidney, which are 
partially implicated in the respiratory and renal lesions caused by these viruses, 
respectively. In addition, increased levels of TLR3, MDA5 and IFN-β expression 
correlated to the severity of pathogenicity of IBVs in the trachea and kidney. 
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Chapter 6: New insights into in vitro and in vivo 
immunopathogenesis of infectious bronchitis virus 793B 
serotype 
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6.1 Introduction 
Infectious bronchitis virus (IBV), the prototype of the family Coronaviridae of the 
order Nidovirales, is an important pathogen in chickens. The M41 and 793B are 
among the most important and prevalent serotypes of IBV worldwide (Jackwood, 
2012). The first known strain of the 793B serotype, also known as 4/91 (Parsons et 
al., 1992) and CR88, was isolated in France in 1985 (Picault et al., 1986). This 
serotype may have entered the UK in the winter of 1990/91, when it was 
sometimes associated with mortality in breeding hens and deep pectoral muscle 
myopathy (Gough et al., 1992; Parsons, et al., 1992). Afterward, it was discovered 
that this serotype had been present in most European countries (de Wit, et al., 
2011). In Asia, the first time the 793B serotype was recorded was in China in 2003 
where it was named Taian-03, (accession number AY837465). Presently, 793B type 
viruses have been detected in several Asian countries, including Japan (Mase et al., 
2008), India (Sumi et al., 2012) and Iran (Bijanzad et al., 2013). A more recent study 
has reported the presence of several variant field viruses from many Middle East 
countries from 2009-2014 (Ganapathy et al., 2015). Among these, 793B was the 
dominant genotype detected by this study. 
Vaccination is generally considered essential for the protection of commercial 
chickens from virulent IBVs (Jackwood & de Wit, 2013). Massachusetts (M41) and 
H120 strains, in combination with 793B, are the most commonly used in many 
parts of the world (Jackwood & de Wit, 2013). Such vaccines have been proven to 
confer protection against a wide range of IBV strains, including homologous and 
non-homologous IBV genotype/serotypes (Awad et al., 2015; Cook JKA, 1999; 
Jackwood & de Wit, 2013). However, for almost two decades, 793B has been 
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associated with disease and for most of that period one or more live 793B vaccines 
have been in use (Cook et al., 1996; Martin et al., 2014). Of late, in a study on 
genotypes of IBVs circulating in the Middle East between 2009 and 2014, the 793B 
field strain has been shown to be clustering distinctly compared to strains from 
earlier years (Ganapathy, et al., 2015). The alterations in translated amino acid 
sequences were reported to be minimal but still may have played an important role 
in the persistence of this virus, despite the use of live 793B vaccines (Ganapathy, et 
al., 2015). 
Based on the above facts, persistence of 793B strains is of concern for effective 
control of diseases caused by IBV. There are limited reports on pathogenesis and 
host immune responses to 793B (Bijanzad, et al., 2013; Boroomand et al., 2012; Raj 
& Jones, 1996a). As IBV 793B infections continue to be a major threat to poultry 
health in many parts of the world, better understanding of immunopathogenesis of 
the virus need to be developed to control the infection adequately. To further 
examine on the interaction between the 793B and host, a series of in vitro and in 
vivo examinations were conducted similar to one in Chapter 3, 4 and 5. 
6.2 Materials and methods 
6.2.1 Cell and organ cultures 
Monolayers of primary chicken kidney (CEK) cells were prepared from kidneys of 
specific-pathogen-free (SPF) chicken embryos after 18 day incubation as described 
in Chapter 2.1.ii. Chick tracheal organ cultures (TOCs) were prepared from 
18-day-old SPF ECE (Chapter 2.1.iii). 
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6.2.2 SPF chicks 
The SPF eggs were procured from a commercial source (Chapter 2.1.i) and hatched 
in our facility as described in Chapter 5. Chicks were kept up to 14 days of age (doa) 
in an isolation unit (University of Liverpool) throughout the experiment and reared 
on deep litter with water and feed provided ad libitum as described in Chapter 
2.5.ii. 
6.2.3 Virus  
The IB virus was isolated from caecal tonsils of a laying flock that had suffered a 
drop in egg production. The virus stock was propagated in chicken TOCs prepared 
from 19 to 20-day old SPF ECE (Chapter 2.3.i). Confirmation of genotype was done 
by RT-PCR (Chapter 2.4.vi) followed by sequencing (Chapter 2.5.vii). The results 
showed that the virus had 99% identity across the S1 region with published 
sequences. The TOC supernatant was free of, NDV, AIV, avian metapneumovirus 
(aMPV) and infectious laryngotracheitis virus (ILTV) by RT-PCR, and free of bacterial 
or fungal contaminations. 
6.2.4 Virus titration 
For CEK cell infection study, the virus was titrated on CEK cells using an immune 
cytochemical focus assay described previously in Chapter 2.3.iv and expressed as 
MOI (Nelli, et al., 2012). For infection of TOC and chicks, virus was titrated in TOC 
and expressed in median ciliostatic doses (CD50)/ml as discussed in detail in Chapter 
2.3.iii (Cook, et al., 1976b). 
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6.2.5 Experimental design 
6.2.5.1 Virus infection in cell and organ cultures  
Confluent monolayer of CEK cells was washed three times with PBS, and then 
infected with 793B strain of IBV at a multiplicity of infection (MOI) 1.0 or mock 
infected with cell culture medium (Appendix I) as described in Chapter 3.3.3. Cells 
were analysed at 24 and 48h post-infection (hpi) to determine the effect of virus 
infection on cell metabolic activity, induction of apoptosis and cell culture 
supernatant to titrate infectious virus in TOC expressed as CD50/ml (Cook, et al., 
1976b). 
TOCs were infected with 793B strain using a dose of 4 log10 CD50 per individual ring 
or mock-infected with TOC medium (Appendix I) without virus as detailed in 
Chapter 4.3.3. Samples of TOC supernatant or complete rings were collected at 24 
and 48 hpi. TOC rings were analysed for apoptotic cells using in situ Terminal 
deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) assay and 
supernatants were titrated for quantification of infectious virus. 
6.2.5.2 Virus infection of SPF chicks  
Fifty SPF chicks were allocated to 2 groups of 25 birds.  The chicks in the infected 
group were inoculated oculonasally with 105.0 CD50/bird of the virus and those in 
the control group were inoculated similarly with TOC medium (Appendix I) to serve 
as uninfected controls. At 1, 3, 7, 9 and 14 days post infection (dpi) five chicks from 
each group were sacrificed and tissue samples of trachea and kidney were 
collected. A portion of tissue samples were stored in RNALater (Qiagen, Crawley, 
UK) and kept at -20°C until processing for RT-PCR. The remaining portion was fixed 
in 10% formalin for future histopathological examination. Blood samples were 
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collected from 5 randomly selected chicks at 1, 7 and 14 dpi from both groups to 
monitor the antibody response. The clinical signs were observed daily throughout 
the experimental period. 
6.2.6 Measurement of CEK cells metabolic activity by MTT assay 
CEK cells were analysed for metabolic activity at 24 and 48 hpi using CellTiter 96, a 
non-radioactive cell proliferation assay, according to the manufacturer’s 
instructions as described in Chapter 2.8.i. 
6.2.7 Analysis of apoptosis by flow cytometry 
CEK cells were used for analysis of apoptosis induction by staining with Annexin 
V-FITC and PI using commercial V-FITC apoptosis kit, according to the 
manufacturer’s instructions (Chapter 2.8.ii). 
6.2.8 Detection of apoptotic cells in TOC 
Apoptotic cells were detected and quantified by the TUNEL assay using the 
peroxidase (POD) in situ cell death detection kit according to the manufacturer's 
instructions (Chapter 2.9). A total of five sections were analysed for each time 
point. For each sample, the total number of positive cells/400× microscopic field 
was calculated. 
6.2.9 Quantification of infectious virus 
Cell culture and TOC supernatants were used to titrate infectious virus in TOC 
expressed in CD50/ml as discussed in Chapter 2.3.iii (Cook, et al., 1976b). 
6.3.10 Histopathological lesions 
For histopathological examination, the upper part of the trachea and anterior 
kidney tissues were fixed in 10% buffered formalin, embedded in paraffin and 7 µm 
sections were cut for hematoxylin and eosin (H&E) staining. After staining, the 
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sections were scored individually according to the criteria described in Chapter 
2.6.ii (Chen & Itakura, 1996). 
6.2.11 Quantification of the viral RNA 
RNA was extracted from trachea and kidney samples using the RNeasy Plus Mini Kit 
following the manufacturer’s instructions (Chapter 2.4.i). For quantification of viral 
RNA quantitative reverse transcription PCR (qRT-PCR) was carried out as described 
in Chapter 2.4.v.  
6.2.12 Total RNA isolation and cDNA synthesis 
At each time point, total RNA was extracted from trachea and kidney samples using 
the RNeasy Plus Mini Kit following the manufacturer’s instructions (Chapter 2.4.i). 
RNA concentration was quantified by NanoDrop® ND-1000. The cDNA was 
generated from 1 µg of RNA using the Superscript III First-strand cDNA synthesis 
system with random primers as per the manufacturer’s recommendations as 
described in the Chapter 2.4.iii. 
6.2.13 Host gene expression analysis 
QRT-PCR of cDNA samples in triplicate was performed using LightCycler 480 SYBR 
Green I Master mix and primers as described in the Chapter 2.4.iv. QRT-PCR data 
was normalized using a relative standard curve method to 18S ribosomal RNA (18S 
rRNA) expression (Kuchipudi, Tellabati, et al., 2012) and the data were presented as 
fold difference in gene expression of virus versus mock infected samples. 
6.2.14 ELISA 
Serum samples collected from all the groups at 1, 7 and 14 dpi were tested using 
commercial ELISA kits (IDEXX) according to the manufacturer's instructions 
(Chapter 2.10.i). 
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6.2.15 Statistical analysis 
All the parametric data were analysed using the one-way analysis of variance 
(ANOVA), followed by the post-hoc least significant difference (LSD) multiple 
comparison test. Differences between groups were considered significant at 
P<0.05. For only the trachea and kidney lesion score and viral load the significant 
differences between the groups were analysed by Kruskal-Walis test followed by 
Dunn’s mean test. Differences between groups were considered significant at 
P<0.05. 
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6.3 Results 
6.3.1 In vitro study 
6.3.1.1 IBV 793B infections resulted in significant increase in apoptosis of CEK 
cells and TOCs   
CEK cells and TOCs were infected with 793B or were mock infected. CEK cell 
metabolic activity and percent of apoptotic cells was evaluated at 24 and 48 hpi by 
MTT assay and Annexin V binding assay, respectively. A significant (P<0.05) 
reduction in the cell metabolic activity was found in IBV infected CEK cells 
compared with mock infected cells both at 24 and 48 hpi (Figure 6. 1 A). A 
significantly (P<0.05) higher apoptosis in IBV infected CEK cells was also found at 24 
and 48 hpi (Figure 6.1 B).  Total apoptotic cells in IBV or mock infected TOCs were 
evaluated by TUNEL assay. We found that IBV infection resulted in significant 
increase in total apoptotic cells in TOCs compared with mock infected controls at 
24 and 48 hpi (Figure 6.1 C). Notably, infection of CEK cells with 793B resulted in 
significantly (P<0.05) greater cell death as evidenced by reduced metabolic activity 
(Figure 6.1 A) and increased apoptosis (Figure 6.1 B) compared with mock-infected 
at 24 and 48 hpi. In contrast, lower infectious virus production was observed from 
793B infected CEK cells and TOCs at 48 hpi compared at 24 hpi (Figure 6.1 D).  
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Figure 6.1. IBV 793B infections resulted in significant increase in apoptosis of 
chicken embryo kidney (CEK) cells and chicken embryo tracheal organ cultures 
(TOCs). At 24 and 48 hpi cell metabolic activity of CEK cells was evaluated by (A) 
MTT assay and percent of apoptosis by (B)  Annexin V binding, respectively. Total 
apoptotic cells in TOCs were evaluated by (C) TUNEL assay. Virus production in the 
(D) CEK cells and TOC supernatants were determined in chicken embryo TOCs at 
designated time points after infection. Data represents mean of triplicate wells 
with error bar showing standard error. Significant differences between the groups 
were detected by one-way ANOVA, followed by the post-hoc LSD multiple 
comparison test indicated with different letters (P<0.05). 
B 
A 
C 
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6.3.1.2 Host gene expression in CEK cells 
CEK cells were infected with 793B or mock infected at a MOI of 1.0 and mRNA 
expression of INF-α, INF-β, TLR3 and MDA5 was analysed at 9 and 24 hpi as 
illustrated in Figure 6.2 A & B, respectively. No significant (P<0.05) change at 9 and 
24 hpi in the levels of IFN-α (Figure 5A) expression was noticed in IBV infected CEK 
cells compared with mock infected cells.  Notably, IFN-β expression showed no 
significant change at 9 hpi (Figure 6.2 A) but a significant (P<0.05) down-regulation 
at 24 hpi (Figure 6.2 B) in IBV infected CEK cells compared with mock infected cells. 
It was observed that expression of TLR3 and MDA5 was significantly up-regulated at 
9 hpi (Figure 6.2 A) but down-regulated at 24 hpi (Figure 6.2 B) in IBV infected CEK 
cells compared with mock infected cells (P<0.05). 
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Figure 6.2. Relative mRNA expression of INF-α, INF-β, TLR3 and MDA5 in CEK cells 
infected with IBV strains 793B at MOI 1.0 or mock-infected and gene expression 
was analysed at (A) 9 and (B) 24 hours post infection (hpi). Relative mRNA 
expression was determined by real-time PCR normalised to 18S rRNA. Graphed 
values the mean of three biological replicates with error bars as standard error and 
are expressed as fold change relative to the mocked-infected group. Significant 
differences between the groups were detected by one-way ANOVA, followed by 
the post-hoc LSD multiple comparison test indicated with different letters (P<0.05). 
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6.3.1.3 Host gene expression in TOCs 
Transcriptional regulation of Type I IFN, TLR3 and MDA5 in TOCs infected with IBV 
strain 793B or mock infected was analysed at 9 and 24 hpi (Figure 6.3).  INF-α 
expression was not significantly changed in TOCs at 9 hpi (Figure 6.3 A) and was 
down-regulated at 24 hpi in IBV infected TOCs compared with mock infected 
controls. There was a significant (P<0.05) up-regulation in the expression levels of 
IFN-β and TLR3 at 9 and 24 hpi (Figure 6.3)  in 793B  infected TOCs compared to 
controls. No significant change in expression level of MDA5 was observed at 9 hpi 
(Figure 6.3 A), but the expression was significantly (P<0.05) up-regulated at 24 hpi 
(Figure 6.3 B) in IBV infected CEK cells compared with mock infected cells. 
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Figure 6.3. Relative mRNA expression of INF-α, INF-β, TLR3 and MDA5 TOCs 
infected with IBV strains 793B at a dose of 4 log10 CD50 per individual ring or 
mock-infected and gene expression was analysed at (A) 9 and (B) 24 hours post 
infection (hpi). Relative mRNA expression was determined by real-time PCR 
normalised to 18S rRNA. Graphed values are the mean of three biological replicates 
with error bars as standard error and are expressed as fold change relative to the 
mocked-infected group. Significant differences between the groups were detected 
by one-way ANOVA, followed by the post-hoc LSD multiple comparison test 
indicated with different letters (P<0.05).    
6.3.2 In vivo study 
B 
A 
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6.4.2.1 Clinical Signs 
No clinical signs or mortalities were observed in the control groups during the 
experiment. A few chicks of the infected group showed very mild clinical signs 
including sneezing, coughing, head shaking and eye scratching at 2 dpi and 
recovered by 5 dpi.  
6.3.2.2 Histopathology 
Normal tracheal epithelia, with healthy cilia and goblet cells, were observed in the 
uninfected control birds (Figure 6.4 A). Histopathological lesions in tracheas were 
induced by 793B at 1 dpi. However, these lesions become more severe and peaked 
by 3 dpi with mean scores of 1.72 (Table 6.1). The most consistent lesions occurred 
mainly in the form of loss of cilia, decreased goblet cells, infiltration of 
lymphocytes, plasma cells and heterophils (Figure 6.4 B). 
The kidneys of the chicks from uninfected control group showed no obvious lesions 
(Figure 6.4 C). In the 793B infected group, the main histopathological kidney lesions 
consisted of interstitial lymphoid infiltration with mild lymphoid nodules (Figure 6.4 
D) and these changes became more severe and peaked by 9 dpi with mean scores 
of 1.3 (Table 6.2) 
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Figure 6.4. Histopathological findings in trachea (at 3 dpi) kidney (at 9 dpi) samples, 
using Haematoxylin and Eosin (H&E) stains, (A) Uninfected control group trachea (B) 
793B infected group trachea showing mild epithelial deciliation, with moderate 
lymphocyte and heterophil infiltration (C) Uninfected control group kidney (D) 793B 
infected group kidney showing mild leucocyte interstitial infiltration. 
  
50 µm 50 µm 
A B 
C D 
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Table 6.1. Histopathology of the trachea in SPF chicks infected with IBV 793B strain 
 
 
 
 
 
 
 
 
 
 
 
 
      
 
Data are expressed as the mean histopathological lesion score ± SEM (n = 5). Tracheal lesions scores as follows: no change (0), mild (1), 
 moderate (2) or severe (3).  
Days post 
infection 
Bird 
No. 
Epithelial 
deciliation 
Epithelial 
degeneration 
Decrease 
mucous cells 
Heterophil 
infiltration 
Epithelial 
hyperplasia 
Lymphoid 
infiltration 
Total 
score 
Mean 
score±SE 
1 
1 0 0.5 0 0 0 0 0.5 
0.7±0.33 
2 0 0 0 0 0 0 0 
3 0 0 0 0 0 0 0 
4 0.5 1 0 0 0 0 1.5 
5 0.5 0 1 0 0 0 1.5 
3  
1 0 0 0 0 0 0 0 
3.5±1.72 
2 0 0 0 0 0 0 0 
3 2 1 2 1 1 1.5 8.5 
4 1 1.5 0 0 0 0 2.5 
5 1.5 1.5 0 1 1 1.5 6.5 
7  
1 2.5 1 3 0.5 1 2 10 
8.3±0.71 
2 3 1 2 0.5 0 1 7.5 
3 2 1 2.5 0 1 2 8.5 
4 2.5 1 1 0.5 0 1 6 
5 2 1 3 0.5 0.5 2.5 9.5 
9 
1 0 1 0 0 1 1 3  
2 1 0.5 3 0 1 1 6.5  
3 1.5 0.5 3 0 1 1 7 4.1±1.14 
4 1 0.5 0.5 0 0.5 0.5 3  
5 0.5 0 0 0 0 0.5 1  
14 
1 0 0.5 0.5 0 0.5 1 2.5  
2 0 0 0 0 1 1.5 2.5  
3 0 0 0 0 0 0 0 1.5±0.47 
4 0 0 0 0 0.5 1 1.5  
5 0 0 0 0 0.5 0.5 1  
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Table 6.2. Histopathology of the kidney in SPF chicks infected with IBV 793B strain 
 
ND: not done as sample lost during processing; Data are expressed as the mean histopathological lesion score ± SEM (n = 5). Kidney lesions scores 
as follows: no change (0), mild (1), moderate (2) or severe (3).  
Days post 
infection 
Bird 
No. 
Epithelial 
deciliation 
Ducto-
tubular 
dilation 
Heterophil 
infiltration 
Lymphoid 
infiltration 
Epithelial 
degeneration 
Epithelial 
hyperplasia 
Lymphoid 
nodules 
Fibroblastic 
proliferation 
Total 
score 
Mean 
score±SE 
1 
1 0 0 0 0 0 0 0 0 0 
0.2±0.12 
2 0 0 0 0 0 0 0.5 0 0.5 
3 0 0 0 0 0 0 0.5 0 0.5 
4 0 0 0 0 0 0 0 0 0 
5 0 0 0 0 0 0 0 0 0 
3  
1 0.5 0 0 0 0 0 0 0 0.5 
0.4±0.10 
2 0 0 0 0 0 0 0.5 0 0.5 
3 0 0 0 0 0 0 0.5 0 0.5 
4 0 0 0 0 0 0 0.5 0 0.5 
5 0 0 0 0 0 0 0 0 0 
7  
1 0 0 0 0 0 0 0 0 0 
0.40±0.40 
2 0 0 0 0 0 0 0 0 0 
3 0 0 0 1 0 0 1 0 2 
4 0 0 0 0 0 0 0 0 0 
5 0 0 0 0 0 0 0 0 0 
9 
1 0.5 0 0 0.5 0 0 0 0 1  
2 0 0 0 0.5 0 0 0 0 0.5  
3 0 0 0 0.5 0.5 0 0 0 1 1.3±0.43 
4 0.5 0 0 0.5 0 0 0 0 1  
5 0.5 0.5 0 2 0 0 0 0 3  
14 
1 ND ND ND ND ND ND ND ND ND  
2 ND ND ND ND ND ND ND ND ND  
3 ND ND ND ND ND ND ND ND ND  
4 ND ND ND ND ND ND ND ND ND  
5 ND ND ND ND ND ND ND ND ND  
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6.3.2.3 Viral RNA quantification in trachea and kidney 
Viral RNA load in the tracheas of birds of uninfected control group on all days post 
infection were below the detection limit (Figure 6.5). The viral RNA load in trachea 
the infected group was detected at 3 dpi and the peak was observed at 7 dpi. In 
kidneys of infected chicks viral RNA load was first detected at 7 dpi and peak load 
was observed at 9 dpi. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.5 Quantification of viral RNA, expressed as a log relative equivalent units (REU) of 
RNA in Trachea and Kidney samples of chicken. Birds (n=5/group) were infected with IBV 
strain 793B at a dose of 10
5.0 
CD
50
/bird and analysed for quantification of viral RNA at 01, 
03, 07, 09, and 14 days post infection (dpi). Data represents the mean with error bars as 
standard error. Significant differences between the groups were detected by 
Kruskal-Walis test followed by Dunn’s mean test indicated with different letters 
(P<0.05). 
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6.3.2.4 Relative IFN-α and IFN-β mRNA expression 
The mRNA expression data for IFN-α and IFN-β in the trachea are illustrated in   
Figure 6.6 A & B, respectively. No significant change in the IFN-α mRNA expression 
levels at any dpi was noticed in the infected group compared with uninfected 
control group (Figure 6.6 A). After peaking at 1 dpi, tracheal samples of chicks 
infected with 793B resulted in significantly (P<0.05) greater IFN-β mRNA expression 
at 1, 3, 7 dpi compared with uninfected control group (Figure 6.6 B). Conversely, on 
subsequent dpi no significant changes in level of IFN-β mRNA expression were 
detected in infected group compared with uninfected control group.  
The mRNA expression data for IFN-α and IFN-β in the kidney is illustrated in   Figure 
6.7 A and B, respectively. No significant (P<0.05) differences in the IFN-α expression 
levels at any dpi was noticed in any infected group compared with uninfected 
control group. At 1 and 3 dpi, IFN-β mRNA expression in kidney samples of chicks 
infected with 793B was up-regulated (P<0.05) compared with uninfected control 
group. No significant changes in level of IFN-β expression was observed in any 
infected group at the other time points (7, 9 or 14 dpi). 
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Figure 6.6. Relative Type I interferon (IFN) (A) IFN-α and (B) IFN-β mRNA 
expression in trachea of chickens (n=5/group) infected with IBV strain 793B at a 
dose of 10
5.0 
CD
50
/bird and gene expression was analysed at 01, 03, 07, 09, and 
14 days post infection (dpi). Relative mRNA expression was determined by 
quantitative reverse transcription PCR (qRT-PCR) using SYBR Green method and 
the data were normalised to 18S rRNA expression. Data represents the mean 
with error bars as standard error and are expressed as fold change relative to the 
uninfected controls group. Significant differences between the groups were 
detected by one-way ANOVA, followed by the post-hoc LSD multiple comparison 
test indicated with different letters (P<0.05).    
B 
A 
Days post infection 
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Figure 6.7. Relative Type I interferon (IFN) (A) IFN-α and (B) IFN-β mRNA expression 
in kidney of chickens (n=5/group) infected with IBV strain 793B at a dose of 10
5.0 
CD
50
/bird and gene expression was analysed at 01, 03, 07, 09, and 14 days post 
infection (dpi). Relative mRNA expression was determined by quantitative reverse 
transcription PCR (qRT-PCR) using SYBR Green method and the data were 
normalised to 18S rRNA expression. Data represents the mean with error bars as 
standard error and are expressed as fold change relative to the uninfected controls 
group. Significant differences between the groups were detected by one-way 
ANOVA, followed by the post-hoc LSD multiple comparison test indicated with 
different letters (P<0.05).    
B 
A 
Chapter Six                                           In vitro and in vivo immunopathogenesis of 793B 
161 
 
6.3.2.5 Expression of mRNA of TLR3 and MDA5 in the trachea and kidney 
The mRNA expression of TLR3 and MDA5 in the tracheal samples from chicks 
infected with IBV strain 793B or the uninfected control group are illustrated in 
Figure 6.8 A & B, respectively. It was observed that expression of TLR3 (Figure 6.8 
A) in the infected group was significantly (P<0.05) up-regulated at 1 and 3 dpi 
compared to the uninfected control group. No significant (P<0.05) changes in TLR3 
mRNA expression levels were detected in the infected group compared with the 
uninfected control group on subsequent dpi. Similarly, 793B infection resulted in 
significantly (P<0.05) greater MDA5 expression in the trachea at 1 dpi compared 
with the uninfected control group (Figure 5.9 B). No significant changes in level of 
MDA5 expression was observed in the infected group at the other time points (3, 7, 
9 or 14 dpi). 
The mRNA expression data for TLR3 and MDA5 in the kidney is illustrated in Figures 
6.9 A and B, respectively. We found that 793B infection resulted in significantly 
(P<0.05) higher mRNA expression of TLR3 (Figure 6.9 A) compared with the 
uninfected control group only at 3 dpi. Notably, no significant changes in level of 
TLR3 mRNA expression were observed in any infected group at the other time 
points (1, 7, 9 or 14 dpi) compared with the uninfected control group. At 3 and 7 
dpi, MDA5 mRNA expression (Figure 6.9 B) in kidney samples of chicks infected 
with 793B was up-regulated and was significantly (P<0.05) higher compared with 
the uninfected control group.  
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Figure 6.8. Transcriptional regulation of innate viral sensing molecules (A) TLR3 and 
(B) MDA5 in trachea of chicken (n=5/group) infected with IBV strain 793B at a dose 
of 10
5.0 
CD
50
/bird and gene expression was analysed at 01, 03, 07, 09, and 14 days 
post infection (dpi). Relative mRNA expression was determined by quantitative 
reverse transcription PCR (qRT-PCR) using SYBR Green method and the data were 
normalised to 18S rRNA expression. Data represents the mean with error bars as 
standard error and are expressed as fold change relative to the uninfected controls 
group. Significant differences between the groups were detected by one-way 
ANOVA, followed by the post-hoc LSD multiple comparison test indicated with 
different letters (P<0.05).    
Days post infection 
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A 
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Figure 6.9. Transcriptional regulation of innate viral sensing molecules (A) TLR3 and 
(B) MDA5 in kidney of chicken (n=5/group) infected with IBV strain 793B at a dose of 
10
5.0 
CD
50
/bird and gene expression was analysed at 01, 03, 07, 09, and 14 days post 
infection (dpi). Relative mRNA expression was determined by quantitative reverse 
transcription PCR (qRT-PCR) using SYBR Green method and the data were 
normalised to 18S rRNA expression. Data represents the mean of three biological 
replicates with error bars as standard error and are expressed as fold change 
relative to the mock-infected group. Significant differences between the groups 
were detected by one-way ANOVA, followed by the post-hoc LSD multiple 
comparison test indicated with different letters (P<0.05).    
Days post infection 
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6.3.2.6 Transcription profile of proinflammatory cytokines in the trachea and 
kidney 
The changes in levels of 3 pro-inflammatory cytokines in trachea are illustrated in 
Figure 6.10. The results indicate that, the level of IL-1β mRNA expression peaked at 
7 dpi, with mRNA expression being significantly (P<0.05) higher at 3 and 7 dpi in 
chicks infected with 793B compared with uninfected control. Figure 6.10 B and C 
shows the expression of IL-6 and LITAF, respectively wherein, at 7 dpi, a peak 
increases in the expression was noticed in chicks infected with 793B. However, 
mRNA expression was significantly (P<0.05) higher at 3 and 7 dpi in chicks infected 
with 793B compared with uninfected control.  
Conversely, in the kidney samples, IL-1β mRNA expression level expression peaked 
at 9 dpi in all infected group and was significantly (P<0.05) up-regulated in 793B 
infected group compared to uninfected control group (Figure 6.11 A). At 7 and 9 
dpi, IL-1β mRNA expression in infected group was significantly (P<0.05) 
up-regulated compared with uninfected control group. The mRNA expression of 
IL-6 and LITAF in kidneys from the infected group peaked at 14 dpi (Figure 6.11 B & 
C) and was significantly (P<0.05) up-regulated compared with uninfected control 
group but. However, at 7 and 9 dpi, IL-6 and LITAF mRNA expression level was 
significantly (P<0.05) up-regulated in 793B infected group compared to uninfected 
control group.  
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Figure 6.10. Transcription profile of proinflammatory cytokines (A) IL-1β, (B) IL-6 and (C) 
LITAF in trachea of chicken (n=5/group) infected with IBV strain 793B at a dose of 10
5.0 
CD
50
/bird and gene expression was analysed at 01, 03, 07, 09, and 14 days post infection 
(dpi). Relative mRNA expression was determined by quantitative reverse transcription PCR 
(qRT-PCR) using SYBR Green method and the data were normalised to 18S rRNA 
expression. Data represents the mean with error bars as standard error and are expressed 
as fold change relative to the uninfected controls group. Significant differences between 
the groups were detected by one-way ANOVA, followed by the post-hoc LSD multiple 
comparison test indicated with different letters (P<0.05).    
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Figure 6.11. Transcription profile of proinflammatory cytokines (A) IL-1β, (B) IL-6 
and (C) LITAF in kidney of chicken (n=5/group) infected with IBV strain 793B at a 
dose of 10
5.0 
CD
50
/bird and gene expression was analysed at 01, 03, 07, 09, and 14 
days post infection (dpi). Relative mRNA expression was determined by 
quantitative reverse transcription PCR (qRT-PCR) using SYBR Green method and 
the data were normalised to 18S rRNA expression. Data represents the mean with 
error bars as standard error and are expressed as fold change relative to the 
uninfected controls group. Significant differences between the groups were 
detected by one-way ANOVA, followed by the post-hoc LSD multiple comparison 
test indicated with different letters (P<0.05).    
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6.3.2.7 ELISA 
Serum samples from both the groups collected prior to infections were free of the 
IBV antibodies (Figure 6.12). At 7 and 14 dpi, all chicks inoculated with 793B 
showed a positive IBV antibody response with significant (P<0.05) difference 
compared with uninfected control group. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.12. Infectious bronchitis virus (IBV) antibody titres of the different 
groups (n=5/group) infected with IBV strains 793B or uninfected control at a dose 
of 10
5.0 
CD
50
/bird. Data is expressed as mean values ± SEM. Significant 
differences between the groups were detected by one-way ANOVA, followed by 
the post-hoc LSD multiple comparison test (P<0.05). Asterisks indicate that 
values between the groups were significantly different (P<0.05) at those time 
point. Cut-off point titre = 396. 
Cut-off 
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6.4 Discussion 
Infectious bronchitis virus (IBV) 793B occurs frequently in vaccinated and 
non-vaccinated flocks and causes severe economic losses. In the present study, 
immunopathogenesis of 793B serotype was comprehensively analysed after in vitro 
and in vivo infections. 
To assess the effect of in vitro infection, we infected CEK cells and TOCs with 793B 
or mock infected. Overall a significant higher death rate of CEK cells was observed 
in the infected group compared with mock-infected. We found that IBV infection 
resulted in increased apoptosis in CEK cells as well as in TOCs. As discussed in 
Chapter 3 and 4, that IBVs are known to induce apoptosis in infected cells and B-
cell lymphoma 2 (Bcl-2) family proteins modulate IBV-induced apoptosis (Li, et al., 
2007; Liu, et al., 2001; Zhong, Liao, et al., 2012; Zhong, Tan, et al., 2012). Our 
findings suggest a correlation between apoptosis in CEK cells and TOCs and the 
ability of 793B to cause kidney or respiratory lesions respectively in chicken. The 
potential for apoptosis to cause such tissue damage has also been recognized for 
the Coronavirus infections (SARS-CoV) (Tan, et al., 2004) which was discussed in 
Chapter 3. 
Another objective of in vitro study was to analyse the early innate mechanism 
involved in 793B infection of CEK cells and TOCs. Infection of 793B resulted in 
significantly higher up-regulation of innate immune sensing genes TLR3 and MDA5 
along with higher IFN-β mRNA levels in CEK cells and TOCs at 9 hpi than mock-
infected group. Notably, expression of all the innate immune genes tested, was 
down-regulated at 24h after IBV infection in CEK cells. As discussed in Chapter 3, 
this could be a consequence of host shut-off induced by IBV virus replication 
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(Kamitani, et al., 2006; Tohya, et al., 2009). In addition, coronavirus N protein has 
been shown to interfere with induction of Type I IFN, which in turn can also inhibit 
the production of various pro-inflammatory cytokines and chemokines via global 
translational shutdown (Zhong, Tan, et al., 2012). However, TLR3, MDA5 and IFN-β 
expression was up-regulated in TOCs at 24 hpi. The difference between the 
expression profile of the innate immune genes at 24 hpi in CEK cells and TOCs could 
be due to difference in the dynamics of virus replication. 
Several in vitro and ex vivo studies have suggested a key role of TLR3 in viral 
detection (Alexopoulou, et al., 2001; Bowie & Haga, 2005; Finberg & Kurt-Jones, 
2004; Tabeta, et al., 2004). TLR3 has been reported (discussed in Chapter 3 and 4) 
to contribute to detrimental effects caused by West Nile virus in mice (Wang, et al., 
2004) and influenza virus infection (Le Goffic, et al., 2006). A recent study showed 
that MDA5, but not TLR3, is involved in the sensing of IBV (Kint, et al., 2015). 
However, in the in vivo pathogenicity part of present study (discussed later), we 
observed that mRNA levels of TLR3 and MDA5 were comparable with the pattern of 
histopathological lesion scores in trachea and kidney produced by 793B. This could 
be explained by the hypothesis that MDA5 activation is a protective antiviral host 
response against the virus whereas TLR3 contributes to the detrimental effects of 
the viral infection. However, further studies should be performed to confirm this 
hypothesis. In addition, significantly lower infectious virus production was observed 
from 793B infected CEK cells and TOCs supernatant at 9 and 24 hpi. This could be 
consequential with the increased antiviral state induced by IFN-β and/or increased 
apoptosis as discussed in Chapter 3 and 4. 
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In this study we also investigated the immunopathogenesis in SPF chicks infected 
with 793B. Our findings showed that chicks responded to 793B infection as chicks 
displayed very mild clinical signs but no mortalities. In agreement with this, it has 
been reported that the birds inoculated with 793B serotype unlikely to cause 
mortality or severe clinical signs in infected chicks in uncomplicated cases 
(Benyeda, et al., 2010; Bijanzad, et al., 2013; Otsuki, et al., 1990). We also found a 
positive IBV antibody response with significant difference with control at 7 and 14 
dpi in chicks infected with 793B which shows the establishment of infection.  
We noted that infection of 793B resulted in obvious histopathological changes in 
the trachea and kidney similar to those reported in previous experiments (Bijanzad, 
et al., 2013; Chen et al., 1996; Chousalkar, et al., 2007; Kotani, et al., 2000). These 
pathological changes in the trachea peaked by 7 dpi in the trachea and by 9dpi in 
kidney. A similar trend was found for viral load in trachea and kidney. Interestingly, 
these peak values of histopathological changes and viral load were found to be 
associated with peaks of expression of inflammatory cytokines, such as IL-6 and 
IL-1β, and higher LITAF mRNA expression values. This suggests a role of both these 
cytokines and virus load in the development of pathological lesions. Similar findings 
were reported after experimental infection with IBV QX (Jang, et al., 2013) and 
other strains (discussed in Chapter 5).  An association between IL-6 and IL-1β with 
high virus loads and the development of tracheal lesions has also been observed 
following IBV-M41 infection (Okino, et al., 2014) 
The role of TLR3 in viral immunology has been discussed in Chapter 3 (Akira, 2001; 
Le Goffic, et al., 2007). It was observed that 793B infection resulted in significantly 
higher up-regulation of TLR3 levels in trachea at 1 dpi and in kidney at 3 dpi. 
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Parallel with our findings, previous studies have also reported a significant increase 
of TLR3 mRNA expression in trachea of IBV infected chicks when compared to the 
uninfected controls (Kameka, et al., 2014; Wang, et al., 2006). In contrast, in the 
most recent study, no significant changes was observed in TLR3 expression in 
kidney following infection with attenuated CK/CH/LHLJ/04V strain, which could be 
due to loss of virulence (Xu et al., 2015). In our study, MDA5 mRNA expression 
values peaked in 793B infected trachea and kidney at 1 and 3 dpi, respectively. 
MDA5 mRNA expression levels were reported to be significantly increased in 
chicken kidney tissue after nephropathogenic IBV infection suggesting a role of 
chicken MDA5 in IBV infection (Cong, et al., 2013).  
In addition, it has been reported that in vitro virulent IBV infection leads to a 
significant induction of IFN-β transcription through an MDA5- dependent activation 
of the IFN response (Kint, et al., 2015). Concurrent with TLR3 and MDA5 activation, 
we found a significant up-regulation of IFNβ but not IFNα mRNA expression at 1 dpi 
in trachea and 3 dpi in kidney after IBV infections. Many previous studies claims 
that the activation of the TLR3 pathway works towards an up-regulation of INF-β 
production in chicks (Kameka, et al., 2014; Karpala, et al., 2008; Parvizi, et al., 
2012). Altogether, in this study we found that mRNA levels of TLR3 and MDA5 
showed the same pattern as that of histopathological lesion scores in trachea and 
kidney produced by 793B. 
This study represents some of the underlying mechanisms of induction of host 
responses by 793B in chicks as well as in vitro. We are reporting that in vitro higher 
apoptosis together with elevated levels of TLR3, MDA5 and IFN-β expression 
correlates with in vivo pathogenicity of 793B in tracheas and kidneys. Additionally, 
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in vivo results provided further evidence that the higher upregulation of expression 
of proinflammatory cytokines (such as IL-6 and IL-1β) and LITAF induced by 793B in 
trachea and kidney of SPF chicks may be ascribed to histopathological damage 
caused by the virus in those respective organs.  
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The data from this Chapter have been published (Appendix III) in peer-reviewed 
journal as below: 
Rajesh Chhabra, Anne Forrester, Stephane Lemiere, Faez Awad, Julian Chantrey, 
and Kannan Ganapathy. (2015) Mucosal, cellular and humoral immune responses 
induced by different live infectious bronchitis virus vaccination regimes and the 
protection conferred against infectious bronchitis virus Q1 strain. Clinical and 
Vaccine Immunology 22 (9): 1050-59. 
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7.1 Introduction 
The prevention of infectious bronchitis (IB) in chickens is achieved through the use 
of live and inactivated vaccines, which provide protection against virulent field IB 
viruses in the event of an exposure. Despite these preventative measures, 
outbreaks of IB frequently occur in many poultry producing countries (Gelb, Wolff, 
et al., 1991; Gough, et al., 1992; Liu & Kong, 2004). This is probably due to the 
emergence of new variants of infectious bronchitis virus (IBV) (Gelb, Wolff, et al., 
1991; Gough, et al., 1992; Jia et al., 1995; Liu & Kong, 2004; Pohuang et al., 2009). 
For the successful protection of chickens against infection, it is essential to identify 
the prevalent genotypes in the region and to determine the cross-protective 
potential of available vaccines and optimise strategic vaccination programmes. 
IB was first described in the USA during the 1930s and was identified in the UK in 
1948. Thereafter, many IBV variants were isolated from Europe, significantly a 
variant called 793B that emerged in the 1990s (Parsons, et al., 1992). Later, IBV QX 
was first identified in China (Wang Y, 1998) before spreading to Europe 
(Worthington, et al., 2008). Another IBV genotype, Q1, genetically and serologically 
distinct from the classical IBVs, was also reported in China (Yu, et al., 2001), the 
Middle East (Ababneh et al., 2012) and Europe (Toffan, et al., 2011). To contain this 
strain, an effective vaccination programme is needed. However, very little is known 
about the cross protection induced by the commercially available vaccines or 
vaccination regimes against this variant Q1. 
An effective and long-lasting protection against IBV infection requires the activation 
of effector, memory cell-mediated and humoral immune responses against the 
virus (Cavanagh, 2007). A number of studies have reported the systemic and local 
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humoral immune response (HIR) to IBV vaccination (Cavanagh, 2007; Ignjatovic & 
Galli, 1994; Mockett & Darbyshire, 1981). In chickens, experimentally challenged 
with IBV, the development of a cell mediated immune response (CMI) has been 
correlated with effective virus clearance, reduction of clinical signs and resolution 
of lesions (Collisson, et al., 2000). The presence of cytotoxic CD8+ T lymphocytes 
(CTL) represents a good correlation for  decreasing infection and corresponds with 
a reduction in clinical signs, as CTL activity is major histocompatibility complex  
restricted and these T cells mediate cytolysis (Pei, et al., 2001). It has additionally 
been shown that the transfer of CTLs obtained from spleen of IBV-infected 
chickens, was protective to naïve chicks against a subsequent IBV challenge 
(Collisson, et al., 2000; Seo, et al., 2000). During the course of experimental viral 
infection, Kotani et al (2000) showed that the clearance of the IBV from the 
tracheal mucosa occurred at an early phase of the infection and CTLs at the 
tracheal mucosa were proposed to be involved in this clearance (Kotani, et al., 
2000). To date, there is no information available on the tracheal mucosal 
leukocytes after vaccination with live IBV vaccines.  Nevertheless, Okino et al (2013) 
have quantified the relative expression of the CTLs genes in tracheal samples from 
vaccinated and further challenged birds. The up regulation of these genes, in the 
tracheal mucosa of the full-dose vaccinated birds, was significantly increased at 24 
hours post infection (hpi), demonstrating the development of a memory CMI 
(Okino, et al., 2013). However, these researchers did not directly measure the 
activity of CMI, such as the cytotoxic mechanism of CTLs. 
Despite all these reports, the kinetics of, and the relationship between local and 
systemic HIR and CMI induced by different IBV vaccination regimes, needs to be 
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better understood for protection against emerging IBV strains. Thus, the objective 
of our study was to measure the local as well as systemic HIR and CMI induced by 
two different IBV vaccination regimes administered to commercial broiler chicks, 
and to estimate the protection achieved against a recently isolated virulent Q1 
strain.   
7.2 Materials and methods 
7.2.1 Chicks 
One hundred twenty broiler chicks with IBV MDA, aged 1-day-old, were obtained 
from a commercial hatchery (Chapter 2.5.i). Chicks were kept in an isolation unit 
(University of Liverpool) throughout the experiment and reared on deep litter with 
water & feed provided ad libitum as described in Chapter 2.5.ii. 
7.2.2 Challenge virus 
The virulent Q1 isolate used in this study was kindly provided by Merial Animal 
Health. RT-PCR (as described Chapter 2.4.vi) followed by sequencing (Chapter 
2.5.vii) confirmed that the allantoic fluid, from eggs used to propagate the virus, 
was free of Newcastle disease virus, avian influenza virus, infectious bursal disease 
virus, infectious laryngotracheitis virus and avian metapneumovirus. Q1 IBV was 
also free of bacterial or fungal contaminants. The virus was titrated in the chicken 
tracheal organ culture (TOC) as described in Chapter 2.3.iii and expressed in 50% 
(median) ciliostatsis doses (CD50)/ml (Cook et al., 1976a). 
7.2.3 Vaccine preparation 
As recommended by the manufacturer (Merial Animal Health Limited, UK), the 
vaccines were prepared by thoroughly mixing one vial of live IBV (Massachusetts-
type) H120 (Bioral H 120®) vaccine with 100 ml of sterile water (SW). For combined 
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vaccinations, one vial of each Bioral H 120® and live IBV (793B-type) CR88 
(GALLIVAC® IB88) vaccines were mixed together in 100 ml of SW. Immediately after 
preparation, the vaccines and SW were kept in a cold box (at 0°C). Each chick 
received a total of 100 μl of the appropriate vaccine ocularly (50 μl) and nasally (50 
μl) or SW. To quantify the virus, titration of live IBV vaccine for H120 and CR88 was 
performed by using 9-11 days of age (doa) specific pathogen free (SPF) 
embryonated chicken eggs (ECE) inoculated via the allantoic cavity (Chapter 2.3..iii). 
The ECE were examined for IBV specific lesions (curling and dwarfing) of the 
embryos up to 5 days post inoculation. Viral titres were calculated as described 
earlier (Reed & Muench, 1938) and expressed as the egg infective dose (EID50/ml). 
The titre of the vaccine viruses used was 3.5 log10 EID50/chick and 4.25 log10 
EID50/chick for the H120 strain and CR88 strain, respectively. 
7.2.4 Experimental design 
One hundred and twenty broiler chicks, aged 1-day-old, were divided into three 
groups (n=40 chicks/group) (Table 7.1). Chicks in group I were inoculated 
oculonasally with 100 μl of live H120 vaccine alone. In group II, chicks were 
inoculated oculonasally with 100 μl of both live H120 and CR88 vaccines 
simultaneously. Chicks in both groups (I and II) were again inoculated with a live 
CR88 vaccine at 14 doa. Group III received only 100 μl of SW oculonasally and was 
kept as a control. Samples (5 birds/group) of serum, tears and heparinized blood 
were collected at 0, 4, 7, 14, 21 and 28 doa before sacrificing the birds. The tears 
and serum samples were stored at -20°C, and blood samples were processed 
immediately for peripheral blood mononuclear lymphocytes isolation. Five chickens 
from each group per interval were humanely euthanized for the collection of 
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approximately 1 cm of the upper trachea in OCT to be snap-frozen in liquid 
nitrogen for immunohistochemistry (IHC). The rest of the trachea was used for 
tracheal washes. At 28 doa, 10 birds from each group were challenged via           
ocular-nasal route with Q1 (104.0 CD50/bird) and observed daily for clinical signs.  
After 5 days post challenge (dpc), all 10 birds from each group were necropsied and 
tracheal samples were collected; a portion placed in the RNALater and stored          
at -70°C until processing for examination of viral RNA load. The remaining portions 
were examined by histopathology and ciliostatsis test. The kidneys from all groups 
were also taken for histopathology and viral RNA load examination. 
 
Table 7.1. Study design showing groups, vaccine and vaccination regimes.  At 28 
day of age, 10 chicks from each group were challenged with a virulent IBV Q1.  
 
 
 
 
IBV vaccine 
(dosage/chick in 100 μl) 
 
Group/days of age 
 
I II III 
0 14 0 14 0 14 
H120 
(3.5 log10 EID50) 
√  √    
CR88 
(4.25 log10 EID50) 
 
 
√ 
√ √   
Sterile water  
(SW) 
    
 
√ 
 
 
√ 
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7.2.5 Sample collection for antibody detection 
The potential of the vaccines to induce antibody production was assessed 
individually by using samples of sera, tears and tracheal washes.  Tears were 
collected using sodium chloride as described before (Ganapathy et al., 2005), 
immediately centrifuged at 3000 x g for 3 min before storing the supernatant 
at -70°C until used. To collect the tracheal washes, the trachea was clamped with 
two artery forceps at both the ends, and washed with 1 ml PBS using a syringe with 
19 gauge needle (Raj & Jones, 1996c). The collected samples were centrifuged at 
3000 x g for 3 min, and the supernatant stored at -70°C until further use. 
7.2.6 ELISAs 
To detect IBV antibodies, serum samples were tested using commercial ELISA kits 
(IDEXX) as described in Chapter 2.10.i.  
Immunoglobulin A (IgA) in tears and tracheal washes was assayed using commercial 
IgA chicken ELISA kit (Abcam, Uk) according to the manufacturer’s instructions. In 
brief, 100 µl of 1:25 dilution of individual tears or tracheal washing was added in 
the 96-well immunoplates pre-coated with anti-IgA antibodies and incubated for 20 
min at room temperature (25°C). After the removal of unbound samples by 
washing, 100 µl anti-IgA antibodies conjugated with horseradish peroxidase (HRP) 
was added. Following incubation of the plate for 20 min at room temperature and 
washing step, the amount of enzyme bound in complex is measured by the addition 
of 100 µl TMB. Reaction was stopped after 10 min of incubation by adding 100 µl 
stopping solution and absorbance was measured at 450 nm. The quantity of IgA in 
the test sample was interpolated from the standard curve constructed from the 
standards and corrected for sample dilution as per manufacturer’s instructions. 
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7.2.7 Haemagglutination inhibition (HI) test 
HI testing was performed using 4 HAU as described in Chapter 2.10.ii. Prior to the 
HI test, back-titration of the HA antigen was carried out to ascertain the 4 HAU. The 
HI titres were read as the reciprocal of the highest dilution showing complete 
inhibition and the HI geometric mean titres were expressed as reciprocal log
2
. 
7.2.8 Cellular immune responses 
7.2.8.1 Analysis of T lymphocyte subsets (CD4+:CD8+) ratio in peripheral blood 
To determine the percentage of T-lymphocyte subpopulations, blood was collected 
from the cephalic vein in heparin tubes (Sigma-Aldrich, UK) at final concentrations 
of 20 µg/ml of blood, and further diluted (1:1) with RPMI 1640 medium                
(Sigma-Aldrich, UK). The prepared blood samples (1 ml each) were then over 
layered onto 0.5 ml of Histopaque-1.077 gradient (Sigma-Aldrich, UK) and 
centrifuged in 1.5 ml Eppendorf vial at 8000 x g for 90 sec.  After centrifugation, the 
buffy coat formed of mononuclear cells was gently collected, washed twice with a 
RPMI 1640 medium and adjusted to 1×107 cells/ml. The cells were resuspended in 
0.5% bovine serum albumin (BSA, Sigma-Aldrich, UK) in PBS (blocking solution) and 
incubated at room temperature for 15 min. The sample (100 μl) was incubated with 
antibodies against surface domains of CD4 (mouse anti-chicken CD4-FITC clone 
CT-4; 0.5mg/ml; Southern Biotech, Birmingham, AL, USA) and CD8 (mouse 
anti-chicken CD8a-FITC clone CT-8; 0.5mg/ml; Southern Biotech) receptors of 
T-lymphocytes (antibody final concentrations as 0.2 μl/100 μl of sample) for 30 min 
in the dark. The stained cells were detected by flow cytometry (BD Accuri® C6, BD 
Bioscience San Jose, CA, USA) to count the T lymphocytes. The unstained cell 
sample was used as a negative control to adjust the threshold. 
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7.2.8.2 Immunohistochemical detection of CD4+, CD8+ and IgA-bearing B-cells in 
tracheal sections 
The trachea samples collected from each bird were immediately placed in 
aluminium foil cups containing cryo embedding compound (OCT, Solmedia 
laboratory, Shrewsbury, UK) and frozen in liquid nitrogen (-190°C). The 
OCT-embedded tracheal samples were cut into 5 μm sections using a 
pre-cooled cryostat (LEICA CM 1900, Germany), mounted on glass slides (Thermo 
Scientific, UK) and kept overnight in dark for drying. The sections were fixed in 
ice-cold acetone for 10 min, air dried at room temperature and stored at -80°C until 
staining.  Staining was carried out as described earlier (Rautenschlein et al., 2011), 
with some modification. Just prior to staining, slides were removed from -80°C and 
air dried at room temperature for 10 min.  After endogenous peroxidase inhibition 
using 0.03% hydrogen peroxide (H2O2) in PBS for 20 min, the endogenous biotin or               
biotin-binding proteins in tissue sections were blocked with blocking serum using 
VECTASTAIN® Elite ABC kit (Vector Laboratories, Burlingame, USA).  Following 
blocking, tissue sections were stained overnight at 4°C in the dark to detect CD4+, 
CD8+  and IgA+ cells by using mouse monoclonal antibodies to chicken CD4 (clone 
CT-4; 0.5 mg/ml) and CD8a (clone CT-8; 0.5 mg/ml) at 1:1000, and to chicken IgA 
(clone A-1; 0.5 mg/ml)  at 1:2000. All monoclonal antibodies were procured from 
Southern Biotech, Birmingham, AL, USA.  The colour development was done by 
addition of 4% 3,3-diaminobenzidine (DAB, VECTOR Laboratories, Burlingame, USA) 
substrate containing 2% H2O2 and 2% buffer stock solution. Sections were then 
washed in super quality water, and counter stained with hematoxylin (Merck, 
Germany) for 1 minute, followed by washing in tap water for 5 min. Finally, sections 
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were dehydrated for 1 min in 96% ethanol, 2 min in 100% ethanol, 3 min in 100% 
ethanol, 2 min in 100% xylene, 3 min in 100% xylene, 3 min 100% xylene and later 
mounted with DPX mounting medium and covered with a coverslip. The stained 
cells were counted in 5 selected microscopic fields at a 400x magnification 
(fields/trachea). For each sample, the average number of positive cells/400× 
microscopic field was calculated for each cell type as described previously 
(Rautenschlein, et al., 2011). 
7.2.9 Ciliary protection 
At 5 dpc, trachea samples were evaluated according to standard procedure for 
ciliary movement, and the ciliary protection for each group was calculated. In brief, 
following euthanasia, trachea was removed aseptically and immediately placed in 
warm (37oC) TOC medium (Appendix 1). Each trachea was cut into approximately 
0.6-mm-thick rings (3 rings from the upper, 4 rings from the middle and 3 rings 
from the lower) using a tissue chopper (as described in Chapter 2.3.iii) and the 
tracheal rings were placed in a petri dish containing warm TOC medium. Each ring 
was examined under a low power microscope (100 x magnifications). Cilia beating 
in each ring were scored as: All cilia beating = 0, 75% cilia beating = 1, 50% cilia 
beating = 2, 25% cilia beating = 3, 0% cilia beating = 4.  A ciliary activity score of 4 
indicates 100% ciliostatsis. According to the European Pharmacopoeia’s reference 
standards, individual birds yielding 80% or more tracheal explants with ciliary 
activity were considered to have been protected by the vaccine against the 
challenge virus (Council of Europe, 2007). 
 
 
Chapter Seven                              Immune responses to IBV vaccines and Q1 protection        
184 
 
Protection scores were calculated according to the following formula: 
1 −  
(Mean score for vaccinated/Number birds challenged group)
(Mean score for unvaccinated Number birds unchallenged)
 ∗ 100 
 
7.2.10 Histopathological evaluation 
At 5 dpc, kidneys and tracheas from humanely euthanized birds were collected and 
fixed in 10% formalin. The tissues were embedded in paraffin wax (50-60ºC) and 
sections were cut to 7μm thickness. Tissue sections were stained by haematoxylin 
and eosin (H&E) for microscopic evaluation, the scores attributed according to the 
criteria described in the Chapter 2.6.ii (Andrade et al., 1982; Chen, et al., 1996). 
7.2.11 Real time RT-PCR (RT-qPCR) 
RNA was extracted from trachea and kidney samples using the RNeasy Plus Mini Kit 
following the manufacturer’s instructions (Chapter 2.4.i). For quantification of viral 
RNA quantitative reverse transcription PCR (qRT-PCR) was carried out as described 
in the Chapter 2.4.v.  
7.2.12 Statistical analysis 
The comparisons of the means of anti-IBV antibody levels; CD4+:CD8+ ratio in 
peripheral blood; immunohistochemical detection of CD4+, CD8+ and IgA-bearing 
B-cells in tracheal sections were performed using one-way analysis of variance 
(ANOVA), followed by the post-hoc LSD multiple comparison test using GraphPad™ 
Prism version 6.00 software. Kruskal-Wallis test followed by Dunn’s test was used 
for statistical analysis of the non-parametric RT-qPCR and histopathological 
evaluation data. Differences were considered significant at P<0.05. 
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7.3 Results 
7.3.1 Systemic humoral immune response 
7.3.1.1 ELISA 
On the day of vaccination, the mean of maternally derived anti-IBV antibody titre 
was 1750±203. Subsequently, the antibody levels in all three groups declined to 
below cut-off point (396) by 14 doa. After the booster vaccination with the CR88 at 
14 doa, a significant increase in the antibody titres till 28 doa was observed in 
groups I and II, as shown in Figure 7.1. On these time points, the levels of 
antibodies were not significantly different between the vaccinated groups (P<0.05).  
After 14 doa though, the antibody titres in group III was always less than the cut-off 
value of 396 in this assay. 
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Figure 7.1. Anti-infectious bronchitis virus (IBV) antibody titres of the different 
groups vaccinated with a live H120 alone (group I) or in combination with CR88 
(group II) at day-one.  Both groups were again vaccinated with CR88 at 14 days of 
age. One group (group III) was kept as control. Where values were significantly 
(P<0.05) different these are shown with different letters and all other values were 
not significantly (P<0.05) different between the groups on those sampling points. 
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7.3.1.2 HI test 
The level of serotype specific antibodies against homologous and heterologous 
antigens was evaluated by a HI test (Table 7.2).  The HI antibody response against 
all the antigens used showed no significant difference (P<0.05) between the groups 
from 0 to7 doa. However, a lower antibody response was obtained in all groups 
when the antigen used in the HI test was heterologous (Q1) to the viruses used in 
the vaccination. On 14 doa, the mean HI antibody titre to the M41 was significantly 
higher (P<0.05) in group II than group I and III. Thereafter, at 28 doa, the levels of 
antibodies to M41 in group I and II were very similar and significantly higher than 
group III (P<0.05). At 21 doa, group II showed significant increase of HI antibody 
response against CR88, following revaccination with a homologous antigen. A 
similar increase was observed in group I on the same sample day. Thereafter, at 28 
doa, the HI antibody titre to CR88 antigen was overall significantly higher in group II 
(log2 8.2) than that in group I (log2 4.4) and that in group III (log2 1.8). At 21 doa, the 
titres to Q1 in groups I and II were higher compared to group III (P<0.05). At 28 doa, 
the mean HI titre to Q1 was significantly higher (P<0.05) in group II than group I 
with a mean difference of 1.2 log2. 
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Table 7.2. Geometric mean anti-IBV HI antibody titre (log2) in serum of chickens vaccinated with live H120 alone (group I) or in combination 
with CR88 (group II) at day-one.  Both groups were again vaccinated with CR88 at 14 days of age. One group (group III) was kept as control. 
Significant differences between the groups (n=5 per group) for each homologous as well as heterologous antigen for each interval are 
represented by different letters (P<0.05) 
 
 
 
 
 
HI antigen Groups  
Anti-IBV HI antibody titer (log2) (geometric mean ± standard error) at days of age 
0 4 7 14 21 28 
M41 
Group I 9.2±0.374A 8.2±0.970A 7.4±0.400A 5±0.000B 5±0.548A 4±0.447A 
Group II 9.2±0.374A 8.8±0.374A 7.4±0.400A 6.4±0.510A 5.4±0.400A 4.4±0.400A 
Group III 9.2±0.374A 7.2±0.374A 6.4±0.748A 4.8±0.200B 4±0.632A 2±0.632B 
CR88 
Group I 8.4±0.400A 7.8±0.374A 6.8±0.490A 5±0.316A 6.8±0.583 A 4.4±0.678B 
Group II 8.4±0.400A 8.4±0.245A 6.8±0.374A 5.8±0.200A 7±0.548 A 8.2±0.583A 
Group III 8.4±0.400A 7.6±0.400A 7.4±0.245A 4.6±0.600A 3.4±0.245 B 1.8±0.490C 
Q1 
Group I 7±0.316A 3±0.316A 2.4±0.245A 2.2±0.200B 4.4±0.510 A 4.4±0.510B 
Group II 7±0.316A 3±0.678A 3.4±0.400A 3.8±0.374A 5±0.548A 5.6±0.245A 
Group III 7±0.316A 3.4±0.316A 2.2±0.200A 2±0.000B 2±0.000B 2±0.000C 
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7.3.2 Mucosal humoral immune responses 
In both, groups I and II, the level of IgA in tears increased significantly (P<0.05) 
compared to control group III from 4 doa, continuing to rise until and initially 
peaking on 14 doa. In the vaccinated groups, after the second vaccination at day 
14, IgA values fell, then increased slightly again through to 28 doa, the day of 
challenge. The IgA levels in group II were significantly higher (P<0.05) than group I 
from 14 doa until 28 doa, the end of the observation period (Figure 7.2, a).  
The level of IgA in tracheal washes in both vaccinated groups was detected from 4 
doa, peaking at 7 doa before declining till 28 doa. No significant (P<0.05) difference 
in the level of IgA in tracheal washes induced by the two vaccine groups was 
observed at any doa (Figure 7.2, b). IgA levels in tears and tracheal washes of both 
vaccinated groups were significantly higher than the levels from the unvaccinated 
control group. 
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Figure 7.2. Detection of IgA production using ELISA in (a) tears (b) tracheal washes 
of chickens (n=5 per group) vaccinated with a live H120 alone (group I) or in 
combination with CR88 (group II) at day-one.  Both groups were again vaccinated 
with CR88 at 14 days of age. One group (group III) was kept as control. The IgA 
antibody levels in tears and tracheal wash from control chickens (group III) 
remained below the detectable level. Asterisks indicate values between the two 
vaccine groups were significantly different (P<0.05) on those time point. Error bars 
indicate standard error of the mean. 
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7.3.3 Systemic cell-mediated immune response 
7.3.3.1 CD4+:CD8+ ratio in peripheral blood 
Flow cytometry results showed that at 7 doa, the CD4+:CD8+ ratios were slightly 
higher in both vaccinated groups compared to that of the non-vaccinated group, 
though there was no significant difference (P<0.05) between the CD4+:CD8+ ratios 
of the vaccinated and non-vaccinated groups observed up to 14 doa (Figure 7.3).  
After the booster vaccination with the CR88 at 14 doa, the ratio of CD4+:CD8+ on 
21 doa showed slight increase in both vaccinated groups, being significantly higher 
(P<0.05) in group I compared to that of group II and III.  At 28 doa, the ratio was 
significantly higher (P<0.05) in group II compared to groups I and III. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.3. The ratio of CD4+:CD8+analyzed by flow cytometry in peripheral blood of 
chickens vaccinated with a live H120 alone (group I) or in combination with CR88 
(group II) at day-one.  Both groups were again vaccinated with CR88 at 14 days of 
age. One group (group III) was kept as control. Depicted are the mean values (n=5 
per group) and one standard error. Where values were significantly (P<0.05) 
different these are shown with different letters and all other values were not 
significantly (P<0.05) different between the groups on those time point.  
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7.3.3.2 Mucosal cell-mediated immune responses in the trachea 
The kinetics of CD4+, CD8+ and IgA-bearing B lymphocytes in the trachea were 
studied by IHC (Figure 7.4).  The number of CD4+ lymphocytes in the trachea 
increased significantly (P<0.05) from 4 doa in both vaccinated groups compared to 
the control (Figure 7.5, a). The number of CD4+ cells reached its peak at 4 doa in 
group I and at 7 doa in group II, before gradually decreasing until 14 doa. After the 
second immunization, CD4+ cells strongly increased in number by 21 doa in 
comparison to the non-vaccinated controls before declining again. The difference 
between the vaccinated groups I and II was not statistically significant (P<0.05). The 
CD8+ cells subpopulation in groups I and II started to increase significantly (P<0.05) 
at 4 doa, reaching peak at 7 doa and then declining (Figure 7.5, b).  After 
revaccination with CR88 at 14 doa, both vaccinated groups showed a strong 
increase in the number of CD8+ cells. The number of CD8+ cells were significantly 
higher in group II than group I at 21 and 28 doa (P<0.05).  Overall, the dynamics of 
the CD8+ cell subpopulations in both vaccinated groups were more dominant than 
CD4+ cells.  At 7 doa, the IgA-bearing B cells increased in vaccinated groups I and II, 
peaking at 14 doa and showing significant difference compared with the 
unvaccinated group (P<0.05). The number of IgA-bearing B cells was significantly 
higher in group II than group I at 21 doa, whereas, no significant (P<0.05) difference 
was observed between both vaccinated groups at 28 doa (Figure 7.5, c).  
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Figure 7.4. Immunohistochemical detection of CD4+ cells in group II at 28 days of 
age (A), CD8+  cells  in group II at 28 days of age (B), IgA-bearing B-cells group II at 
28 days of age (C), in tracheas of chickens vaccinated with live H120 alone (group I) 
or in combination with CR88 (group II) at day-one.  Both groups were again 
vaccinated with CR88 at 14 days of age. One group (group III) was kept as control 
(D). Magnification (400x). Arrows indicate positive cells. 
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Figure 7.5. Summary of CD4+ cells (a), CD8+ cells (b), and IgA-secreting cells (c) 
determined by immunohistochemical staining in the trachea  of chickens 
vaccinated with a live H120 alone (group I) or in combination with CR88 (group II) 
at day-one.  Both groups were again vaccinated with CR88 at 14 days of age. One 
group (group III) was kept as control. Depicted are the mean values (n=5 per group) 
and one standard error. Where values were significantly (P<0.05) different these 
are shown with different letters and all other values were not significantly (P<0.05) 
different between the groups at those time points 
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7.3.4 Protection 
After challenge, no clinical signs were observed in either vaccinated groups.  In the 
unvaccinated group, respiratory signs including as coughing, sneezing, head 
shaking, tracheal rales and nasal discharge were observed until 5 dpc. The highest 
percentage of ciliary protection (97%) was observed in group II, followed by group I 
(89.75%). The unvaccinated challenged group (group III) showed little protection 
(12%) compared to the vaccinated challenged groups. 
Viral RNA loads, in all tracheal samples collected, were significantly higher (P<0.05) 
(4.416 log REU RNA) in the unvaccinated challenged group (III) compared to the 
vaccinated groups (I and II) as measured by real time RT-qPCR, at 5 dpc. The 
vaccinated groups, I and II showed mean log REU of viral RNA of 1.016 and 0.555, 
respectively, with no significant difference between these groups (Figure 7.6).  
Overall viral RNA in the kidney samples of all the groups was low compared to 
tracheal samples. The viral RNA load in kidneys in group III was significantly higher 
(P<0.05) than in group II, whereas, group I showed no significant difference 
(P<0.05) in log REU of viral RNA with either of group II and III. 
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Figure 7.6. Quantification of infectious bronchitis virus (IBV) expressed as log REU 
of RNA, in trachea and kidney measured by real time RT-PCR after 5 dpc from 
chickens experimentally challenged at 28 days of age with Q1 strain of IBV (n=10 
per group). The chickens were previously vaccinated with a live H120 alone (group 
I) or in combination with CR88 (group II) at day-one.  Both groups were again 
vaccinated with CR88 at 14 days of age. One group (group III) kept as control 
received sterile water. Significant differences between the groups were detected by 
Kruskal-Walis test followed by Dunn’s mean test indicated with different letters 
(P<0.05). 
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7.3.5 Histopathology 
Histopathological lesions in tracheas and kidneys were induced by challenge virus 
in all the groups at 5 dpc. Marked histopathological changes occurred in group III 
(non-vaccinated group) with mean scores of 10.2 and showed significant difference 
with group II (P<0.05), but not with group I (Figure 7.7). The mean lesion scores for 
kidneys in group III was significantly higher (P<0.05) than group II, whereas, group I 
showed no significant difference (P<0.05) in mean lesion scores with either group II 
and III. However, overall mean lesion scores in kidneys were low compared to 
mean tracheal lesion scores. 
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Figure 7.7. Means of histopathological scores of lesions in trachea and kidney 
samples after 5 dpc from chickens experimentally challenged at 28 days of age with 
Q1 strain of infectious bronchitis virus (n=10 per group). The chickens were 
previously vaccinated with a live H120 alone (group I) or in combination with CR88 
(group II) at day-one.  Both groups were again vaccinated with CR88 at 14 days of 
age. One group (group III) kept as control was inoculated with sterile water. 
Significant differences between the groups were detected by Kruskal-Walis test 
followed by Dunn’s mean test indicated with different letters (P<0.05). 
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7.4 Discussion 
The vaccination regime, chosen in this study for group I, is based on the research 
demonstrating that improved protection was seen when two vaccines used were of 
different serotypes (Awad, et al., 2015; Cook JKA, 1999; Terregino, Toffan, Beato, et 
al., 2008). These researchers also emphasized that the vaccination programme 
used in their experiments may not protect the respiratory tract against challenge 
with every new IBV serotype to emerge. It is also evident that despite the use of 
Mass type vaccine at day 0, followed by 793B type vaccine at 14 doa (same as in 
group 1 in this study), significant number of new IBVs are still emerging under field 
conditions e.g. QX, IS/885/00, IS/1494/06 and most recently Q1. Therefore, in order 
to optimize the use of currently available vaccines, to achieve better immunity and 
to assess protection against newly emerged Q1 strain, the vaccination regime for 
group II was also included in this work. 
At 1-day-old, chicks had high ELISA anti-IBV antibody titres in all groups, which 
declined and dropped to below the cut-off point by 14 doa.  In the groups that 
received the vaccine at one day old, these low antibody levels could result from the 
partial neutralization of the vaccine virus in the target tissues by the maternal 
antibodies present in the broilers at that age, with a consequently low replication 
of the vaccine virus and poor stimulation of the humoral response (Davelaar & 
Kouwenhoven, 1977; Mondal & Naqi, 2001). Later, after the second vaccination at 
14 doa, an increase in the antibody titres was observed until 28 doa (day of 
challenge) in groups I and II with no significant difference in antibody levels 
between these vaccinated groups (P<0.05).  HI antibody levels declined by 14 doa 
against the homologous and heterologous virus antigens, showing similar patterns 
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to declining ELISA titres. Interestingly, by 28 doa, there was no significant 
difference between vaccinated groups I and II in terms of the level of antibodies to 
M41, whereas, the HI titres to 793B and Q1 were significantly higher in group II 
than group I (P<0.05). The role of antibody in the control of IBV infection remains 
controversial as workers have shown that circulating antibody titres did not 
correlate with protection from IBV infection (Gelb, et al., 1998; Gough & Alexander, 
1979; Raggi & Lee, 1965). However, other studies demonstrated the importance of 
humoral immunity in disease recovery and virus clearance (Thompson et al., 1997; 
Toro & Fernandez, 1994). In our study, as expected, the higher HI titres were 
obtained using antigen homologous to vaccine strains. However, the chicks also 
appeared to be protected against heterologous challenge. This could be due to the 
presence of local immunity of the upper respiratory tract, induced by vaccination 
thus reducing the replication of challenge virus.  
The role of IgA antibodies is important for mucosal immunity to IBV and its 
presence in tears following IBV antigen inoculation has been reported earlier (Cook 
et al., 1992; Toro & Fernandez, 1994). In this study, a gradual increase in IgA levels 
was observed in tears for both vaccinated groups during the first two weeks after 
vaccination. These results are in agreement with previous research reporting 
similar kinetics of lachrymal fluid IgA production to H120 vaccination (Okino, et al., 
2013; Toro et al., 1997). In addition, after the second vaccination, lachrymal IgA 
levels decreased in both vaccinated groups, though, the levels in group II remained 
significantly higher (P<0.05 ) than group I. This observation may indicate a decrease 
of lachrymal IgA levels after the second vaccination is most likely due to partial 
neutralization of the anti-IBV IgA. A sharp decrease of IgA-IBV in vaccinated chicks 
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was also observed after challenge (Davelaar, et al., 1982). In addition, no significant 
rise in specific lachrymal IgA of vaccinated chickens was detected after subsequent 
challenge with Ark-IBV isolate, explaining the probable role of neutralizing 
antibodies in the lachrymal fluid at the time of challenge (Joiner, et al., 2007). 
IBV-specific IgA can also be found in tracheal washes after an infection with strain 
of IBV M41 (Cook, et al., 1992; Thompson, et al., 1997). In this study, the pattern of 
IgA in tracheal washes in both vaccinated groups I and II was closely parallel, 
reaching peak at 7 doa and thereafter, declining till 28 doa, suggesting a short 
duration of the local humoral immunity in the trachea.  Although there have been 
conflicting reports on the relative concentrations of IgA in the avian respiratory 
tract (Chhabra & Goel, 1980; Gillette, 1981; Holmes, 1973), our results are 
consistent with Hawkes et al (1983), which showed IgA antibodies in tracheal 
washes only at day 7 after vaccination (Hawkes, et al., 1983).  Interestingly, in both 
vaccinated groups, the second vaccination did not cause any rise in tracheal IgA 
level.  Similar findings have also been reported, revealing that the revaccination 
with homologous IBV (M41 or H strains) (Gillette, 1981), and secondary M41 IBV 
exposure (Thompson, et al., 1997), did not induce the secondary secretary antibody 
response in tracheobronchial washings. 
Consistent with the notion that CMI is protective against IBV (Chubb et al., 1988; 
Seo, et al., 2000), we next sought to study the level of systemic and local cellular 
immune responses. CD4+ cells may directly produce antiviral cytokines, which 
increases B cell activity and promotes the proliferation, maturation, and functional 
activity of CD8+ CTLs, thus playing a critical role in controlling IBV infection (Raj & 
Jones, 1997a; Seo & Collisson, 1998). The ratio of CD4+:CD8+ has been widely 
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shown to be indicative of the general immune system status (Chen et al., 2011; 
Dalgaard et al., 2010). In this study, the CD4+:CD8+ ratio showed no significant 
(P<0.05) variation among the groups till 14 doa. Nevertheless, the ratio at 28 doa 
was found significantly higher (P<0.05) in group II than in groups I and III indicating 
that second vaccination at 14 day-old in group II has probably enhanced the cellular 
immunity by promoting the differentiation and proliferation of CD4+ cells in 
peripheral blood. There are no specific data regarding the effects of different IBV 
vaccination on CD4+:CD8+ ratio in peripheral blood so as to compare the present 
findings, however, Yohannes et al. (2012) have  reported significantly (P<0.05) 
higher CD4+:CD8+ ratio in IBV infected chicks than in the controls (Yohannes et al., 
2012). In addition, the high CD4+:CD8+ ratio has also been associated with 
increased humoral incompetence in chickens, as a low CD4+:CD8+ ratio and a 
reduced response against sheep red blood cells have been reported earlier 
(Dunnington EA, 1992). In this study, significantly (P<0.05) higher HI titres at 28 doa 
to 793B and Q1 in group II than those in group I may be attributed to the high 
CD4+:CD8+ ratio in group II at that time point. However, the significance of this in 
relation to protection remains to be determined. 
The results of IHC in tracheal tissue showed that the number of CD4+ lymphocytes 
started increasing from 4 doa in both vaccinated groups, as compared to the 
control. At 28 doa, no significant difference was reported between the vaccinated 
groups. The  CD8+ cells subpopulation in both vaccinated groups started to increase 
significantly (P<0.05) at 4 doa, reaching peak at 7 doa and then declining in number 
until 14 doa, suggesting that infiltration and recruitment of these cells occurs in the 
first two week of initial IBV vaccination. Similar to the findings of the present study, 
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in the trachea, CD8+ cells recruitment in response to infection were at a maximum 
by 7 days post infection (dpi) and CD4+ cells were not recruited until 5 dpi. This was 
reported by Raj & Jones (1996a). This work also showed an overall higher 
infiltration of CD8+ cells in numbers compared to CD4+ cells in both vaccinated 
groups. This observation is consistent with a previous study (Raj & Jones, 1996a), 
where CD8+ cells were also found to predominate compared to CD4+ cells in 
trachea after IBV infection. Moreover, the current study also documents 
significantly higher number of CD8+ cells in vaccinated chicks of group II compared 
to group I on 21 and 28 doa, respectively. The IgA-bearing B cells in vaccinated 
groups reached peak at 14 doa, however, the number of these cells were 
significantly higher in group II in comparison to group I at 21 and 28 doa (P<0.05). 
This pattern of recruitment of B cells later than either class of T cells is in 
accordance with earlier study (Janse, et al., 1994) who contended that local 
immunity against IBV is mediated mainly by T-cells. 
In this study, following the Q1 challenge, ciliary protection was higher in group II, 
vaccinated with mixed H120 and CR88 vaccines at day-old, than in group I, 
vaccinated at day old with H120 alone. Furthermore, the results of RT-qPCR 
showed that the viral RNA load at 5 dpc in the trachea, was higher in group I than 
group II although the difference was not statistically significant (P<0.05). In 
agreement with this, the scores of histopathology in the trachea showed that the 
damage caused by the Q1 was higher in group I than II and showed no significant 
difference in mean lesion scores with either of group II and III. On the basis of these 
tracheal histopathological assessments, chickens in group II were better protected 
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compared with those in group I and this better protection might be attributed by 
various factors including those discussed below. 
Although the anti-IBV ELISA antibody titre results indicated that there was no 
significant difference between the two vaccinated groups at the day of challenge, 
group II showed higher ciliary protection than group I. This observation is 
consistent with previous studies which have shown that circulating antibody levels 
were of minor importance in the protection of the respiratory mucosa against IBV 
challenge (Holmes, 1973; Ignjatovic & Galli, 1994).  
From our results, it appears that such overall higher protection could be due to 
significantly higher levels of CD8+ cells in the tracheal tissues in group II than group 
I at day of challenge. Previous study has shown that CD8+ cells are important 
contributors to viral clearance in respiratory virus infections, utilizing 
contact-dependent effector functions, IFN-γ and tumour necrosis factor-α (Bruder 
et al., 2006). Therefore, we may speculate that the group II’s higher CD8+ cell 
reaction than the group I could have contributed to the faster viral clearance after 
challenge with Q1, explaining the differences between the vaccinated groups  in 
their tracheal protection. This possible explanation agrees with other studies that 
emphasized the involvement of local CD8+ cells in the infection of chickens with 
respiratory pathogens, such as Newcastle disease virus (Russell et al., 1997) and 
Mycoplasma gallisepticum (Javed et al., 2005). Additionally, group II’s higher levels 
of IgA in lachrymal fluid, compared to group I, could reduce the tracheal 
histopathological damage which also corroborates the hypothesis that the 
traditional role of IgA is to prevent pathogen entry at mucosal surfaces and 
neutralize virus in infected epithelial cells (Lamm, 1997). IBV-specific IgA antibodies 
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in lachrymal fluid were correlated with resistance to IBV reinfection (Cook, et al., 
1992; Davelaar, et al., 1982; Toro & Fernandez, 1994). Our results are in agreement 
with a recent study by Okino et al (2013), in which the authors concluded that IBV 
IgA antibodies in lachrymal secretions and the expression of granzyme-A and CD8 
genes in tracheal tissues after H120 vaccination, provides a reliable approach to 
monitor immune protection status in the trachea, as shown by examination for 
ciliostatsis, histopathology and viral replication (Okino, et al., 2013). For our study, 
we aimed to stain for a variety of cell-surface markers and thereby identify the T 
cell populations infiltrating the trachea. This provides further information about the 
role of cell-mediated immunity in protection given by different live IBV vaccination 
regimes against a novel IBV Q1 challenge. 
The results of RT-qPCR and scores of histopathology in the kidneys showed that the 
damage caused by the Q1 was higher in group I than II, and showed no significant 
difference in the mean lesion scores with either of group II and III. Specific cytotoxic 
T lymphocytes have been shown to be important for the systemic clearance of 
nephropathogenic IBV and reduction of kidney lesions (Collisson, et al., 2000). A 
plausible explanation is that a higher CD8+ cells response in the tracheal tissues 
(the portal of entry of challenge virus) in group II compared to group I could have 
prevented the challenge virus becoming viraemic thus failing to reach the kidneys. 
This provided an efficient prevention of kidney infection, as measured by viral RNA 
load and histopathological lesion scores in renal tissue.  
In conclusion, chicks vaccinated with H120 and CR88 at day-old, followed by CR88 
at 14 doa, showed significantly higher CD8+ responses in the trachea and higher 
lachrymal IgA levels compared to those vaccinated with H120 alone. In terms of 
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ciliary protection against Q1, though both vaccinated groups were protected, the 
combined vaccination of H120 and CR88 of day-old chicks, followed by CR88 at 14 
doa, showed higher ciliary protection and less RNA load in trachea and kidneys, 
wherein histopathological lesions are reduced. This study highlighted the potential 
modulation of chick immune response with the use of currently available live 
vaccines so that better protection against variant IBVs can be afforded.  
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Avian infectious bronchitis virus (IBV) continues to cause serious economic losses in 
chicken production globally. Vaccination has been considered as the most reliable 
approach for controlling IBV infection (Meeusen, et al., 2007). However, current 
vaccines have proved to be poor in controlling IBV especially when new variant 
viruses have emerged (De Wit, 2000; de Wit, et al., 2011). Concurrent circulation of 
both classic and variant IBVs have been identified in most parts of the world, raising 
major challenges to global prevention and control efforts. During the past few 
decades there have been reports of new virulent field isolates that represent 
variant strains and the field cases reported until now suggest that these variants 
have wide tissue tropism and high pathogenicity (Gelb, Lunt, et al., 1991; Jackwood, 
2012; Shaw, et al., 1996; Zanella, et al., 2000). Though the mechanisms behind 
difference in susceptibility of chickens to infection by different IBVs have been 
studied and hypothesized extensively, but these are still not well understood.  
The first two studies (Chapter 3 and 4) involved the use of in vitro and ex vivo 
systems to study the host determinants of IBV pathogenicity. The role of apoptosis 
and innate immune responses was investigated in chicken embryo kidney (CEK) 
cells and tracheal organ cultures (TOCs) following infection with IS/885/00-like, QX-
like and M41 IBV strains. We noted that nephropathogenic IBV strains 885 and QX 
induced greater apoptosis in CEK cells than the respiratory tropic M41, whereas 
M41 induced higher apoptosis in TOCs than 885 and QX. Furthermore, compared to 
M41, 885 and QX caused greater induction of toll like receptor 3 (TLR3), melanoma 
differentiation associated protein 5 (MDA5) and interferon beta (IFN-β) in CEK cells.  
In contrast, M41 infection caused higher induction of these three genes than 885 or 
QX in TOCs. From these studies we concluded that higher apoptosis together with 
Chapter Eight                                                                                            General Discussion     
207 
 
elevated levels of TLR3, MDA5 and IFN-β expression correlates with pathogenicity 
of IBV strains in kidney and trachea. A recent study showed that MDA5, but not 
TLR3, is involved in the sensing of IBV (Kint, et al., 2015). It is possible that this 
difference may have been due to variation in the MOI used and origin of 
cells/TOCs. However, further work is required to understand the precise role of 
MDA5 and TLR3 in host defence against IBV infection and/or disease pathogenesis. 
More comprehensive work needs to be done to paint a clearer picture of how IBV 
regulates apoptosis during infection, since recent reports have suggested the 
possible activation of more than one apoptotic pathway during infection. 
Our findings from above studies raised a tantalizing possibility of using CEKs and 
TOCs to rapidly predict the tissue tropism and virulence of novel IBV strains. In spite 
of advantage of using in vitro model is that explants of the same animals can be 
used to compare different viral strains, for corroborating the in vitro results, the in 
vivo work (Chapter 5) was undertaken. In this study we investigated the differential 
immunopathogenesis in chickens infected with the three IBVs used in the above 
studies. It was confirmed that the histopathological changes, proinflammatory and 
innate immune gene response could be induced on a diverse scale depending on 
the IBV strain. Our results showed that greater upregulation of expression of 
proinflammatory cytokines (IL-6, IL-1β and  LITAF) and innate immune response 
genes (TLR3, MDA5 and IFN-β) was induced by M41 in trachea and 885 and QX in 
kidney. Moreover, we observed that mRNA levels of these genes correlated with 
the pattern of histopathological lesion scores in trachea and kidney produced by 
IBV strains used in this study. This has also been supported by a more recent study 
(Okino, et al., 2014) in which upregulation of expression of proinflammatory 
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cytokines such as IL-6, IL-1β, induced by the M41 strain of IBV was found to be 
partially associated in the pathological alterations in trachea of non-immune 
challenged chickens. Parallel with our findings, previous studies also reported a 
significant increase of TLR3 mRNA expression in trachea of IBV infected chickens 
when compared to the uninfected controls (Kameka, et al., 2014; Wang, et al., 
2006). Also MDA5 mRNA expression levels were reported to be significantly 
increased in chicken kidney tissue after nephropathogenic IBV infection suggesting 
a role of chicken MDA5 against IBV infection (Cong, et al., 2013).   
The present results about correlation of innate immune response genes (TLR3, 
MDA5 and IFN-β) expression with the tracheal and kidney pathology in chickens 
infected with different IBVs further confirm our in vitro work findings. In spite of 
our work on the evaluation of differential modulation of PRRs (TLR and MDA5), 
type I IFNs, and pro-inflammatory cytokine mRNA expression in chickens in 
response to different virulent IBV strain, analysis of expression of these molecules 
may not be sufficient to completely understand the IBV immunologic mechanisms. 
Further studies may employ these findings to understand the underlying 
mechanism of natural host’s response to different attenuated IBV strains as well as 
in context of vaccine induced immune responses and protection against challenge 
with virulent IBVs. For almost two decades IBV 793B has been associated with 
disease and for most of that period one or more live 793B vaccines have been in 
use (Cook, et al., 1996; Martin, et al., 2014). The persistence of such 793B is of 
concern and challenges our ability to both diagnose and control it. Therefore, 
better understanding of immunopathogenesis needs to be developed for an 
effective control of diseases caused by virus. In chapter 6 we comprehensively 
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evaluated the immunopathogenesis after 793B infection either in vitro or in vivo. It 
has been found that in vitro higher apoptosis together with elevated levels of TLR3, 
MDA5 and IFN-β expression correlated with in vivo pathogenicity of 793B in trachea 
and kidney. In addition, the higher upregulation of expression of proinflammatory 
cytokines (such as IL-6 and IL-1β) and LITAF in trachea and kidney of SPF chicks 
coincided with the highest viral loads and microscopic tracheal lesions, indicating a 
role for both of these cytokines with high virus loads and the development of 
lesions in these organs. In contrary, most recent studies showed that MDA5, but 
not TLR3, is involved in the sensing of IBV (Kint, et al., 2015). Furthermore, no 
significant changes in TLR3 expression were observed in kidney following infection 
with attenuated CK/CH/LHLJ/04V strain, which could be due to the use of different 
strains of virus (Xu, et al., 2015).  Future studies should be performed to further 
characterize the role of TLR3 during the IBV infection in chickens. 
In the past two decades the majority of the serotypes/genotypes of IBV that have 
emerged appear to be endemic (Bochkov, et al., 2006) and this constant 
emergence of variant strains of virus poses a serious threat to health, production 
and welfare of birds. IBV genotype, Q1, which is genetically and serologically 
distinct from the classical IBVs, was first time reported in China (Yu, et al., 2001). 
Since its identification, Q1 has been reported from many parts of world such as the 
Middle East (Ababneh, et al., 2012), Europe (Toffan, et al., 2011) and South America 
(Jackwood, 2012). To contain this strain, an effective vaccination programme is 
needed. However, very little is known about the cross protection induced by the 
commercially available vaccines or vaccination regimes against this variant Q1. In 
addition, the kinetics of, and the relationship between local and systemic humoral 
Chapter Eight                                                                                            General Discussion     
210 
 
and cell mediated immune responses induced by different IBV vaccination regimes, 
needs to be better understood for protection against emerging IBV strains. 
Therefore, in Chapter 7, day-old broiler chicks were vaccinated with live H120 alone 
(Group I) or in combination with CR88 (Group II).  Both groups were again 
vaccinated with CR88 at 14 days of age (doa). One group was kept as the control 
(Group III). At 28 doa, all the groups were challenged with Q1. 
After the second vaccination at 14 doa, an increase in the antibody titres using 
ELISA was observed until 28 doa (day of challenge) in groups I and II with no 
significant difference in antibody levels between these vaccinated groups (P<0.05).    
The cytotoxic T cell response in the tracheal tissues and level of IgA in lachrymal 
fluid were significantly higher in the group vaccinated with H120 and CR88 at 
day-old followed by CR88 at 14 doa (Group II) in comparison to the group 
vaccinated with H120 alone at day-old followed by CR88 at 14 doa (Group I). 
Combined vaccination of H120 and CR88 of day-old chicks followed by CR88 at 14 
doa (Group II) showed higher protection against Q1 owing to higher cytotoxic T cell 
response in the tracheal tissues and a high level of IgA in lachrymal fluid. This study 
shows the benefits of assessing local and cellular immune response besides serum 
antibodies in IBV vaccination-challenge studies. Taking the above into account, the 
future studies should be performed on the activity of CMI, such as the measuring 
the cytotoxic mechanism of CTLs. In addition, our study confirms the suitability of 
measuring the viral load in trachea and kidney by qRT-PCR for evaluating the 
efficacy of vaccines by challenge infection. 
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Essentially, the findings of the studies presented here shed some light on the 
importance of in vitro and in vivo comparison of virulence, immunopathogenesis 
and protection study involving variant IBVs. The data set we have produced in 
chapters 5 and 6 were obtained from SPF chicks without maternally derived 
antibodies. These data may have further implications for a better understanding of 
IBV immunopathogenesis if further in-depth studies are undertaken using 
commercial broilers and SPF chicks with maternally derived antibodies. Our results 
have been published in scientific journal and presented in national and 
international conferences.  
In spite of the novel aspect our work on the evaluation of differential modulation 
innate immune mediators in response to IBV infection in vivo as well as in vitro, 
analysis of expression of these molecules may not allow complete understanding of 
IBV immunological mechanisms. One major characteristic of IBV virions is the high 
variability of the S1 subunit resulting in the occurrence of new strains. Most 
serotypes differ as much as by 20-25% from each other in their S1 sequence but 
some serotypes show a difference of 50% (Cavanagh, 2007). Because of the high 
diversity in the different S1 sequences, understanding the molecular mechanism of 
IBV pathogenicity and the relation of IBV to host is a key point in IBV control. 
Further studies are needed to identify the role of these viral proteins responsible 
for mediating the differential host innate responses against different IBVs and the 
cellular source of innate mediators produced in the target organs. 
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Phosphate buffered saline (PBS) 
NaCl                                                                                                                  85.0 g                                                       
Di-sodium hydrogen orthophosphate (Na2HPO4)                                              10.7 g   
                      
Sodium dihydrogen orthophosphate (NaH2PO4.2H2O)                                3.90  g  
                       
Made up to 1 litre with sterile distilled water 
 
0.02% EDTA (Ethylenedinitrilo)-tetraacetic acid, Dipotassium salt)   in PBS 
EDTA                      0.1 g  
PBS                         500 ml 
Trypsin solution 0.25% 
0.02% EDTA                90 ml 
Trypsin54 2.5%                10 ml  
Stock antibiotic solution 
Crystapen55                                                                                                                    600 mg                                                                                                                      
Streptomycin sulphate BP 56                                                                                           1.0 g                                                                                               
Sterile distilled water                                                                                                       4 ml                                                                                                            
4ml of this stock solution was added to 1000 ml of medium for a 1x solution. For 
preparing 10x antibiotic medium, 4ml was added to 100ml of medium. 
 
 
 
 
                                                          
54
 Life Technology, UK 
55
 Glaxo, Greenford, UK 
56
 Evans Medical, Greenford, UK 
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Growth medium for CEK cells 
10x Minimum Essential Medium-Eagles57                                                          100 ml   
7.5% Sodium bicarbonate58                                                                                           20 ml                                                                                                
Penicillin-streptomycin solution                                                                                      4 ml   
L-glutamine 200 mM59               
10 ml 
Fetal bovine serum60                                                                                                         5 ml 
Sterile distilled water                                                                                  to make 1000 ml                                                                                                 
TOC culture medium  
10x Minimum Essential Medium-Eagles 61                                                              100 ml                                                                
7.5% sodium bicarbonate                                                                                              20 ml                                                                                                
Sterile distilled water                                                                                                    900 ml                                                                                                 
Penicillin-streptomycin solution                                                                                     4 ml                                                                                      
HEPES buffer  
HEPES 62                                                                                                                            2.95 g                                                                                                                        
NaCl                                                                                                                                   4.09 g                                                                                                                                
CaCl2 
                                                                                                                                 0.08 g                                                                                                                             
Add sterile distilled water to 500ml distilled water, pH adjusted to 6.5 with 1N 
NaOH 
 
                                                          
57
 Life Technology, UK                                                      
58 Life Technology, UK 
59 Sigma-Aldrich, UK 
60 Sigma-Aldrich, UK 
61 Life Technologies, UK                                                      
62 Life Technologies, UK                                                      
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Tris-buffer saline (TBS) 
Tris63                 6.05 g    
NaCl                                                                                                                                  8.76 g    
Sterile distilled water                                                                                                  800 ml                                                                                                 
Adjust pH to 7.5 with 1M HCl and make volume to 1000 ml using distilled water 
cDNA synthesis reaction mixture I64 
Random hexamers                   1 μl 
10mM dNTP mix                                           1 μl 
diethyl-pyrocarbonate (DEPC) treated water        to 10 μl 
cDNA synthesis mix65 
10X RT buffer                    2 μl 
25 mM MgCl2                                                                       4 μl 
0.1 M DTT                   2 μl 
RNasrOUT (40U/μl)                                      1 μl 
Superscript III (200 U/µl)                                         1 µl         
 
 
 
 
 
 
                                                          
63
 Sigma-Aldrich, UK 
64 Invitrogen, Paisley, Scotland 
65 Invitrogen, Paisley, Scotland 
Appendix I     
243 
 
Quantitative reverse transcription PCR (qRT-PCR) reaction mixture 
10x Tris-borate-EDTA (TBE)68 
This was purchased at 10X concentration and diluted to1X concentration when 
required.               
 Oligos69 for RT-PCR 
Oligos received were reconstituted as per manufacturer’s instructions. The stock 
oligos were diluted to 1:10 to make working solutions  
Working Oligo             Stock Oligo                               Sigma Water                  
SX4-        10µl                                   90 µl                                             
       A      B 
SX1+    10 µl    10 µl                                  80 µl                                                                                
SX2-    10 µl   10 µl                                  80 µl    
SX3+    10 µl    10 µl                                                           80 µl                                               
 
 
 
                                                          
66
 Qiagen, UK 
67 Qiagen, UK 
68 Sigma-Aldrich, UK 
69 Invitrogen, Paisley, Scotland 
2x Rotor Gene probe66 12.5  µl         
IBVRT1  2 µl         
IBVRT2  2 µl         
IBVRT3 TaqMan® probe 0.5 µl         
Rotor-Gene RT Mix67 0.25  µl         
RNase-free water 5.75  µl         
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10mM dNTP’s Working Solution 
dATP, dCTP, dGTP, dTTP at 100mM70  
Take 20µl of each dNTP, total volume 80µl 
Add 120µl of sigma water to give 200µl of 10mM dNTP’s 
RT-PCR reaction mixture 
5X Buffer71                                                                                                                      1 µl                     
DTT                                                                                                                                     0.5 µl                 
dNTP                                                                                                                                   0.25 µl                      
Ultra-pure Water                                                                                                           2.13 µl                      
RNase inhibitor                                     0.12 µl                                                                                                                 
Superscript II (200 U/ µl)72                                                                                           0.25 µl                                                                            
Negative Oligo (10 pmoles/µl) (SX2-)           0.75 µl                                                                                                                                           
Nested PCR 1 reaction 
PCR Supermix 73                                                                                                                19 µl                                   
SX1+                                                                              0.5 µl                                                        
SX 2-                                                                    0.5 µl                                                              
Nested PCR 2 reaction  
 PCR Supermix                                                                                                                23.5 µl                                                                                                               
SX3+                 0.5 µl                                                                              
SX 4-                                                                               0.5 µl 
 
                                                          
70
 Invitrogen, Paisley, Scotland 
71 Invitrogen, Paisley, Scotland 
72 Invitrogen, Paisley, Scotland 
73 Invitrogen, Paisley, Scotland 
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Loading Buffer  
Ficol                                                                                                                                         3 g                                                                                                                                       
1XTBE                                                                                                                                 20 ml                                                                                                                                 
Gel preparation 
1.5% agarose74                                                                0.58 g 
TBE                                                                                                                                     35 ml
   
4% Paraformaldehyde (PFA)  
For 250 ml: 
1. Weigh out 10 g Paraformaldehyde (wear mask) into suitable bottle/flask 
2. Add approximately 200 ml 1xPBS 
3. Heat solution on stirring hotplate to 60°C (do in fume hood as noxious 
fumes), if solution has not fully dissolved add a few drops of 1M NaOH 
(solution won’t dissolve if not at correct pH) 
4. Cool solution, check pH is 7.2-7.4 
5. Top up to final volume of 250 ml with 1x PBS 
6. 4% PFA can be stored for up to 1 month, room temperature 
 
 
 
                                              
                                                          
74
 Sigma-Aldrich, UK 
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RNeasy® Mini Kit for total RNA extraction 
Before start 
 Equilibrate all buffers to room temperature 
 Remove tissues from RNAlater®  to stabilize  
 Add 10 µl of β-mercaptoethanol (β-ME) to 10 ml of RLT buffer (can be 
stored at room temperature up to 1 month) 
 Add 4 volumes of ethanol (96-100%) to RPE buffer to make a working 
solution. 
Protocol 
1. To the harvested cells or tissues (≤30 mg), add 600 µl of prepared RLT buffer 
containing β-ME into 2 ml Eppendorf tube 
2. Disrupt and homogenize the tissue using stainless steel beads in a 
TissueLyser75 
3. Centrifuge the lysate at 13000 rpm for 3 min, carefully remove the 
supernatant into a clear 1.5 ml Eppendorf tubes 
4. To this, add 1 volume of 70% ethanol and mix well by pipetting 
5. Transfer up to 700 µl of the sample, including any precipitate, to an RNeasy 
Mini spin column placed in 2 ml collection tube 
6. Centrifuge at 8000 rpm for 15 s, discard flow through 
7. Add 700 µl of buffer RW1 to the spin column 
8. Centrifuge at 8000 rpm for 15 s, discard flow through 
9. Add 500 µl of buffer RPE (working solution) to the spin column 
                                                          
75
 QIAGEN, UK 
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10. Centrifuge at 8000 rpm for 15 s, discard flow through 
11. Add 500 µl of buffer RPE (working solution) to the spin column 
12. Centrifuge at 8000 rpm for 2 min, discard flow through 
13. Place the spin column in a new 1.5 ml collection tube and add 30 µl of 
RNase-free water directly to the spin column 
14. Centrifuge at 8000 rpm for 1 min to elute the RNA 
15. Store RNA at -70oC 
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QlAamp viral RNA extraction 
Equilibrate samples and buffers to RT 
Before start 
 Equilibrate samples and all buffers to room temperature 
 Add 310 µl Buffer AVE into the tube containing 310 µg lyophilized carrier 
RNA 
 Mix the carrier RNA completely  
 For extracting RNA from 55 samples, add the 310 µl reconstituted carrier 
RNA to 31ml buffer AVL (stable at refrigeration temperature for 48 hours) 
 Before use of buffer AVL, look out for precipitation.  If there is any 
precipitation, heat the buffer AVL at 80oC for no more than 5 min (but not 
more than 6 times) 
Protocol 
1. To 140 µl of sample, add 560 µl of buffer AVL containing carrier RNA into 1.5 
ml Eppendorf tube 
2. Vortex for 15 sec 
3. Incubate at room temperature for 10 min 
4. Pulse centrifuge  
5. Add 560 µl of 100% ethanol 
6. Vortex for 15 sec 
7. Pulse centrifuge 
8. Label the spin columns 
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9. Carefully transfer 630 µl from tube into spin column 
10. Centrifuge at 8000 rpm for 1 min, discard flow through 
11. Place spin column into a clean collection tube and add 500 µl of buffer AW1 
12. Centrifuge at 8000 rpm for 1min, discard flow through 
13. Place the spin column into a clean collection tube add 500 µl of buffer AW2 
14. Centrifuge at 13,000 rpm for 3 min, discard flow through 
15. Place the spin column into a clean 1.5 ml Eppendorf tube and add 60 µl of 
RNase-free water  
16. Incubate the spin column at room temperature for 1 min 
17. Centrifuge at 8000 rpm for 1min to elute the RNA 
18. Store RNA at -70oC 
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Haemagglutination inhibition test 
HA test for preparation of 4 HA antigen 
1. Add 25 µl of PBS to each well of a U-bottom micro-titre plate. 
2. Add 25 µl of virus antigen to the first well. 
3. Make two fold dilutions of 25 µl of the virus antigen across the plate, 
discard final 25 µl. 
4. Add a further 25 µl of PBS to each well (total volume 50 µl) 
5. Add 25 µl of 1% (v/v) chicken RBC’s to each well (total volume 75 µl). 
6. Mix by gently tapping and leave for 40-60 min at room temperature or till 
control RBC’s settled to a distinct button. 
7. HA is easily determined by tilting the plate to observe the presence of tear 
shaped streaming of the RBC’s. 
8. HA titre is the one before the tear drop where complete HA (no streaming) 
occurs. 
9. Calculate 4 HA units for HI test. 
Haemagglutination Inhibition Test (HI) 
1. Column1 of each plate is for controls 
a. RBC control: 50 µl of PBS + 25 µl of RBC’s  
b. Virus control:  25µl PBS + 25 µl antigen + 25 µl RBC  
2. Add 25 µl of PBS to each well of a U-bottom micro-titre plate in Column 2 
3. Add 25 µl of antiserum all wells in Column 2 
4. Make two fold dilutions of 25 µl of the virus antigen across the plate, 
discard final 25 µl 
5. Add 25 µl of 4 HA antigen to all wells 
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6. Incubate at room temperature for 30 min 
7. Add 25 µl RBC’s to all wells 
8. Mix by gently tapping and leave for 40-60 min at room temperature 
9. HI is easily determined by tilting the plate to observe the presence of tear 
shaped streaming of the RBC’s 
10. The HI titres is the reciprocal of the highest dilution showing complete 
inhibition and the HI geometric mean titres expressed as reciprocal log
2
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Appendix II 
(Data collection sheets) 
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Result sheet for IBV clinical signs 
 
Group................. 
Date Day dpi Comments  
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Multiwall data sheet ELISA or HI 
 
 
1 2 3 4 5 6 7 8 9 10 11 12 
A             
B             
C             
D             
E             
F             
G             
H             
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Result sheet for counting apoptotic cells in TOC rings by TUNEL assay 
 
Group…………….Time point ………… 
 
Field 
Number of Tracheal ring 
1 2 3 4 5 
1      
2      
3      
4      
5      
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Sheet for histopathological lesions scoring for trachea 
 
 
 
 
 
Lesion of 
trachea  
Days post infection 
1 3 7 9 14 
Groups 
A B A B A B A B A B 
Epithelial 
deciliation 
          
Epithelial 
degeneration  
          
Decrease 
mucous cells 
          
Heterophil 
infiltration  
          
Epithelial 
hyperplasia 
          
Lymphoid 
infiltration  
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Sheet for histopathological lesions scoring for kidney 
 
 
 
 
Lesion of 
kidney  
Days post infection 
1 3 7 9 14 
Groups 
A B A B A B A B A B 
Epithelial 
degeneration 
          
Ducto-
tubular 
dilation 
          
Heterophil 
infiltration 
          
Lymphoid 
infiltration 
          
Epithelial 
regeneration 
          
Epithelial 
hyperplasia 
          
Lymphoid  
nodules 
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Result sheet for IHC data 
 
Group…………….Time point ………… 
 
Flied 
Number of birds (Tracheal ring) 
1 2 3 4 5 
1      
2      
3      
4      
5      
 
 
 
 
 
 
 
 
 
 
 
 
Appendix II     
259 
 
 
 
Result sheet for ciliostatsis test 
 
        Group................ 
  
Ring 
No 
B1 B2 B3 B4 B5 B6 B7 B8 B9 B10 
1 
 
          
2 
 
          
3 
 
          
4 
 
          
5 
 
          
6 
 
          
7 
 
          
8 
 
          
9 
 
 
         
10 
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Appendix III 
(Published manuscripts) 
 
 
 
 
 
